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Abstract 
Bioactive glasses undergo dynamic changes in vivo to produce an apatite 
layer permitting a strong bond with living tissues including both bone and 
soft tissues, and their compositions can be modified and tailored. The aim 
of this project was to generate high phosphate low fluoride containing 
bioactive glasses and explore their bioactivity and biological performances 
in vitro.  
Bioactive glasses (0-7% F- content, constant 6.33% P2O5 in Mol.%) were 
produced and the particles immersed in Tris Buffer solution or cell culture 
medium (α-MEM) to determine apatite formation and ion (Ca, P, Si and F) 
release. Bioactive glass conditioned medium was used to treat pre-
osteoblasts MC3T3-E1 for cytotoxicity, pre-osteogenic and pro-angiogenic 
responses, and to human oral fibroblasts and epithelial cells for 
proliferation. Antibacterial ability was explored by incubating supra- and 
sub-gingival bacteria with bioactive glass particulates.  
Rapid apatite formation was observed in F- containing bioactive glasses 
after only 2 h immersion in Tris buffer solution, while it was not detectable 
until 72 h in the F- free bioactive glass. Alkaline phosphatase activity, cell 
number, collagen formation, bone-like mineral nodules and osteogenic 
gene expression of MC3T3-E1 cells were significantly promoted in low F- 
bioactive glass (P6.33F1) conditioned medium. MC3T3-E1 VEGF gene 
expression was increased, and protein production was dose-dependently 
promoted with F- containing bioactive glass conditioned medium, which 
also promoted human oral fibroblast proliferation, but suppressed 
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epithelial cell numbers. After incubation with glass particulates, the growth 
of L. casei, S. mitis, A. actinomycetemcomitans and P. gingivalis, was 
significantly inhibited; the antibacterial activity being dependent on the F- 
content of the bioactive glasses.  
As a potential bone graft substitute in vivo, such novel bioactive glasses 
would be expected to stimulate bone formation and overcome problems 
associated with infection and the poor vascularisation in large bone graft 
sites. Additionally, they could reduce the need for further clinical 
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Chapter 1 Literature review  
 
For clarity, the literature reviewed in this thesis is organized from four 
parts to reflect the structure as well as rationale of this project. Part one 
provides the background information of periodontium, including soft and 
hard tissues. Literature presented in parts two and three provides the 
knowledge of periodontitis pathogenesis and periodontal regeneration. In 
summary, the above three sections describe the biological basis of bone 
grafts for periodontal defective bone repair, as well as rationale for the 
experimental chapters. Finally, part four focuses on the theory of bioactive 
glass. Specifically, the effects of phosphate and fluoride on bioactive glass 
structure and bioactivity as well as effects on bone biology are discussed.  
1.1 Periodontium 
As depicted in Fig. 1.1, the healthy periodontium comprises gingiva 
(overlaying epithelium and underlying connective tissues), periodontal 
ligament (PDL), cementum and alveolar bone (Nanci and Bosshardt, 
2006). A healthy periodontium can provide tissue seals at the cervical 
portion of teeth, preserve the position of teeth inside the alveolar socket of 
maxilla and mandible, provide support to the teeth during mastication and 
protect the dentin and provide nourishment to teeth (Nanci and Bosshardt, 
2006).  
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Gingiva is made up by overlying epithelium (defined as junctional, sulcular 
and mucogingival epithelium depends on their sites) and the underlying 
gingival fibres (connective tissues).  
The oral gingival epithelium is the lining of the oral cavity surface being 
subject to wear and tear, with a deeper lamina propria (connective tissue) 
underneath and a basement membrane in–between (Fig. 1.2A). 
Histologically, oral gingival epithelium is stratified and consisted of four 
layers, from the bottom to superficial, namely the stratum basal (basal 
layer), stratum spinosum (prickle cell layer), stratum granulosum (granular 
layer) and the stratum corneum as shown in Fig. 1.2B.  
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Figure 1.2  Schematic illustration of the oral mucosa layers  
1: Stratum basal 
2: Stratum spinosum 
3: Stratum granulosum 
4: Stratum corneum 
(Adapted from: http://meddic.jp/lamina_propria_mucosae  
and http://am-medicine.com/2014/07/oral-potentially-malignant-disorders.html ) 
 
Epithelial cells, the predominant cells in epithelium, are metabolically 
active and able to react to external stimulus by producing numerous 
cytokines, adhesion molecules, growth factors and enzymes. More 
importantly, they can generate a family of potent antimicrobial peptides for 
immunity protection against bacterial infection (Bartold et al., 2000). Other 
cells such as, Langerhans cells, melanocytes and Merkel cells also can be 
found in the basal layer of epithelium to provide immunity protection and 
Merkel cells form epidermal complexes named Merkel cell–neurite, which 
is considered to be involved in mechano-perception (Bartold et al., 2000, 
Horch et al., 1974).  
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Based on the location and composition, oral gingival epithelium can be 
categorized into three different types. Firstly, the mucogingival epithelium 
is continuous from the mucogingival junction to the gingival crest. Then, 
extending from the tip of gingival crest to cover the lateral wall of the 
sulcus is the sulcular epithelium (Schupbach and Glauser, 2007). 
Junctional epithelium is enclosed from the bottom of the gingival sulcus to 
the alveolar bone crest and provides the junction between the gingiva and 
the tooth by an epithelial attachment, which is a structural complex 
consisting of a basal lamina-like structure that is adherent to the tooth 
surface by hemi-desmosomes of the superficial cell layer (Nanci and 
Bosshardt, 2006). This structure forms an efficient barrier against 
periodontal pathogens and their products. It also acts as an important 
initiator, regulator and mediator of the host immune response against 
bacteria (Bartold et al., 2000). 
Epithelium has a notable capacity to regenerate following injury. Within 
hours of gingival injury, epithelial cells from the wound margins commence 
migration to cover the exposed connective tissue surface under locally 
released stimulation factors such as epidermal growth factor, platelet-
derived growth factor A and B, fibronectin and other cytokines (Green et 
al., 1997). Epithelial migration will continue along the surface of tooth root 
until collagen fibres are encountered, which is called epithelialization and 
explains the formation of a ‘‘long junctional epithelium’’ (Bartold et al., 
2000). As epithelium migrates at a much faster rate than the formation of 
new connective tissue attachment to the root surface, excluding or 
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delaying rapid re-epithelialization forms an essential requirement to 
achieve periodontal regeneration.  
The gingival connective tissue, also known as lamina propria, is 
underlying epithelium and consisting largely of collagen fibres (about 60% 
by volume), fibroblasts (5%), vessels, nerves, and matrix (about 35%) 
(Vignoletti et al., 2014, Newman et al., 2011). Type I collagen is the main 
collagen and preferentially organized into denser fibrils to provide the 
tensile strength to the gingival tissue, while type III collagen appears to be 
preferentially localized as thinner fibres in a reticular pattern near the 
basement membrane. Fibronectin, osteonectin, vitronectin, elastin and 
tenascin are also distributed throughout the gingival connective tissues 
(Steffensen et al., 1992).  
Fibroblasts of mesenchymal origin play a major role in the development, 
maintenance and repair of gingival connective tissues. Their principal 
function is to synthesize and maintain the extracellular matrix components 
of the connective tissue. Fibroblasts are sensitive to changes in the local 
environment and will respond to a variety of stimuli, either endogenous 
(such as growth factors, cytokines and other inflammatory mediators), or 
exogenous (such as bacterial challenges and mechanical forces) (Bartold 
et al., 2000). Macrophages, mast cell, endothelial cells, 
polymorphonuclear leucocytes, lymphocytes and plasma cells are also 
present in this connective tissue. 
The gingival connective tissue serves primarily to protect the tooth root 
surface and alveolar bone from the external oral environment. In addition, 
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it aids in the support and fixation of teeth within their alveolar housing and 
provides adequate support for the epithelial tissues.  
 Periodontal ligament 1.1.2
The periodontal ligament (PDL) is a specific connective tissue, which is 
highly cellular and vascular, situated between the cementum covering the 
tooth root and the bone that forms the socket wall (Nanci and Bosshardt, 
2006). It is primarily composed of bundles of Type I collagen fibres namely 
alveolar crest fibres, horizontal fibres, oblique fibres, periapical fibres and 
interradicular fibres, according to their anatomic locations. The PDL is a 
physically small, but functionally important tissue. It forms a meshwork of 
interconnected fibres rather than a stretch cable-like form to support the 
teeth in their sockets and at the same time to permit them to withstand the 
considerable forces of mastication. It has the capacity to act as a sensory 
receptor necessary for the proper positioning of the jaws during 
mastication and the feelings such as pain and pressure and also to 
provide nutrition to the bone and the cementum (Bartold et al., 2000). In 
addition, the PDL is also a cell reservoir to permit tissue homeostasis, 
repair, and regeneration. Besides the principle fibroblasts, other cells 
including osteoblasts, osteoclasts, epithelial cells, rests of malassez, 
monocytes and macrophages, undifferentiated mesenchymal cells, 
cementoblasts and odontoclasts are also present (Nanci and Bosshardt, 
2006).  
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 Cementum 1.1.3
Anatomically, cementum is an integral part of the tooth firmly attached to 
the radicular dentin, however, it is a functional component of the 
periodontium (Grzesik and Narayanan, 2002). The main function is to 
serve as the site of attachment for PDL to the root surface (Bosshardt and 
Selvig, 1997). The composition of cementum is considered similar to that 
of bone (Saygin et al., 2000). It comprises approximately 45-50% 
inorganic matrix in which mainly hydroxyapatite and 50-55% organic 
component including collagen and non-collagenous proteins such as Type 
I collagen, bone sialoprotein and osteopontin (Saygin et al., 2000). 
Cementoblasts, cementoclasts and fibroblasts are found in cementum and 
responsible for the cementum formation while the regeneration of 
cementum in periodontal defects can be achieved by cells originating from 
the PDL. 
      
 Alveolar bone 1.1.4
Alveolar bone provides primary support for the teeth and constantly 
undergoes remodelling depending on functional stimuli. The 
macrostructure of alveolar bone can be considered as the thickened inner 
and outer dense cortical plate with less dense trabecular bone 
sandwiched in between. There are numerous small canals in the alveolar 
walls through which vessel and nerve branches can enter to supply teeth. 
Like other bones, alveolar bone also consists of bone matrix and bone 
cells. 
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 Bone cells 1.1.4.1
There are three distinct types of bone cells: the matrix producing 
osteoblasts, tissue resorbing osteoclasts and osteocytes.  
Osteoblasts, responsible for the synthesis and secretion of bone matrix, 
with characteristic morphology of protein synthesizing cells, including 
abundant rough endoplasmic reticulum and prominent Golgi apparatus, as 
well as various secretory vesicles (Florencio-Silva et al., 2015). Thus, they 
can regulate the mineralization process such as synthesizing tightly 
packed collagen to provide lattices for the growth of hydroxyapatite 
crystals (Kirsch, 2012). They also secrete a number of proteins such as 
osteocalcin, osteopotin and bone sialoprotein linked to the mineralization 
and maturation of bone matrix (Florencio-Silva et al., 2015).  
Osteocytes are non-proliferative, terminally differentiated cells of the 
osteoblast lineage and reside within the bone matrix and in newly formed 
osteoid (Noble, 2008). They are distributed throughout the bone matrix 
and extensively interconnected, thus, osteocytes probably sense bone 
deformation and regulate osteoclast/osteoblast functions through 
mechanosensor action (Seeman and Delmas, 2006, Bonewald and 
Johnson, 2008).  
Osteoclasts are derived from monocyte lineage cells and attracted to bone 
surfaces to fuse and form multinucleated cells to complete bone resorption 
(Boyce, 2013). Osteoclasts also play other roles, such as, they can 
regulate osteoblast precursors differentiation and, drive the hematopoietic 
stem cells move from the bone marrow to the bloodstream; they are also 
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involved in immune responses including cytokine secretion to affect their 
own functions and other cells in inflammatory and neoplastic processes 
affecting bone (Boyce et al., 2009). 
 Bone matrix 1.1.4.2
Organic component: 
The organic matrix of bone, gives tensile strength, is secreted by 
osteoblasts and constitutes about 10% bone volume (Posner and Beebe, 
1975). It mainly consists of collagenous proteins (up to 85-90%), which 
are predominantly type I collagen and some type III and V collagens 
(Clarke, 2008). The organic matrix also contains some non-collagenous 
proteins including proteoglycans, glycosylated proteins and other growth 
factors such as bone morphogenic proteins, osteocalcin, osteonectin, and 
bone sialoprotein, which contribute in bone mineralization, and 
remodelling (Buck and Dumanian, 2012).  
Inorganic component: 
The inorganic bone matrix, constitutes 90% of overall bone volume, gives 
stiffness to resist compression and, is considered to be the main mineral 
store in humans. It contains 99% of the body’s calcium, 85% of the 
phosphorous and 40-60% of the magnesium and sodium (Buck and 
Dumanian, 2012). Hydroxyapatite [Ca10(PO4)6(OH)2] is the main 
component in inorganic matrix, with small amounts of carbonate, 
magnesium and acid phosphate (Clarke, 2008).  
Bone remodelling is a dynamic process involving continuous removal of 
discrete packets of old bone, replacement of these packets with newly 
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synthesized matrix, and subsequent mineralization of the matrix to form 
new bone (Kini and Nandeesh, 2012). It is dominated by osteoclasts and 
osteoblasts to maintain normal physiological structure and mineral content 
(Das and Crockett, 2013). The bone remodelling process is composed of 
four sequential phases, named osteoclast activation, bone resorption, 
reversal phase and new bone formation, in which the remodelling sites 
may develop randomly but also are targeted to areas that require repair 















33 | P a g e  
 
1.2 Periodontitis 
Periodontitis is defined by the American Academy of Periodontology (AAP) 
as ‘Inflammation of the supporting tissues of the teeth. Usually, it is a 
progressively destructive change leading to loss of bone and periodontal 
ligament. It is an extension of inflammation from gingiva into the adjacent 
bone and ligament’ (Barbato et al., 2015). Up to 15% of adults in the UK 
are estimated to have severe periodontitis, with different degrees of bone 
loss needing treatment (NRAS, 2014). In the FY2003 Fact Sheet, the 
American Association for Dental Research reports that ‘48% of adults 
aged 35 – 44 years of age have inflammation of the gingiva (gingivitis), 
and 22% destructive periodontal disease – a major cause of tooth loss’ 
(Nanci and Bosshardt, 2006).  
As depicted in Fig. 1.3 below, periodontitis causes irreversible damage to 
the supporting tissues and affects all parts of the periodontium including 
the gingiva, PDL, cementum and alveolar bone. This eventually leads to 
the loss of teeth (Bostanci and Belibasakis, 2012).  
 
Figure 1.3  Schematic representation of periodontitis. 
(Taken from: http://www.streetlanedentalimplants.co.uk/gumdisease.html ) 
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Periodontitis can be classified into chronic and aggressive periodontitis 
(Armitage, 2004). Chronic periodontitis is the most common form with the 
following characteristics: prevalence mainly in adults; slow to moderate 
progression rate of periodontium destruction; major role of local factors 
such as plaque; smoking and emotional stress can also affect the disease 
characteristics; association with systemic diseases such as diabetes. 
Aggressive periodontitis occurs in a severe and rapidly progressing form 
and most often affects young adults aged 25-30 years old. It particularly 
affects first molars and incisors with rapid loss of clinical attachment and 
bone destruction and lacks of association with systemic diseases (Brigido 
et al., 2014, Dentino et al., 2013).   
In periodontitis, the initiation and progression of periodontium destruction 
is related to the presence and development of a subgingival biofilm 
containing specific bacteria and the major pathogens including 
Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) and 
Porphyromonas gingivalis (P. gingivalis) have been identified (Algate et al., 
2015, Dentino et al., 2013). The severity and progression of periodontitis 
is also influenced by host factors such as genetics and oral hygiene, 
together with environmental factors such as smoking and diet (Jonasson 
and Rythen, 2016, Page et al., 1997).  
A strong correlation has been established between P. gingivalis and 
periodontal disease activity in adults (Duncan, 2003). As a keystone 
pathogen for periodontitis, this Gram-negative anaerobe species is a late 
colonizer in bacterial plaque, however, it can rapidly and actively invade 
gingival sulcus epithelial cells, and potentially the underlying soft and hard 
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tissues. P. gingivalis can survive, replicate and disseminate from cell to 
cell through actin cytoskeleton bridges, and affect cell-cycle pathways 
after intracellular invasion (Bostanci and Belibasakis, 2012). It can block 
the epithelial cell interleukin-8 (IL-8) response to other oral bacteria, 
suggesting that the host may not detect the presence of local bacterial 
colonization and cannot direct leukocytes to remove them (Darveau, 
2009), resulting in the rapid establishment and growth of other species 
found in subgingival biofilms. These properties may be among the reasons 
that P. gingivalis is so frequently associated with active tissue destruction 
(Page et al., 1997).  
A. actinomycetemcomitans, previously known as Actinobacillus 
actinomycetemcomitans, has been frequently associated with the initiation 
and progression of aggressive periodontitis from longitudinal studies of 
both humans and animals (Fine et al., 2010). It is found in 90% of 
localised aggressive periodontitis and 30-50% of severe adult periodontitis 
(Raja et al., 2014). A. actinomycetemcomitans is a Gram-negative, non-
motile, facultative anaerobic coccobacillus bacterium producing a variety 
of virulence factors to modulate the host immune system, inducing tissue 
destruction and inhibiting tissue repair. A. actinomyctemcomitans 
produces two important exotoxins named cytolethal distending toxin (CDT) 
and leukotoxin to cause death of the host tissues by blocking cell 
proliferation and inducing cell death (Fine et al., 2010, Raja et al., 2014, 
Johansson, 2011, Haubek and Johansson, 2014), In addition, leukotoxin 
is demonstrated to induce a substantial pro-inflammatory effect in human 
endothelial cells (Haubek and Johansson, 2014). A. 
36 | P a g e  
 
actinomyctemcomitans also can produce lipopolysaccharide (LPS) to 
induce the expression of membrane IL-1 in macrophages, enabling them 
to promote bone resorption in vitro (Henderson et al., 2003). In addition, A. 
actinomyctemcomitans has been reported to produce a number of, as yet 
unidentified,  proteins with cell cycle-inhibitory activity to cause T cell 
apoptosis and to inhibit osteoblast proliferation and bone collagen 
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1.3 Periodontal regeneration 
The ultimate goal of periodontal therapy is the regeneration of the original 
architecture and function of the periodontal complex including both soft 
(gingiva, periodontal ligament) and hard (bone, cementum) tissues 
(Ivanovski et al., 2014). The initial phase is aimed to eliminate infection 
and inflammation by removing root surface plaques and to control the 
bacterial infection by an effective oral hygiene programme (Garrett, 1996). 
However, regenerative procedures such as guided tissue regeneration 
(GTR) are required to regenerate the lost periodontal tissues in some 
cases.  
Wound healing involves migration, adhesion, proliferation and 
differentiation of several cell types (Grzesik and Narayanan, 2002). The 
healing of damaged tissues depends upon two crucial factors: the 
availability of appropriate cell types and the presence or absence of cues 
and signals necessary to recruit and stimulate these cells (Polimeni et al., 
2006). Due to the complex structure of periodontium, the healing outcome 
of periodontal regeneration will be determined by the biological 
environment where this healing takes place (Vignoletti et al., 2014). Fig. 
1.4 represents the possible healing patterns of a periodontal wound. The 
healing results are dependent on the three possible cell types that 
predominate that wound site. The over- and down-growth of epithelial cells 
results in a long junctional epithelium characterized by a thin epithelium 
extending apically interposed between the root surface and the gingival 
connective tissue (Fig. 1.4 A). The excessive proliferation of connective 
tissues may result in connective tissue adhesion (Fig. 1.4 B). With the 
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over predominance of bone cells, there is root resorption and even 
ankyloses (Fig. 1.4 C). Therefore, as shown in Fig. 1.4 D, a regenerated 
periodontium develops with the ingress of periodontal ligament (PDL), 
perivascular cells from the bone and appropriate growth of epithelium, 
connective tissues and cementum (Polimeni et al., 2006).  
 
Figure 1.4 Possible healing patterns for a periodontal wound 
(Adapted from http://www.dr-tlc.com/services/bone-grafting/ and 
  http://pocketdentistry.com/61-periodontal-regeneration-and-reconstructive-surgery/) 
 
Conventional periodontal therapies such as open flap debridement provide 
a critical access to detoxify root surfaces and arrest the disease process, 
thus, establishing an improved periodontal form favours tissue regrowth 
(Sam and Pillai, 2014). However, if the periodontal defect is deep and 
broad, it could be left empty and filled with the fast-growing epithelial cells 
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to form long-epithelium which prevents the bone and PDL cells to refill the 
pocket. Therefore, based on the above solid biologic principal, GTR 
technique was proposed by Melcher to selectively guide cell proliferation 
and tissue expansion within the tissue compartments (Melcher, 1976). It 
uses a membrane which covers the periodontal defect to isolate the 
defective area from overlying soft tissue, thus blocking fast growing soft 
tissue cells from invading the area and allowing cells from PDL and bone 
to repopulate the defective area as represented in Fig. 1.5 below 
(Ivanovski et al., 2014, Karring, 2000). A Cochrane review has compared 
the application of GTR and open flap debridement for the treatment of 
intra-bony defects, GTR was found to improve the relevant clinical 
parameters including attachment gaining, pocket depth reduction, and 
more gaining in hard tissue probing at re-entry (Bartold et al., 2016). 
 
Figure 1.5 The procedure of guided tissue regeneration. 
(Taken from: http://www.davidlkresedds.com/bone-and-tissue-regeneration) 
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There are two types of GTR membranes consisting of non-resorbable and 
resorbable barrier materials. The non-resorbable membranes have 
suitable mechanical properties to maintain the space necessary for new 
bone and periodontal attachment to occur (Ivanovski et al., 2014). 
However, a significant limitation is that a second surgical procedure is 
required to remove the non-resorbable barrier membrane generally four to 
six weeks after the surgery (Wolff and Mullally, 2000). Therefore, there 
has been significant interest and development of biodegradable GTR 
membranes which would be biologically degraded in order to negate the 
risk of an additional surgical procedure. The resorbable barriers mainly 
consist of synthetic polymers such as lactide/glycolide copolymers and 
natural barrier materials include those made from collagen, calcium 
sulphate or enamel matrix proteins (Wolff and Mullally, 2000). Due to the 
non-supportive structure and low mechanical properties of those 
resorbable materials, they are prone to collapse and adhere to what they 
cover, thereby losing the ability to maintain space for periodontal tissue 
regeneration and as a result, graft materials are often required to support 
those resorbable barriers (Darby, 2011). In addition, if the periodontal 
defect is broad, deep and complex, the effectiveness of membrane alone 
is limited.  
Therefore, to promote more effective periodontal regeneration, the 
combination of bone grafts to support the membranes was developed and 
reported in numerous studies such as, in supra-alveolar and two wall infra-
bony (missing buccal wall) defect models of periodontal regeneration, the 
additional use of a grafting material gave superior histological results of 
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bone repair to barrier membranes alone (Palmer and Cortellini, 2008). For 
Class II furcation defects, the addition of a bone replacement graft to the 
GTR procedure resulted in improved vertical probing depth reduction and 
attachment gain (Wolff and Mullally, 2000, Ivanovski, 2009). A Cochrane, 
PubMed-MEDLINE and Scopus databases study also found that the 
combined GTR technique with filling material and membranes obtained a 
greater success rate both in 4-wall lesions and in through-and-through 
lesions (Sanchez-Torres et al., 2014). In addition, in periodontal defects 
such as lesions with more than 5mm depth, lower teeth, apicomarginal 
and through-and-through lesions which have the worst healing prognosis, 
the application of bone grafting materials seem to be more necessary to 
maintain the space for cell repopulation and to act as osteoinductive or 
osteoconductive materials for the formation of host bone (Bashutski and 
Wang, 2009, Sanchez-Torres et al., 2014). 
Autografts are considered as the ‘gold standard’, but significant drawbacks 
including extra painful harvest surgery, donor site morbidity and 
inadequate supply limit their clinical utilization. Allografts are another 
alternative, but sterilization process to minimize disease transmission and 
eliminate immunogenic factors destroys all osteogenic cells and organic 
factors. Xenografts are from nonhumans with sufficient supply but with 
greater antigenicity, more sterile processing is required and results in 
obviously reduced osteoinductive properties. (Lareau et al., 2015, Shibuya 
and Jupiter, 2015, Jakob et al., 2012, Bhatt and Rozental, 2012, 
Zimmermann and Moghaddam, 2011).  
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Therefore, the above limitations have driven the research community to 
investigate alternatives that incorporate the use of synthetic bone graft 
substitutes to improve periodontal regeneration such as simplifying the 
periodontal surgery process without using or minimal the GTR technique. 
Jones et al. suggested some general criteria for an ideal bone-graft 
substitute (Jones et al., 2006, Jones et al., 2007): the scaffold needs to act 
as a template for new bone growth; resorb at the same rate as the bone is 
repaired, produce degradation products that are non-toxic and can be 
excreted easily by the body; is biocompatible and promotes cell adhesion 
and activity, stimulating new bone growth (osteogenesis); bond directly to 
the host bone, creating a stable interface; exhibit mechanical properties 
matching those of the host bone; can be produced into required shapes to 
match the irregular bone defect; has the potential to be produced 
commercially and sterilised to meet international standards for clinical use. 
Furthermore, natural bone is highly vascularized, therefore, an ideal 
scaffold also needs to form blood vessels to actively support nutrient, 
oxygen and waste transport (Bose et al., 2012). In the periodontal bony 
defect treatment, surrounding soft tissue reestablishment including 
epithelium and periodontal ligament is also required. Being an 
antibacterial agent to eliminate the active disease and avoid infection 
during or after the surgery is another important requirement.  
Bioactive glasses are amorphous and biocompatible products composed 
of silicate, calcium, sodium and phosphorus, and are both osteocnductive 
and osteoionductive (Kurien et al., 2013, Nandi et al., 2010). When 
immersed in solution or embedded in vivo, they undergo ion-exchange 
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rapidly with the surrounding fluids to form a film of apatite layer on the 
surface. This layer allows bioactive glasses to bond strongly to living 
tissues including both bone and soft tissues and creates an enriched 
osteoconductive environment (Wilson et al., 1981). Active degradability is 
also a desired property depends on bioactive glass morphology, surface 
area, implantation site and composition and type (Jones, 2013). 
Furthermore, whether bioactive glasses take an active role in stimulating 
angiogenesis is also a topic of much discussion (Gorustovich et al., 2010, 
Keshaw et al., 2005, Day, 2005, Jones, 2013). The most important and 
outstanding advantage for the bioactive glass is that the chemical 
composition can be modified and tailored according to the specific 
requirements, such as to be osteoinductive, angiogenic, antibacterial and 
maybe to guide the periodontal soft tissue growth to improve the 
periodontal regeneration (Gorustovich et al., 2010, Keshaw et al., 2005, 
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1.4 Bioactive glass 
 Glass formation 1.4.1
A glass is defined as a vitreous state and considered to be an extremely 
undercooled liquid (Vogel et al., 2012). It is conventionally produced by 
cooling the molten liquid. As the liquid temperature decreases, its viscosity 
quickly increases to prevent atoms rearranging themselves into a 
crystalline form, as the crystalline material consists of regular and 
repeating units, while glassy solids have randomly arranged atoms without 
long-ordered patterns. 
 
Figure 1.6 Temperature and specific volume correlation of a glass formation 
 
Fig. 1.6 above represents the correlation of liquid, glass and crystalline 
states in a diagram of temperature-specific volume (volume/unit mass). If 
the normal molten liquid is cooled slowly, it will start to crystallize when the 
temperature reaches its melting point (Tm) followed by a sudden decrease 
in the specific volume as the crystallization occurs. In contrast, when the 
molten liquid is cooled quickly below its Tm, it will move into a super-
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cooled state and being accompanied by a continuous specific volume 
change over a wide temperature range and finally transits to the glass 
state. The glass state-changing temperature is known as transition 
temperature (Tg), which is related to the energy required to break and 
reform covalent bonds in glasses. In silicate glasses, the Tg is not fixed 
and depends mainly on the glass composition, which means a more 
disrupted glass network with fewer covalent bonds will decrease the Tg. 
 Glass structure 1.4.2
In 1932, Zachariasen proposed a random network theory to explain the 
roles of different elements throughout a glass structure, and how they 
interact with each other (Zachariasen, 1932). This model can be applied to 
various glasses and will be described with a focus on oxide silicate 
glasses, especially bioactive glasses. 
As represented in Fig. 1.7 below, in a two-dimensional network, the bond 
lengths within the polyhedra and bonding angles between the adjacent 
polyhedra distinguish glasses (vitreous) from crystals. In vitreous silica, 
there are no two atoms structurally equivalent and the atoms as well as 
polyhedra are arranged in an irregular manner, suggesting a glass 
network is not periodic or symmetrical, while the crystalline silica leads to 
a periodic structure. If in three-dimensional network model, oxygen atoms 
form tetrahedra to surround the silicon atoms and the relative orientation 
of two tetrahedra with a common corner will be the same throughout the 
entire crystalline silica. In other words, the angle between the bonds from 
an oxygen atom to the two neighbouring silicon atoms is the same for all 
46 | P a g e  
 
oxygen atoms. However, in vitreous silica the bond angle varies from 
oxygen to oxygen atom (Zachariasen, 1932).  
 
Figure 1.7 Illustrations of the structural differences between crystalline and 
vitreous silica. Both crystalline and vitreous structures exhibit the same building unit, 
marked with blue circles, but different angles between these units marked with green 
lines (Burson et al., 2015).    
 
Zachariasen classified the oxides in a glass into three groups according to 
their roles on the glass structure (Zachariasen, 1932). 
Network formers: Oxides that have the capacity to form glasses, such as 
SiO2, are known as network formers. They are considered as the 
backbone of a glass. For example, silicate glasses are comprised of 
silicon polyhedra which are coordinated by oxygen atoms throughout the 
structure. Network forming silicon atoms are connected together via 
oxygen atoms known as bridging oxygen atoms (Si-O-Si) and are also co-
ordinated with non-bridging oxygen atoms (Si-O-) which do not link two 
silicon atoms together, but carry a negative charge instead. Fig. 1.8 below 
depicts network former atoms covalently linked with bridging and non-
bridging oxygen atoms. 
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Figure 1.8 The structure of two-dimensional glass network  
(Taken from: http://www.rsc.org/education/eic/issues/2006nov/glassbones.asp ) 
 
Network modifiers: Cations like Na+ and Ca2+ are unable to form a 
continuous three-dimensional network on their own. They act to weaken 
the glass network by creating non-bridging oxygen atoms, to reduce the 
glass stability and make it more reactive. As represented in Fig. 1.9 below, 
when network modifier Na2O/CaO is introduced into a silica glass, the 
bridging oxygen Si-O-Si bonds are broken down, and two non-bridging 
oxygen Si-O- bonds are formed. Then the two negative charges on the 
non-bridging oxygens are compensated by Na+/ Ca2+ cations.  
 
Figure 1.9 Illustration of the reaction between silica tetrahedral unit and 
sodium/calcium oxide (Taken from: 
https://digitalfire.com/4sight/education/the_chemistry_physics_and_manufacturing_of_gla
ze_frits_340.html ) 
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Intermediate oxides: Intermediate oxides cannot form glasses on their 
own, but they can take part in the network to reinforce or weaken the glass 
network structure. Elements such as Al, Zn, Ti and Pb could behave as 
intermediate oxides. Fig. 1.10 below represents the aluminium oxide, 
Al2O3, as an intermediate oxide in a silicate glass network, where the AlO4 
tetrahedral groups can replace the SiO4 tetrahedra.  
 
Figure 1.10 Aluminium in a silicate glass as intermediate oxide  
(Taken from: http://www.chemguideforcie.co.uk/section4/learningfg.html ) 
 
Some studies found that the decreased glass transition temperature was 
caused by the addition of network modifiers as they disrupted bridging 
oxygens and opened up the glass structure (Elgayar et al., 2005, Angell, 
1983, Angell, 1986). Therefore, this random network theory can be applied 
to explain or predict various glass properties. It can be envisaged that 
different numbers of bridging oxygen atoms per silicon atom can cause 
vast changes in the structure of the glass network. Due to the possible 
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variation in the number of bridging oxygen and non-bridging oxygen atoms 
in silicon tetrahedra, the structure of glasses is best described using the 
Qn notation. It is used to describe the structure and quaternary/tetrahedral 
coordination of the glass network forming units. In other words, ‘Q’ stands 
for quaternary and ‘n’ is the number of bridging oxygen atoms per 
tetrahedron (Kavouras et al., 2008). This is represented in Fig. 1.11 below, 
 
Figure 1.11 Illustration of the Q
n
 nomenclature for tetrahedrally coordinated silicate 
glass ‘BO’ refers to bridging oxygen atoms, ‘NBO’ refers to non-bridging oxygen atoms 
(Kavouras et al., 2008)  
 Q0 refers to a single isolated unit without any bridging oxygen atom. 
 In the Q1 structure, there is one bridging oxygen and three non-
bridging oxygens in two silicon tetrahedra. It means the network 
former in the glass is structured so the individual units are dimers. 
 In the Q2 structure, there are two bridging oxygens and two non-
bridging oxygens, which mean the network former forms long 
chains or possibly rings. 
  In the Q3 structure, there are three bridging oxygens and one non-
bridging oxygen, which means a sheet or even a three-dimensional 
structure is formed.  
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 While in the Q4 structure, four bridging oxygens are formed without 
any non-bridging oxygen. It implies three-dimensional networks. 
The Qn structure has a significant influence on the properties of the final 
glass. Generally, it is considered that the lower the Q structure, the higher 
the glass solubility. Recently, some researchers have developed a formula 
to deduce the average number of bridging oxygen atoms per silicon atom 
in bioactive glasses and apply this to theoretically determine the structure 
of new glass compositions, which will be discussed in section 1.4.6.  
 Bioactive glass history 1.4.3
The first bioactive glass was discovered in 1960s by Professor Larry L. 
Hench and the widely known composition, 45S5 Bioglass® (46.1 % SiO2, 
26.9% CaO, 24.4% Na2O and 2.6% P2O5 in Mole), has been in clinical use 
since 1985 (Hench, 2006, Hench, 1988).  
The development of bioactive glass was for the production of new 
biomaterials, and unlike the metallic and plastic materials, would not be 
rejected by the body. Research started in 1968 and was based on a 
simple hypothesis that as hydroxyapatite (HA) is the main mineral phase 
of bones and teeth, if there is a material that can form an HA layer on its 
surface, then it may not be rejected by the body, compared with the other 
metallic and plastic materials used at the time (Hench, 2006).  
Initial research disclosed that bioactive glasses with composition of 45% 
SiO2, 24.5% Na2O, 24.5% CaO, 6% P2O5 (in weight) can bond to bone in 
an animal model and in vitro tests showed that the bioactive glasses 
developed an HA layer in a test solution which did not any contain calcium 
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or phosphate ions (Hench et al., 1971). The further work suggested that 
HA crystals were bonded to collagen fibrils layers, which were produced at 
the interface by osteoblasts. Therefore, a strong and firmly bonded 
interface was created through the chemical bonding of the HA layer to soft 
connective tissues as well as bone (Wilson et al., 1981). Toxicology and 
biocompatibility studies were also carried out to establish safety for 
bioactive glass products (Wilson et al., 1981). Later, in a monkey 
periodontal defect model, bone regeneration was sufficiently rapid by 
bioactive glass particulates while the encapsulation of the site by epithelial 
tissues was prevented (Wilson and Low, 1992).  
In 1985, the first Bioglass® device cleared for commercial clinical use was 
a replacement for the middle ear bone to treat conductive hearing loss. It 
was from the ability of bioactive glass bonding with soft tissue (tympanic 
membrane) as well as bone tissue. The second marketed Bioglass® 
device was the Endosseous Ridge Maintenance Implant (ERMI®) to 
support labial and lingual plates in natural tooth roots and to provide a 
more stable ridge for denture construction following tooth extraction 
(Hench, 2016). Later, more commercial products were marketed such as 
PerioGlas to treat periodontal infra-bony defects, NovaBone as general 
orthopaedic bone grafting in non-load bearing sites and NovaMin for the 
dentinal hypersensitivity treatment (Hench, 2016, Hench and Thompson, 
2010, Hench, 2015, Hench and Jones, 2015).  
 Bioactive glass structure 1.4.4
In 45S5 Bioglass®, SiO2 plays the role of network former while Na2O and 
CaO act as network modifiers. As shown in Fig. 1.8 and 1.9 previously, 
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the Na+ bonds with one non-bridging oxygen atom, while the 2+ charge 
Ca2+ atom forms bonds with two non-bridging oxygen atoms. This 
suggests that network modifiers, with different charges and ionic radii, will 
have significantly different effects on the structure of the bioactive glass 
and its properties. 
However, the effect of P2O5 on bioactive glass structure is controversial. 
Previously, it was believed that phosphorus formed Si-O-P bonds to act as 
a part of the silicate network. However, several recent studies have shown 
the phosphate, instead of entering the silicon glass network, in fact 
separates to form an orthophosphate (PO4)
3- phase, which will be 
discussed in detail later in section 1.4.7. (Pedone et al., 2010, O’Donnell 
et al., 2008b, O’Donnell et al., 2008a, O'Donnell et al., 2009) 
Based on Raman measurements and model studies, West and Hench 
suggested that ring systems may exist in the silica glass structure (West 
and Hench, 1995). Later, researchers explored the Qn structure of 45S5 
bioactive glass structure by X-ray and neutron diffraction with Reverse 
Monte Carlo Modelling and MAS NMR spectra, they found that the host 
silica network was consisted of chains and rings of Q2 Si (67.2%) SiO4 
tetrahedra with some cross-linked with Q3 Si (22.3%) species and a low 
quantity of Q1 Si (10.1%) species as well (Pedone et al., 2010, FitzGerald 
et al., 2007, Lockyer et al., 1995), which is in relatively good agreement 
with the Q structure of the silica glasses. 
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 Bioactive glass bioactivity 1.4.5
The dissolution is important to understand the bioactive glass bioactivity, 
which is considered the time to form apatite. The bioactive glass implants 
bonding ability depends on the surface reactions. It is generally presumed 
that for a composition to be bioactive, a layer of apatite must precipitate on 
the implant surface. The ability of the glass to release ions for forming 
apatite will determine their bioactivity. The mechanism that was proposed 
by Hench et al in 1971 has been accepted as the degradation mode of 
bioactive glasses (Hench et al., 1971). As represented in Fig. 1.12 below, 
there are five stages including three main processes: ion exchange, 
dissolution and precipitation (Hill, 1996, Peitl et al., 2001).  
   
Figure 1.12 Schematic diagram of bioactive glass degradation  
(Taken from: http://www.rsc.org/Education/EiC/issues/2006Nov/GlassBones.asp ) 
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Stage 1:  Na+ atoms, from the glass, exchange with H+ or H3O
+ from the 
surrounding solution.  
Si-O-Na+ + H+ + OH-  Si-OH + Na+ (solution) + OH- 
Rapid ion exchange occurs easily at the surfaces of bioactive glasses 
since Na+ ions are network modifiers with weak bonds to glass networks. 
The consumption of solution H+ results in the solution pH increase.  
Stage 2:  Soluble silica is released in the form of Si(OH)4 and Si-OH 
(silanols) forms at the glass-solution surface. 
2(Si–O–Si) + 2(OH-)  SiOH + OH-Si 
The rising solution pH and free hydroxyl ions (OH-) allows for the 
catalysed alkaline hydrolysis of the network bonds Si-O-Si, resulting in the 
soluble silica release into solution in the form of Si(OH)4 and Si-OH 
(silanols) forms at the glass-solution interface.  
Stage 3:  A SiO2 rich layer with condensation and polymerization is 
formed on the surface. 
2(Si–OH) + 2(OH–Si)  Si–O– Si–O– Si–O– Si–O 
The hydrated silica (Si–OH) formed on the glass surface undergoes 
rearrangement by polymerization and condensation of neighbouring 
silanols and using out alkalis and alkaline earth cations, resulting in the 
formation of a silica rich gel layer.   
Stage 4: Breakage of the silicate network opens the glass network which 
allows Ca2+ and PO4
3- groups to migrate from bioactive glasses through 
the SiO2 rich layer to the glass surface. Consequently, a CaO-P2O5 rich 
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film is formed on top of SiO2 rich layer. This is followed by the growth of 
this amorphous layer via incorporation of soluble calcium and phosphate 
ions from the solution. 
Stage 5: The amorphous CaO-P2O5 film undergoes crystallization by 
incorporating OH- and CO3
2- or F- ions from the solution to form a mixed 
hydroxyl-carbonate apatite layer (HCA).  
Stage 6:  If the bioactive glass is inserted in vivo or cultured with cells, it 
will be incorporated with collagen produced by osteoblasts or fibroblasts 
and form bone with the agglomeration and chemical bonding of biological 
moieties within the growing HCA layer.          
To conclude, the Hench mechanism gives an explanation to the bioactive 
glass’s degradation process including how the ion exchange, subsequent 
apatite layer forms and even further bone formation in vivo. It also 
indirectly suggests that increasing the solubility of the glass would 
increase the rate of apatite formation, as the exchange of Na+ ions at the 
surface of the glass initiates the bioactive glass degradation process. 
However, this mechanism gives no consideration on how glass 
composition influences apatite formation. Numerous studies demonstrate 
that there is a large difference in the rates of apatite formation when the 
glass composition is altered. O’Donnell et al. reported that increasing the 
bioactive glass phosphate content significantly accelerated apatite 
formation in SBF, as phosphate resides in a separated orthophosphate 
phase in the bioactive glass structure (O'Donnell et al., 2009, O’Donnell et 
al., 2008a, O’Donnell et al., 2008b). Hill suggests that for apatite formation 
the surrounding solution must become super-saturated with PO4
3- and 
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Ca2+ ions, therefore altering the glass composition to maximize this 
(increasing CaO relative to Na2O and increasing P2O5 content) would give 
a more rapid formation of apatite (Hill, 1996). Therefore, the effects of 
glass structure and compositions on bioactivity need to be further 
discussed as it is essential for designing new compositions with improved 
bioactivity. 
 Network connectivity 1.4.6
As discussed in section 1.4.4, the glass Qn structure has a significant 
influence on the bioactive glass properties. Therefore, network 
connectivity (NC), defined as the average number of bridging oxygen 
atoms per silicon atom in bioactive glasses, is applied to theoretically 
deduce and predict the structure, reactivity, solubility, as well as the 
bioactivity of new bioactive glass compositions (Towler et al., 2002, Hill, 
1996). For instance, for a glass with an average of two bridging oxygen 
atoms per silicon atom would give a NC of 2.0, three bridging oxygen 
atoms per silicon atom would correspond to a NC of 3.0 and so on. 
Therefore, 
 NC of 4.0 refers to Q4 structures like pure silica glasses (SiO2) 
 NC of 3.0 refers to Q3 structures mainly consisted by three-
dimensional structures 
 NC of 2.0 refers to Q2 structures with chains or rings of infinite 
molar mass 
 NC < 2.0 refers to Q1 structures varying from finite molar mass to a 
single unit 
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For the bioactive phospho-silicate glasses, Hill states that they may be 
regarded as inorganic polymers of oxygen cross-linked by silicon atoms 
(Hill, 1996). In his assumption, silicon existed as a Si4+ ion surrounded by 
four oxygens in a tetrahedral configuration. Phosphorus existed as a P5+ 
ion in the glass network and was present as PO4 tetrahedra, in which one 
of the four oxygens was double bonded to the central P5+ ion. Therefore, 
the network connectivity was calculated using the following equation in the 
molar concentrations: 
𝑁𝐶 = 2 +
[(2 × SiO2) + (2 × P2O5)] − [(2 × CaO) + (2 × Na2O)]
SiO2 + (2 × P2O5)
 
However, there are flaws in this equation as it assumes that phosphate 
exists as part of the glass network with formation of Si-O-P bonds, which 
is no longer believed to be the case due to studies on the effects of 
phosphate to bioactive glasses (Hill and Brauer, 2011, O’Donnell et al., 
2008b, O’Donnell et al., 2008a, O'Donnell et al., 2009, Aguiar et al., 2008, 
Mercier et al., 2011). It is pointed out that phosphate in bioactive glass 
exclusively exists as separated orthophosphate regardless of composition. 
Therefore this equation has been updated to account for the role of 
phosphate in the glass in the modified network connectivity (NC’). 
𝑁𝐶′ = 2 +
(2 × SiO2) − [(2 × CaO) + (2 × Na2O) − (6 × P2O5)]
SiO2
 
If the network connectivity equations are applied to 45S5 glass, a NC of 
1.9 and a NC’ of 2.1 can be achieved. However, FitzGerald et al. explored 
the 45S5 glass structure by 29Si MAS-NMR studies and they found 45S5 
glass consisted mainly of chains and rings of Q2 SiO4 tetrahedra, with 
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some degree of cross linking Q3 units (FitzGerald et al., 2007), which is in 
excellent agreement with the NC’ of 2.1. It shows that the concept of 
network connectivity can be used to supply information for the structure of 
glasses and can be used as a design tool for developing new glass 
compositions.  
Edén et al. (Edén, 2011) suggested that a NC range between 2.0 and 2.6 
was optimum for bioactivity (with NC<1.8 and NC>2.7 being described as 
unfavourable for increased crystallisation tendency), while the NC model 
by Hill (Hill, 1996) recommended an NC close to 2.0 (i.e., a silicate chain 
structure) and <2.4. As mentioned before, glasses with a NC of 2.0 are 
two-dimensional chains or rings, while the structures begin to develop into 
three-dimensional networks as the NC increases above 2.0. Furthermore, 
as described in the Hench dissolution mechanism, the glass bioactivity 
depends on the dissolution process at the bioactive glass surface, which 
allows for the apatite formation. In the two-dimensional chains, there 
would be a larger surface area exposure for the glass to carry out these 
surface dissolution processes with the living tissue. Therefore, a two-
dimensional chain with loose structure and being easier to be broken 
down would be far more effective than the three-dimensional network. Fig. 
1.13 below represents the relationship between bioactivity and NC.  
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Figure 1.13 The relationship between bioactivity and network connectivity 
 
Theoretically, the glass bioactivity changes drastically around a NC of 2.0 
corresponding to Q2 chains mentioned above. Experimentally, Hill et al. 
investigated the bioactivity by testing the apatite formation time of 
Magnesium (Mg) substitution bioactive glasses with NC increased from 
2.17 to 2.41 in SBF (Hill and Brauer, 2011). It was found that bioactivity 
dropped gradually as in Fig. 1.14 below, rather than the theoretical sharp 
cut off in Fig. 1.13 above.    
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Figure 1.14 Bioactivity (defined as tAp
−1
 where tAp is the time of first apatite 
formation in SBF detected by XRD) of glasses vs. NC (Hill and Brauer, 2011) 
 
In order to determine the level of glass bioactivity using this NC model, it is 
critical to have a structural understanding of each species within the glass. 
Without such knowledge, assessing the bioactive behaviour of a specific 
glass composition is extremely problematic. Watts et al. designed a series 
of glasses with Mg substitution, which was thought to act as a network 
modifier and the glass NC kept at 2.13 (Watts et al., 2010). However, 29Si 
MAS NMR investigations showed that the actual NC increased from 2.13 
to 2.41 with increasing Mg substitution. This was due to that Mg in fact 
acts as an intermediate, which partially enters the silicate network (forming 
Si-O-Mg bonds) and consumes cations to keep charge balance. It induced 
a more cross-linked silicate network and increased the actual NC. 
Therefore, in the following sections, the effects of phosphate and fluoride 
on bioactive glasses will be discussed. 
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 Effects of phosphate  1.4.7
Biologically, phosphate is involved in various activities such as membrane 
integrity, energy metabolism, intracellular signalling and skeletal 
mineralization (Michigami, 2013). In the Hench degradation model, 
phosphate plays a vital role in bioactive glass bioactivity by forming a 
CaO-P2O5 rich bilayer after the leaching of Na
+ from the glass (Hench et 
al., 1971). This surface promotes the formation of apatite, necessary for 
bone tissue attachment to an implant. 
Lebecq et al. carried out a systematic in vitro study on phosphorus-free 
glasses (SiO2-CaO-Na2O system) and the phosphorus-containing glasses 
(SiO2-CaO-Na2O-P2O5) (Lebecq et al., 2007). Phosphate was introduced 
into glasses with unchanged Si/Ca and Si/Na ratios. For comparison 
purpose, the Bioglass® 45S5, which contains 2.6 Mol. % P2O5, was also 
studied. All the glass cylinders were embedded in epoxy resin with one 
unprotected surface and subsequently were immersed in SBF to observe 
the surface HCA layer formation. As depicted in Table 1-1, although all the 
glasses formed an HCA layer, the formation time was different. 
Phosphorus-containing glasses formed the HCA layer more rapidly, and 
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Table 1-1 HCA formation time for phosphorus-free and phosphorus-containing 
glasses (Lebecq et al., 2007) 
Glass Name Mol.% of P2O5 HCA formation Time 
A3 0 3-4 days 
P2A3 2 14h 
45S5 2.6 12h 
P6A3 6 6h 
 
To summarise, phosphate is necessary for the apatite formation in 
bioactive glasses and is also important for various biological activities. The 
following sections will further discuss the effects of phosphate on bioactive 
glass structure, bioactivity and bone biology.  
 Phosphate effects on bioactive glass structure 1.4.7.1
O’Donnell et al. investigated the structural role of phosphate in soda-lime-
phosphosilicate glasses based on the 45S5 glass composition and 
glasses studied by Elgayar et al. (O’Donnell et al., 2008a, O’Donnell et al., 
2008b, Elgayar et al., 2005). Two series of glasses were produced. In 
series I, P2O5 was added to the glass with a fixed Na2O:CaO ratio 
(1.00:0.87). In series II, P2O5 was introduced while the amounts of Na2O 
and CaO were adjusted to charge balance for a suspected 
orthophosphate (PO4
-3) species being formed. Series I is a simple 
substitution of phosphate for silica to explore if phosphate would enter the 
glass network as a network former through the formation of ‘Si-O-P’ type 
bonds. Series II investigates whether phosphate would form a second and 
separate orthophosphate phase. Thus, the aim behind the work was to 
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investigate how phosphate exists in the glass structure. The glass 
compositions are listed below in Table 1-2.  
Table 1-2 Glass compositions for series I (fixed Na2O:CaO = 1:0.87) and II (charge 
balanced) (O’Donnell et al., 2008a) 
ID Mol.% NC NC’ 
 SiO2 Na2O CaO P2O5   
Series I       
ICIE1 49.46 26.38 23.08 1.07 2.04 2.13 
ICSW2 47.84 26.67 23.33 2.16 2.00 2.18 
ICSW3 44.47 27.26 23.85 4.42 1.92 2.30 
ICSW5 40.96 27.87 24.39 6.78 1.83 2.44 
ICSW4 37.28 28.52 24.95 9.25 1.75 2.62 
Series II       
ICSW1 51.06 26.10 22.84 0.00 2.08 2.08 
ICSW6 48.98 26.67 23.33 1.02 2.00 2.08 
ICSW7 47.07 27.19 23.78 1.95 1.92 2.08 
ICSW8 43.66 28.12 24.60 3.62 1.79 2.08 
ICSW10 40.71 28.91 25.31 5.07 1.67 2.08 
ICSW9 38.14 29.62 25.91 6.33 1.56 2.08 
 
Network connectivity (NC) assuming P2O5 enters the glass network while modified 
network connectivity (NC’) assuming isolated orthophosphate units 
 
The glass structure was investigated using 29Si and 31P MAS-NMR, and 
the results are summarized in Table 1-3 below. In series I, the 31P MAS-
NMR spectra illustrate a chemical shift range of 8.4 to 10 ppm with an 
approximate constant linewidth of around 9 ppm, which corresponds to an 
orthophosphate structure, suggesting that phosphorus is in an 
orthophosphate environment. When the phosphate content increases, the 
29Si MAS-NMR spectra peak asymmetry became more evident and 
chemical shifted from -78 ppm to -81 ppm, in which the resonance at -78 
ppm can be assigned to a Q2 species and the peak at -86 ppm can be 
assigned to a Q3 species. It suggests that on increasing the phosphate 
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content, more Na and Ca ions are required to charge balance the 
orthophosphate, therefore removing them from their network modifying 
role within the silicate network and increasing the polymerisation causing 
more Q3 units to form, agreeing with the results that the NC’ value 





P MAS-NMR peak positions and full width half maximums 














Series I     
ICIE1 8.4 873 -78.0 516 
ICSW2 10.0 721 -79.0 683 
ICSW3 9.5 721 -78.5 592 
ICSW5 9.0 737 -80.0 584 
ICSW4 9.0 793 -81.0 695 
Series II     
ICSW6 10.7 745 -78.0 524 
ICSW7 10.9 745 -78.0 516 
ICSW8 10.5 769 -78.0 505 
ICSW10 10.5 745 -78.0 469 
ICSW9 10.9 745 -78.0 505 
 
However, in series II, all the 31P MAS-NMR spectra had a single 
resonance at about 10.5 ppm with a FWHM consistent with that of an 
orthophosphate environment (9 ppm).  The 29Si spectra were highly 
symmetrical with a single resonance centred around -78 ppm with line 
widths between 12 and 13 ppm in the 29Si MAS-NMR spectra. The results 
here demonstrate that the P2O5 introduced into the glass exists as a 
separate orthophosphate phase rather than acts as network former. It also 
suggests that when designing a glass which incorporates P2O5, it should 
be assumed to exist as orthophosphate and therefore should be charge-
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balanced. This is in agreement with other NMR and molecular dynamics 
(MD) work on the influence of P2O5 in SiO2-Na2O-CaO-P2O5 bioactive 
glasses (Mercier et al., 2011, Tilocca and Cormack, 2007).  
Subsequently, the same authors used more conventional characterization 
techniques to assess physical properties, including density, thermal 
expansion coefficients (TEC), glass transition temperature (Tg), 
crystallisation temperature (Tc) and heat treated glass structure, which are 
important for processing promising compositions (O’Donnell et al., 2008b). 
Experimental values and theoretical calculated values from glass network 
connectivity based on glass composition were compared to validate the 
above MAS-NMR spectroscopy findings and further confirm the structural 
role of phosphate in bioactive glasses. 
X-ray diffraction was applied to confirm the glassy nature of all 
investigated bioactive glasses. The results showed all glasses, except 
glass ISCW4 from series I, were amorphous. It suggests that there may 
be a maximum P2O5 addition content without glass crystallising as glass 
ISCW4 has the highest P2O5 content of all glasses at 9.25 Mol.% 
(O’Donnell et al., 2008b).  
 Phosphate effects on bioactive glass bioactivity 1.4.7.2
Bioactivity studies were carried out by O’Donnell et al. based on using the 
same two series of glasses in simulated body fluid (SBF) (Kokubo and 
Takadama, 2006) in vitro (O'Donnell et al., 2009). Glass particles with 
diameter < 38 μm were soaked in SBF for up to 21 days and subsequently 
solution pH was measured while filtered and dried glass particles were 
66 | P a g e  
 
analysed HCA layer formation by X-ray diffraction (XRD) and Fourier 
Transform Infrared Spectroscopy (FTIR).  
In the Hench degradation model, bioactive glasses are well known to 
cause a pH rise upon immersion in aqueous solutions as released Na+ 
exchange with H+ or H3O
+ from the surrounding solution, resulting in the 
OH- being left. An alkali environment favours apatite deposition, but can 
negatively affect the surrounding tissue in vivo. In the study of O’Donnell 
et al. (O'Donnell et al., 2009), the results of pH change showed that, in 
both series of glasses, the pH increased after glass dissolution. However, 
as the P2O5 content increased, the solution shifted close to 7.3, which is 
optimal and advantageous in physiological fluid for apatite deposition. It 
could be explained that the amount of released phosphate from the glass 
would buffer the solution alkalinity caused by the sodium and calcium ions. 
At the same time, the large amount of basic ions (Na and Ca) release 
buffered the acidic pH caused by phosphate.  
All glasses showed apatite formation after 21 days in SBF. However, the 
crystalline apatite formation speed was different. Table 1-4 below 
summarised the time for crystalline apatite formation. Generally, apatite 
formation was faster as the P2O5 content increased in both series, which 
indicated that in the studied glass compositions, P2O5 content was even 
more important than NC of the silicate phase for bioactivity.  
 
 
67 | P a g e  
 
Table 1-4 Time for crystalline apatite formation observed by splitting of the FTIR P–
O bending mode at around 550 cm
-1
(sample ICSW4 partially crystalline) (O'Donnell 
et al., 2009, Delia S. Brauer, 2008). 
Glass Mol.% P2O5 Time 
Series I   
ICIE1 0.00 1 week 
ICSW2 2.16 2 days 
ICSW3 4.42 16 h 
ICSW5 6.78 16 h 
ICSW4 9.25 1 day
a
 
Series II   
ICSW6 1.02 2 days 
ICSW7 1.95 2 days 
ICSW8 3.62 16 h 
ICSW10 5.07 16 h 
ICSW9 6.33 16 h 
                                 a
 Sample partially crystalline 
 
On further comparison of glass ICSW9 (6.33% P2O5) from series II against 
45S5 Bioglass® (2.6% P2O5), in FTIR spectra represented in Fig 1.15 
below, it can clearly be seen that after 24h in SBF, the apatite formed far 
more rapidly on the ICSW9 glass with intense, narrow, split peaks in the 
550 cm-1 region, whereas the phosphate peak can hardly be resolved from 
the background in 45S5, which further confirmed the important role of 
phosphate in glass bioactivity.  
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Figure 1.15 Comparison of ICSW9 and 45S5 Bioglass
®
 by FTIR after 24 h in SBF 
(O'Donnell et al., 2009) 
 
Furthermore, a crystallite size analysis, obtained from the XRD peak width 
and position using the Scherrer equation, showed that the size of the 
apatite crystallites were possibly decreased with phosphate content in 
series II bioactive glasses after 21 days immersion in SBF, but the total 
amount of crystals clearly increased evidenced from the increase in the 
areas of the features in the XRD and FTIR data associated with HCA 
crystallinity (O'Donnell et al., 2009). This result is promising, suggesting 
that those biomimetic crystalline apatite particles with smaller or even 
nano-sizes will have greater protein absorption and may encourage 
osteoblast attachment and proliferation in vivo.  
 Phosphate effects on bone biology 1.4.7.3
As phosphorus is present mainly in the form of HPO4
2– and H2PO4
– in 
serum instead of free phosphorus, it will be referred to as phosphate in 
this section. In human adults, phosphate is in a balance through the renal 
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reabsorption and intestinal absorption. Approximately 85% of the total 
phosphate distributes in bone in the form of hydroxyapatite crystals 
deposited in the bone matrix. Intracellular phosphate is around 15% of the 
total amount and only 0.1% phosphate is present in the extracellular fluids 
(Murray J. Favus, 2006), as showed in Fig. 1.16 below.  
 
Figure 1.16 Phosphate distribution in human adults (Murray J. Favus, 2006) 
 
Phosphate plays a vital role and is essential in the biological 
mineralization, which is an ongoing process accomplished by the function 
of osteoblasts and osteoclasts and inorganic ions calcium and phosphate, 
which are main components of hydroxyapatite mineral, Ca10(PO4)6(OH)2 
(Beck, 2003).  
Although phosphate is a necessary component of hydroxyapatite and only 
0.1% exists in the extracellular fluids, it regulates various cellular functions 
in the skeleton and extraskeletal tissues (Michigami, 2013). In the 
mineralization process, active osteoblasts deposit a collagenous 
extracellular matrix, accompanied by the activation of related genes such 
as alkaline phosphatase (ALP), osteocalcin, and osteopontin. Beck et al. 
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found that a decrease in extracellular phosphate production resulted in a 
decreased expression of osteopontin (Beck et al., 1998). Then, they 
further demonstrated that osteopontin expression was strongly regulated 
at the RNA level in response to elevated extracellular phosphate levels 
(Beck et al., 2000). In addition, the same authors later pointed out that the 
ability of phosphate to induce osteopontin gene expression relied on the 
function of the phosphate transport system. The extracellular phosphate 
must be transported into the cell to exert its effect on osteopontin, so that 
the actual response is mediated by the rise in the intracellular phosphate 
level (Beck, 2003). Later, a range concentration of inorganic phosphate, 4-
10 mM, was used to treat osteoblast cell line MC3T3-E1 to identify the 
effects of increased phosphate to osteoblastic differentiation. Beck et al. 
found that genes of osteoblast-related extracellular factors such as 
collagens, periostin, and decorin were down regulated by increased 
phosphate. While genes for transcription factors that may be important in 
the later stages of osteoblast development because in which the 
environment is high in phosphate were up regulated (Beck et al., 2003). 
Similar results were also published by other researchers (Conrads et al., 
2004, Conrads et al., 2005, Hacchou et al., 2007, Ito et al., 2013, Kanatani 
et al., 2003, Muller et al., 2011, Usui et al., 2010). To summarise, it is 
indicated that extracellular phosphate acts as a specific signal that 
regulates the gene expression in osteoblastic cells and it is of importance 
to maintain the proper phosphate concentration in the extracellular 
environment.  
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 Effects of fluoride  1.4.8
The addition of fluoride into bioactive glasses provides a wide range of 
advantages based on the characteristics of fluoride itself and the potential 
of forming fluorapatite (Ca10(PO4)6F2). Fluoride is well known to inhibit 
bacterial enzymes, prevent dental decay by inhibiting dentine and enamel 
demineralisation as well as enhancing remineralization (Brauer et al., 
2009). It is also known to increase bone density, which results in the 
interest of treatment for osteoporosis (Chachra et al., 2008). Fluorapatite 
(FAp) is an apatite phase that is found in teeth and bones (Mojumdar et 
al., 2004). In oral environment, FAp has better stability and lower 
degradation being more acid resistant in comparison to HA, and can 
inhibit caries. Through occluding the dentinal tubule surfaces, fluoride can 
reduce tooth sensitivity (Al-Noaman et al., 2013). For these reasons, 
incorporation of fluoride into bioactive glasses is of great interest for the 
development of dental and orthopaedic applications.  
 Fluoride effects on bioactive glass structure 1.4.8.1
The structural role of fluoride was explored by Brauer et al. (Delia S. 
Brauer, 2008). CaF2 was incorporated into bioactive glasses in increasing 
amounts, while the ratio of all other components was kept constant based 
on the assumption that the added fluoride species will effectively charge 
balance itself and will not use up network modifiers. The theoretical NC 
was calculated assuming fluorine complexes calcium (NC1) or fluorine 
forms non-bridging fluorine attached to silicon (NC2). The experimental 
glass compositions are represented in Table 1-5 below. 
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Table 1-5 Synthetic glass composition in Mol.% and theoretical network 
connectivity  
Glass SiO2 P2O5 CaO Na2O CaF2 NC1 NC2 
A 49.47 1.07 23.08 26.38 0.00 2.13 2.13 
B 47.00 1.02 21.93 25.06 5.00 2.13 1.49 
C 44.52 0.96 20.77 23.74 10.00 2.13 0.78 
D 42.05 0.91 19.62 22.42 15.00 2.13 -0.01 
E 39.58 0.86 18.46 21.10 20.00 2.13 -0.90 
NC1 calculated assuming fluorine complexes calcium, NC2 calculated assuming fluorine 
forms non-bridging fluorines attached to silicon (Delia S. Brauer, 2008)  
 
In 29Si MAS NMR spectra, there was a peak at about -80 ppm 
corresponding to Q2 Si units and a shoulder at about -92 ppm indicating 
the presence of a small number of Q3 Si units, which was in good 
agreement with NC calculated to be 2.13, assuming fluorine was binding 
to calcium, rather than forming non-bridging fluorine attached to silicon. 
Furthermore, there was no change in peak position with increasing CaF2 
addition, which suggested that formation of Si–F bonds did not occur as 
the authors regarded, otherwise peaks would move to less negative 
chemical shift (towards 0 ppm) if there was formation of Si–F bonds in the 
glass (Delia S. Brauer, 2008). Lusvardi et al. also investigated bioactive 
glasses belonging to the Na2O-CaO-P2O5-SiO2 system and modified by 
CaF2 substitution for CaO and Na2O alternatively (Lusvardi et al., 2008). 
The results of molecular dynamics simulations also showed that fluoride 
was almost exclusively bonded to modifier cations (Ca and Na), and no 
appreciable amount of Si-F bonds were detected. Similar results are 
reported by other researchers (Al-Noaman et al., 2012, Pedone et al., 
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2012). This indeed shows that adding CaF2 whilst maintaining the ratio 
between pre-existing components will not alter the silicate structure. 
In the 19F MAS NMR spectra by Brauer et al., peaks were found from -135 
ppm to -120 ppm, as the CaF2 content increased from 5 Mol.% in glass B 
to 20 Mol.% in glass E (Table 1-5). Generally, peaks at about -220 ppm 
and -108 ppm correspond to sodium and calcium fluoride, respectively 
(Hill et al., 2005). Thus, these signals between -135 and -120 ppm were 
assigned to mixed sodium/calcium fluoride species. However, it is 
controversial whether there is a preference for F- bond to calcium or 
sodium (Stebbins and Zeng, 2000, Christie et al., 2011, Brauer et al., 
2009, Lusvardi et al., 2008). Stebbins and Zeng et al. presented results for 
sodium-, potassium-, calcium-, lanthanum- and mixed cation silicate 
glasses, containing 1-2 wt.% fluoride through 19F NMR experiments 
(Stebbins and Zeng, 2000), in which, they observed a preference for 
fluoride to bond to modifiers with higher field strengths, which is defined as 
the ion valence divided by the square of the bond length to its oxygen 
neighbour when six-coordinated. Thus, they suggested a preference for F-
Ca (the Ca field strength is 0.33) over F-Na (the Na field strength is 0.19) 
interactions in F-containing bioactive glasses. However, the NMR study, 
Car-Parrinello molecular dynamics (CPMD) simulations and molecular 
dynamics simulations based on SiO2-Na2O-CaO-P2O5-CaF2 bioactive 
glasses by other researchers suggested that almost all fluoride atoms 
were associated with both sodium and calcium, and no preference for 
fluoride to coordinate to either Na or Ca was observed (Christie et al., 
2011, Brauer et al., 2009, Lusvardi et al., 2008).  
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Furthermore, the glass transition temperature (Tg) decreased with 
increasing CaF2 content, compared with fluoride-free glasses (Brauer et 
al., 2009, Al-Noaman et al., 2012, Delia S. Brauer, 2008). This was 
explained due to the fact that fluorine was complexing calcium. As 
represented in Fig. 1.17 below, in fluorine-free glass, Ca2+ ions bind to 
silicate anions by electrostatic forces and the Ca2+ ions act as ionic 
bridges between two non-bridging oxygens. When CaF2 is added, 
hypothetical CaF+ species are added to the silicate ions, which reduce the 
electrostatic forces between non-bridging oxygens considerably and 
results in a decrease in Tg.  
 
Figure 1.17 Illustration of the hypothetical effect of CaF2 addition on silicate 
network (Brauer et al., 2009, Delia S. Brauer, 2008) 
To summarise, fluoride is readily incorporated into bioactive glasses. It is 
complexed with calcium and sodium rather than forming Si-F bonds, which 
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results in decreasing the compactness of the glass network. By keeping 
the ratio of network former to network modifier constant when adding 
CaF2, the silicate structure and network connectivity will not be altered.  
 Fluoride effects on bioactive glass bioactivity 1.4.8.2
Bioactivity studies were also carried out by Brauer et al. using similar 
bioactive glasses with more extensive fluoride incorporation (Table 1-6) in 
SBF (Brauer et al., 2010).  
Table 1-6 Synthetic glass composition in Mol.% and theoretical network 
connectivity (NC) 
Glass SiO2 P2O5 CaO Na2O CaF2 NC 
A 49.47 1.07 23.08 26.38 0.00 2.13 
B 47.12 1.02 21.98 25.13 4.75 2.13 
C 44.88 0.97 20.94 23.93 9.28 2.13 
D 42.73 0.92 19.94 22.79 13.62 2.13 
E 40.68 0.88 18.98 21.69 17.76 2.13 
F 36.83 0.80 17.18 19.64 25.54 2.13 
G 33.29 0.72 15.53 17.75 32.71 2.13 
H 44.88 0.97 44.87 0.00 9.28 2.13 
 
It was found that the solution pH increased during the first 3 d immersion 
and then kept constant over the remaining 2 weeks of the experiment. 
However, as a function of CaF2 content in glasses (Fig. 1.18 below), 
increased fluoride incorporation resulted in a solution pH decrease from 
8.03 to 7.83 after immersing for 1 w. Similar results were reported by Al-
Noaman et al. in Tris buffer solution (CaF2 content was 0-13% in Mole) 
(Al-Noaman et al., 2012).  
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Figure 1.18 pH of SBF vs. CaF2 content in the glasses at 1 week immersion (Brauer 
et al., 2010)  
As the above pH rise was less pronounced with increasing fluoride content 
and formation of apatite is strongly pH dependent (Lu and Leng, 2005b), 
the authors expected that the apatite deposition in SBF would decrease 
with increasing fluoride content in the glass. However, after 1 week 
immersion in SBF, all glass compositions showed apatite formation with 
characteristic peaks at approximately 560 cm-1 in FTIR spectra in 
comparison to the spectrum of the unreacted glass. And the characteristic 
phosphate peak was more pronounced with increasing fluoride content 
(Brauer et al., 2010). This suggests that additions of fluoride affect apatite 
formation in SBF.  
Lynch et al. carried out work on multi-component bioactive glasses (SiO2-
P2O5-CaO-CaF2-SrO–SrF2-ZnO-Na2O-K2O) with increasing CaF2+SrF2 
content  (0 - 32.7  Mol.%), and found that the fluoride-containing bioactive 
glasses formed apatite as early as 6  h,  while the fluoride-free control did 
not form apatite within 7 days (Lynch et al., 2012). It also suggests fluoride 
addition significantly improved apatite formation of the bioactive glasses.  
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As the XRD patterns of hydroxyapatite (JCPDS 09-432), fluorapatite (15-
876), carbonated hydroxyapatite (JCPD 19-272) and carbonated 
fluorapatite (JCPDS 31-267) are very similar, Brauer et al. applied 19F 
MAS–NMR to further clarify fluoride contents in the glass result in 
formation of FAp rather than HCA (Brauer et al., 2010). After SBF 
treatment for 2 weeks, all fluoride containing glasses showed a prominent 
feature between -101 and -107 ppm, which were assigned as an overlap 
between fluorapatite (-103 ppm) and fluorite (-108 ppm). Furthermore, 
Rietveld analysis was used to plot the results for relative amounts of 
crystal phases, and it is found that sigmoidal curves of increasing relative 
amounts of fluorite with increasing CaF2 content in the glass, while the 
relative amount of apatite decreased. It can be explained that there are 
low phosphate contents (1.07 Mol.% or less) in this series, which favours 
formation of CaF2 rather than apatite, as there is an excess of calcium and 
fluoride ions but not enough phosphate.  
It is attractive in the glass B (lowest CaF2 content, 4.75% in Mole), as the 
XRD traces represented in Fig. 1.19 below, the apatite peaks at 1 week 
were even less pronounced than at 3 days, which was explained by the 
researchers that due to a lower initial pH of the SBF (7.24 instead of 7.27) 
and the solution pH was at around 8.05 at 3 days, dropped to 8.0 at 1 
week and increased to 8.05 again at 2 weeks. The authors then 
suggested that this glass composition was very susceptible to slight pH 
changes and formation of apatite in SBF is strongly pH dependent (Brauer 
et al., 2010). 
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Figure 1.19 XRD patterns of untreated glass B (bottom) and after immersion in SBF 
for 3 days, 1 week and 2 weeks. Crystal phase in XRD pattern is apatite (*)  (Brauer et 
al., 2010) 
However, Shah et al. later investigated the dissolution behaviour of a 
series of fluoride-containing bioactive glasses (0, 4.75%, 9.28% and 
17.76% CaF2 contained) under physiologically relevant conditions of low 
pH (acetate-buffered MEM, pH was adjusted to 4.80) (Shah et al., 2014a). 
It was found that despite the pH remaining below 6 throughout the study, 
bioactive glasses partially dissolved and formed fluorapatite with the 
fluoride incorporation and subsequent release, which suggested that these 
fluoride containing bioactive glasses also formed apatite even at low pH 
conditions.  
Later, in order to further explore the effects of surrounding solution 
characteristics such as pH, composition and presence of proteins on glass 
dissolution and apatite formation, Shah et al. investigated the dissolution 
behaviour of a fluoride-containing bioactive glass in different solutions as 
showed in Table 1-7 below (Shah et al., 2014b). After immersion for 1 w, 
surprisingly, apatite formation was the fastest in acetate buffered MEM (A-
MEM), which had the lowest pH among the four solutions. It is known that 
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an alkaline environment favours apatite formation (Lu and Leng, 2005a), 
therefore,  Shah et al. suggested that a high pH is not necessary for the 
formation of FAp as it is considered to be more stable at low pH conditions 
than HAp or HCA. 
Table 1-7 Compositions of investigated solutions (HEPES refers to 4-(2-
hydroxyethyl)-1-piperazinee-thanesulfonic acid) (Shah et al., 2014b) 





20 mL, sodium 
acetate buffer 
solution, pH 4.6 





20 mL, 1 M 
HEPES buffer 
solution 







20 mL, 1 M 
HEPES buffer 
solution 







20 mL, 1 M 
HEPES buffer 
solution 




In addition, the authors also found that presence of carbonate resulted in 
formation of calcite (calcium carbonate). The apatite formation was 
significantly delayed by the existence of serum proteins (Shah et al., 
2015). These results suggest that in exploring bioactivity of a material, the 
solution composition and properties are important and need to be taken 
into consideration, in particular when studying the bioactive glasses in 
culture. 
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 Fluoride effects on bone biology and microbiology 1.4.8.3
Fluoride, an element that occurs naturally in the human diet, is found in 
water sources, daily foods and also biologically available in the human 
body and approximately 99% fluoride of the total body content is retained 
in the bones (Aaseth et al., 2004). The physiological concentration in 
saliva is about 1 µM (Dogan et al., 2002). 
Generally, fluoride interacts with mineralized tissues in a biphasic manner 
(Chachra et al., 2008, Aaseth et al., 2004). At low doses, it is passively 
incorporated into the minerals such as bone and teeth to form FAp, which 
has better stability than the mineral HA against dissolution. This has 
promoted the application of fluoridated water to reduce dental caries 
incidence. At low dose fluoride is mitogenic and plays positive effects to 
bone cells, improve the mineralized tissue amount and structure as well as 
the interface between the collagen and mineral, which is the principle for 
fluoride use in osteoporosis treatment. High dose fluoride induces 
occurrence of skeletal and dental fluorosis, which is characterized by 
debilitating skeleton and increased fracture risk as well as marked mottling 
and discoloration in the teeth and even increased wear in the enamel.  
Several clinical trials demonstrated the positive effect of fluoride salts on 
bone mass in osteoporosis (Caverzasio et al., 1998, Riggs et al., 1990, 
Bernstein and Cohen, 1967, Bernstein and Guri, 1963, Epker, 1967, 
Menczel, 1964). Its actions on bone appear to be mediated at several 
levels.  
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For bone matrix, fluoride is incorporated into bone mineral during the 
dynamic bone remodelling process. The hydroxyl group (OH-) in 
hydroxyapatite (Ca10(PO4)6(OH)2) is replaced by fluoride to form 
fluorapatite (Ca10(PO4)6F2), which makes the crystal lattice more compact 
and stable (Grynpas, 1990). It was highlighted that the fluoride substitution 
for hydroxyl group would not be completed in therapeutic fluoride 
concentrations, the replacement was only about a third of the hydroxyl 
ions (Boivin et al., 1989). Research carried out by Moreno et al. 
demonstrated that a mixture of FAp and HA would be more stable against 
dissolution than either component individually (Moreno et al., 1977). 
However, extensive substitution of hydroxyl groups with fluoride is 
required to generate skeletal fluorosis, when the bone deposits exceed a 
threshold of about 0.6% of bone ash, which is characterized by an 
augmentation in trabecular bone volume with a parallel increase in osteoid 
volume, often leads to recurrent bone fractures, or micro-fractures (Aaseth 
et al., 2004).  
For bone cells, Farley et al. firstly reported the direct effects of fluoride on 
osteoblastic cell activity (Farley et al., 1983). In micro-molar 
concentrations (2.5-25 μM), fluoride increased the proliferation and 
alkaline phosphatase activity of bone cells derived from chick embryonic 
calvaria. Similar results were reported in human bone cells as well 
(Wergedal et al., 1988). However, negative results were reported later 
(Kopp and Robey, 1990, Chavassieux et al., 1993). Kopp and Robey 
tested the effect of fluoride, in doses ranging from 10-6 to 10-3 M, on first 
passage human osteoblastic bone cells derived from collagenase-treated 
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trabecular bone fragments. No promotion on cell proliferation was 
detected. It was explained that fluoride did not act in vitro upon 
differentiated osteoblastic bone cells derived from adult human patients, 
which was confirmed by the study carried out by Kassem et al. (Kassem et 
al., 1994). The effects of NaF were compared on more differentiated 
human osteoblast-like (hOB) cells derived from trabecular bone explants 
and on osteoblast committed precursors derived from human bone 
marrow, human marrow stromal osteoblast-like (hMS(OB). It was found 
that NaF at concentration of 10-5 M increased proliferation, alkaline 
phosphatase activity, pro-collagen type I and osteocalcin levels of 
hMS(OB) cells but not hOB cells. Wider fluoride concentrations were 
investigated by Qu et al. via using caprine (goat) osteoblasts (Qu et al., 
2008). They found NaF at concentrations of 10−8 to 10−5 M promoted cell 
proliferation, ALP activity and mineralization, whereas at 10−4 to 10−3 M it 
suppressed cell proliferation and induced apoptosis. These results 
suggest that fluoride may act differently to various osteoblastic cells, 
depending upon concentration (micro-molar to milli-molar) and cell types 
and source (animal and site). As to the mechanisms of fluoride action on 
osteoblastic cells, Huo et al. suggested that BMP/Smad signalling 
pathway was involved in the fluoride-induced promotion of osteoblastic 
cell viability and differentiation (Huo et al., 2013). By examining the effect 
of NaF concentrations (10-6 - 5x10-4 M) on osteoblast proliferation, cell 
cycle, apoptosis, oxidative stress, and the level of insulin-like growth 
factor-I (IGF-I), Wang et al. found that all the tested fluoride concentrations 
inhibited osteoblast proliferation and arrested cell cycle at S phase, which 
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was attributed to decreased IGF-I expression and increased oxidative 
stress damage (Wang et al., 2011). Similar results were reported by Yang 
et al. and they linked the increased fluoride-induced osteoblastic apoptosis 
to altered expression of Bcl-2 family members, which are key regulators of 
the mitochondrial response to apoptotic signals and control the release of 
pro-apoptotic proteins (Yang et al., 2011). Ren et al. reported that in 
osteoblast-like MC3T3-E1 cells, NaF affected the OPG/RANKL/RANK 
system, which is important in maintaining the balance between bone 
formation and resorption (Ren et al., 2011).  
For osteoclasts, Okuda et al. analysed the effects of NaF on the activity of 
isolated rabbit osteoclasts via culturing cells on thin slices of bone and 
quantifying osteoclastic resorption by counting the resorption lacunae 
number and measuring their surface area and depth using scanning 
electron microscope (SEM) (Okuda et al., 1990). It was found that NaF at 
modest concentrations of 0.5-1.0 mM was inhibitory. Similar results were 
reported in osteoclasts isolated from chick long bones with a NaF 
concentration at 15 mg/L (approximately 0.8 mM) (Taylor et al., 1989). 
Biphasic effects of fluoride on osteoclasts have been reported as well 
(Taylor et al., 1990). It was found that NaF at concentration of 15-30 mg/L 
inhibited osteoclast activity, while at low dose (approximately 1 mg/L), NaF 
promoted osteoclast function. Recently, in an in vivo model revealed that 
fluoride at concentrations, 5 and 50 ppm in drinking water, slowed the rat 
alveolar bone repair (Fernandes et al., 2012). For the molecular 
mechanism of fluoride to osteoclasts, Pei et al. revealed the nuclear factor 
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of active T cells c1 (NFATc1) and its downstream genes may be involved 
(Pei et al., 2012).  
While NaF may increase bone mass, it is pointed out that the newly 
formed bone appears to lack normal structure and strength (Carter and 
Beaupre, 1990, Riggs et al., 1990, Sogaard et al., 1994, Everett, 2011). 
Studies of 15 osteoporosis patients with sodium fluoride therapy, Aaron et 
al. found a marked increase in trabecular bone volume (43%), which was 
attributed to an increase in trabecular thickness (46%) rather than strut 
number. There were no significant changes in the trabecular bone surface, 
number and the ratio of bone volume/trabecular width after fluoride 
treatment (Aaron et al., 1991). Similar observations were found in rats as 
well (Sogaard et al., 1995, Turner et al., 1995). These results suggest that 
fluoride increases the bone mass but may reduce bone quality. 
Besides the ability to form FAp, to reduce demineralisation as well as 
enhance re-mineralization and to bring positive effects on bone, fluoride is 
also known for highly effective anti-microbial properties (Burke et al., 
2006, Bradshaw et al., 1990). It affects bacterial metabolism through a 
spectrum of actions with fundamentally different mechanisms (Marquis, 
1995, Marquis et al., 2003). Firstly, fluoride can act directly as a bacterial 
enzyme inhibitor, such as inhibiting the glycolytic enzyme enolase in an 
irreversible manner. In addition, fluoride can bind directly to heme then 
inhibits the heme-based peroxidases of bacteria. Another action involves 
the formation of metal-fluoride complexes, most commonly AlF4-, which 
interact with bacterial proton-translocating F-ATPase and nitrogenase 
enzymes, mimicking phosphate to form complexes with ADP at the 
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enzyme reaction centres and resulting in bacterial activity inhibition. In the 
cariogenic dental plaque, fluoride weak-acid character is the most 
pertinent action. It enhances the bacterial membrane permeability to 
protons and compromises the F-ATPases function in exporting protons, 
thereby inducing cytoplasmic acidification and acid inhibition of glycolytic 
enzymes (Marquis, 1995). Therefore, it is an important player to reduce 
the bacterial acid tolerance. Marquis et al. found that fluoride at levels as 
low as 0.1 mM can cause complete arrest of glycolysis by intact cells of S. 
mutans (Marquis, 1995). Overall, the antibacterial effects of fluoride 
appear to be complex, involving both direct and indirect actions on 
bacteria. 
Fluoride is widely used to modify biomaterials. In vitro and in vivo studies 
were carried out by Cooper et al. and they found fluoride ion modification 
of the TiO2 grit - blasted surface enhanced osteoblastic differentiation and 
interfacial bone formation (Cooper et al., 2006). Another fluoride implant 
study revealed that after 8-weeks’ healing, at the bone - implant interface, 
the pull-out, volumetric bone mineral density and osteoblast gene 
expression such as osteocalcin, runx2 and collagen type I gene 
expression were higher in fluoride implants, while the inflammation 
markers (TNF-a and IL-6) and osteoclast gene expression (TRAP) 
decreased (Monjo et al., 2008). In another fluoride containing bioactive 
glass study, they showed promotion in osteoblast proliferation, 
differentiation and mineralization as well (Gentleman et al., 2013). F 
surface-modified titanium specimens significantly inhibit the growth of both 
P. gingivalis and A. actinomycetemcomitans compared with the polished 
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titanium (Yoshinari et al., 2001). Rostami et al. investigated the 
antibacterial ability of bioactive glasses and they found the fluoride 
containing ones had significant antibacterial activity against E. coli, P. 
aeruginosa and S. aureus, which are responsible for most infections, while 
the fluoride-free bioactive glass samples did not show any antibacterial  
activity (Rostami et al., 2015). 
Therefore, combining the positive effects of fluoride on bioactive glass 
structure and bioactivity, in particular, on bone formation and being 
antibacterial, it is rational and of importance to develop low fluoride 
containing bioactive glasses. During the bioactive glass synthesis, fluoride 
is incorporated mainly in the form of CaF2, as apatite contains Ca
2+ and it 
is suggested that the surrounding solution must become super-saturated 
with PO4
3- and Ca2+ ions for rapid apatite formation (Hill, 1996). Thus, the 
addition of CaF2 not only brings fluoride but also calcium, in which the 
biological performance of released Ca2+ cannot be ignored.  
In a normal individual, Ca2+ in the blood is maintained at consistent levels 
(~1.4 mM) (Hofer, 2005). Changes in extracellular Ca2+ concentrations 
affect osteoblast function, bone remodelling and contribute to systemic 
calcium homeostasis including the intracellular calcium, which is a 
ubiquitous second messenger responsible for numerous cellular 
processes such as fertilization, mitosis, neuronal transmission, muscle 
contraction and relaxation, gene transcription and cell death (Valério et al., 
2007). Such as, human osteoblast-like cells showed different responses of 
the intracellular calcium concentration to changes of the extracellular 
calcium concentration (Habel and Glaser, 1998). Foetal rat calvarial cells 
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were treated with a narrow range of Ca2+ concentrations (CaCl2, 0.5–3 mM) 
and responded in a time- and concentration-dependent manner including 
the promotion of differentiation and mineralized bone nodule formation 
(Dvorak et al., 2004). When designing calcium phosphate-based scaffolds 
for bone tissue engineering, Liu et al. suggested that cellular Ca2+ level 
must be taken into consideration, as they found that the ALP activity, Type 
I collagen formation and osteocalcin mRNA expressions reached the 
highest level with a 1.8 mM Ca2+ concentration, however, the above 
cellular activities were significantly decreased as the Ca2+ concentration 
rose from 1.8 to 7.2 mM (Liu et al., 2009). Valerio et al. also reported that 
after treatment with a range of Ca2+ concentrations (100-500 mg/L), the rat 
osteoblast cellular viability was not altered up to 300 mg/L (7.5 mM) and 
decreased thereafter (Valerio et al., 2004). Thus, combining the benefits of 
other ions such as silicon, bioactive glass (BG60S) ionic products with a 
released Ca2+ concentration around 50 mg/L significantly increased 
osteoblast proliferation, in addition, the Ca2+ from BG60S dissolution 
triggered further mobilization of intracellular Ca2+ and may alter osteoblast 
glutamate release, which is important in neurotransmitter in mechano-
sensitivity (Valério et al., 2007, Valerio et al., 2009). Therefore, although 
calcium is important in bioactive glass structure and apatite formation, it is 
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1.5 Hypothesis and aims  
Synthetic biomaterials are an alternative clinical strategy for autografts to 
repair the defective bone tissues. To obtain a favourable biological 
outcome, ideally these synthetic grafts should emulate the chemical and 
physical structure of the native bone tissue, as well as being 
osteoinductive for the bone-forming cells, angiogenic for the vessel growth, 
display antibacterial ability and be non-toxic for the surrounding tissues. 
Due to the complex structure of periodontium, a GTR technique with 
combined bone grafts and bioresorbable membranes is applied for 
periodontal regeneration, to block the fast growing soft tissue cells from 
invading the defective area and allowing cells from PDL and bone to 
repopulate the periodontal defects (Ivanovski et al., 2014, Karring, 2000).  
Bioactive glasses have been widely studied for their specific clinical 
applications due to their significant advantages such as promoting HA 
layer on their surface and bonding with the surrounding living tissues 
including both bone and soft tissues, being osteoinductive and degradable, 
in addition, their compositions can be modified and tailored depend upon 
the requirement.  
Therefore, the strategy adopted in this work in order to achieve the above 
requirements was to consider the effect of bioactive glass compositions on 
material properties and biological performances, especially the effect on 
periodontal soft tissues to guide favouring unimpeded healing and improve 
periodontal regeneration such as simplifying the periodontal surgery 
process without using or minimal the GTR technique.  
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The aim of this thesis is to understand modified chemical compositions 
(high P2O5 content and varied low fluoride addition) on characteristic 
properties of a base bioactive glass (SiO2-P2O5-Na2O-CaO), including pH 
change, ion release and apatite formation in Tris Buffer solution. Novelty 
and contribution to knowledge is gained through relating the observed 
bioactivity change in Tris buffer with the results in cell culture medium and, 
investigating the effects of modified bioactive glass conditioned medium 
on pre-osteoblast cells (osteogenic and angiogenic responses), human 
fibroblasts and epithelial cells. An investigation of the bioactive glass 
antibacterial potential on both supra- and sub-gingival pathogens is also 
presented.  
 Objectives 1.5.1
1) To document the effects of fluoride on pre-osteoblasts (MC3T3-E1), 
human oral fibroblasts and epithelial cells 
2) To design and produce bioactive glasses with high phosphate and 
varied low fluoride content (P2O5 content will be kept constant at 6.33%, 
while F will increase from 0% to 7% in Mole) 
3) To experimentally characterise the bioactive glass properties in Tris 
Buffer solution and cell culture medium (α-MEM), including pH change, 
apatite formation and Ca, Si, P, Na and F release  
4) To assess the cytotoxicity of bioactive glass conditioned medium  
5) To further assess the effect of bioactive glass conditioned medium (72 
h immersion) on cellular response, including osteogenic and angiogenic 
90 | P a g e  
 
potential in pre-osteoblasts and proliferation in human oral fibroblasts and 
epithelial cells  
6) To quantify the antibacterial activity of bioactive glass particulates on 
supra- and sub-gingival pathogens 
 Thesis outline 1.5.2
Relevant background literature is discussed in Chapter 1, including 
periodontium, periodontitis, periodontal regeneration and bioactive glass 
theory, in which the effects of phosphate and fluoride on bioactive glasses 
and bone biology are discussed. The aims as well as outline of this thesis 
are also presented in Chapter 1. 
Chapter 2 represents the experimental work and techniques. Chapters 3 - 
6 focus on the in vitro results of the novel low F-/high P2O5 bioactive 
glasses. The rate of pH change, apatite formation and ion release in both 
Tris buffer solution and cell culture medium (α-MEM) are assessed in 
Chapter 3. Whether this bioactive glass could be used to regulate local 
bone turnover and potentially alleviate problems such as osteoporosis and 
complex bone defects, an investigation of the effects of F- and bioactive 
glass conditioned medium on pre-osteoblasts (MC3T3-E1), including 
osteogenic and angiogenic responses is represented in Chapter 4. To 
further explore the potential application for periodontal soft tissue 
regeneration, the cytotoxicity and proliferation of F- and bioactive glass 
conditioned medium on human oral fibroblasts and epithelial cells are 
reported in Chapter 5. Chapter 6 assesses the antibacterial activity of 
bioactive glass particulates on supra- and sub-gingival pathogens.  
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The overall project conclusions and recommended future work are 
discussed in Chapter 7.  
















92 | P a g e  
 
Chapter 2  Materials and methods 
2.1 Diagram of experimental plan 
 





















Bioactive glass synthesis 







(Tris buffer and α-MEM) 
Ground and sieved 






















VEGF gene expression 
VEGF protein production 
93 | P a g e  
 
2.2 Cell culture 
 Cell lines and culture conditions 2.2.1
 Osteoblast cell line 2.2.1.1
MC3T3-E1 is a pre-osteoblast cell line established from mouse calvaria 
with osteogenic potential to differentiate into osteoblasts and osteocytes 
and, has been demonstrated to form calcified bone tissue in vitro (Wang et 
al., 1999, Jeong and Jeong, 2016). In this study, MC3T3-E1 cells were 
maintained in alpha-Minimum Essential Medium (α-MEM) supplemented 
with 10% fetal bovine serum (FBS), 1% antibiotic (penicillin and 
streptomycin), 1% L- glutamine (all from Invitrogen, UK) and incubated at 
37 ºC, 5% CO2 atmosphere. Medium were changed every 3 days to 
maintain cell cultures. 
 Epithelial cell line 2.2.1.2
The A431 cell line is used as an epithelial cell model derived from an 
epidermoid carcinoma in the vulva of an 85-year old female. These cells 
are morphologically similar to normal differentiated squamous epithelial 
cells (Brown et al., 2014). They were cultured in an incubator at 37 ºC, 
10% CO2 atmosphere in Delbecco modified Eagle’s medium (DMEM) with 
10% FBS, 1% antibiotic and 1% L-glutamine.  
Recently, human oral epithelial primary cells have been marketed from a 
commercial company (Celprogen, USA). They are derived from oral cavity 
epithelia tissue and were cultured in an incubator at 37 ºC, 10% CO2 
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atmosphere with extra-cellular matrix pre-coated flasks in specific medium, 
human oral epithelial cell culture complete medium (Celprogen, USA).  
 Fibroblasts 2.2.1.3
NHOF-1 is a fibroblast strain prepared from human normal oral mucosa 
tissue samples by Professor E Ken Parkinson group (Queen Mary 
University of London) (Lim et al., 2011). They were cultured in an 
incubator at 37 ºC, 10% CO2 atmosphere in DMEM with 10% FBS, 1% 
antibiotic and 1% L-glutamine.  
 Cell passage 2.2.2
At 80-90% confluence, cells were passaged and split in a ratio of 1:3. After 
two washes with phosphate-buffered saline (PBS), 2 ml trypsin/EDTA 
(Lonza, UK) was added to cells grown in T75 plastic tissue culture flasks. 
Cells were incubated at 37 ºC with trypsin/EDTA for approximately 5 min 
until completely detached from the flasks. Once cell attachment was 
dissociated, 8 ml growth medium containing serum was added, in which 
the serum was required to deactivate the proteolytic activity of trypsin. Cell 
suspension was then transferred to a conical centrifuge tube and 
centrifuged at 800 rpm for 5 min to pellet cells. The supernatant was 
carefully removed and cells were re-suspended in fresh growth medium 
supplemented with 10% FBS. An aliquot of the cell suspension was 
seeded into new flasks containing growth medium.  
 Cryopreservation and recovery of cell stocks 2.2.3
For cryopreservation, cells were grown to 80-90% confluence as 
previously described in cell passaging. However, in this case the cell 
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pellets were re-suspended in Freeze down medium (FDM) (10% DMSO in 
FBS). Aliquots of 1 ml suspensions were transferred to 2.5 ml cryovial and 
frozen down to -80 ºC in a freezing container filled with Isoproponal.  Cells 
were stored at -80 ºC for 48 h before transferred to liquid nitrogen for long-
term storage. The use of FDM and Isoproponal filled freezing container is 
to ensure temperature reduces in a controlled manner (1 ºC/min), which 
protects cells against intracellular and extracellular ice formation and 
dehydration occur during the freeze down stage of cryopreservation.  
For the recovery of frozen aliquots, cryovials were removed from liquid 
nitrogen and immediately placed in a 37 ºC water bath until completely 
thawed. Then vials were cleaned with 70% Industrial methylated spirit 
(IMS) and cell suspension aliquots were added to culture medium and 
transferred to conical centrifuge tube. Cells were centrifuges for 5 min at 
800 rpm to pellet the recovered cells. The supernatant was carefully 
removed and cells were re-suspended in fresh growth medium 
supplemented with 10% FBS in T75 flasks. 
2.3 Cellular response to F- concentrations 
 Osteoblasts 2.3.1
 Cell differentiation by quantitative alkaline phosphatase 2.3.1.1
(ALP) activity assay 
Alkaline phosphatase (ALP) is a membrane enzyme localized to the outer 
surface of cells through a phosphatidylinositol-glycolipid anchor (Harrison 
et al., 1995). In bone, it is produced by osteoblasts and deposited in matrix 
(Christenson, 1997). During the bone formation phase, ALP is produced in 
96 | P a g e  
 
extremely high amounts and considered as an indicator of early stage 
osteoblast differentiation (Whyte MP, 1983).  
An enzyme histochemical assay with good analytical sensitivity is widely 
used for ALP activity measurement in vitro (Lee et al., 2013, Ma et al., 
2013b, Sun et al., 2013), in which ALP converts ρ-nitrophenyl phosphate 
into soluble yellow coloured ρ-nitrophenyl (ρNP) (Fig. 2.1). Afterwards, the 
intensity of yellow coloured reaction product ρNP is quantified by 
measuring the absorbance at 405 nm. 
 
Figure 2.1 The soluble yellow coloured reaction product ρNP  
A standard curve (Fig. 2.2), demonstrates a linear relationship between 
absorbance and known amounts of ρNP, is used to determine the quantity 
of ρNP generated by ALP in the cells. Then ALP activity of the test 
samples can be calculated and expressed as nmol/ml/min (Lim et al., 
2014): 
ALP activity (nmol/ml/min) = A / V / T 
Where:  
A is amount of ρNP generated by samples (in nmol).  
V is volume of sample added in the assay well (in ml).  
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T is reaction time (in minutes) 
 
Figure 2.2 ρNP standard curve. The standard curve is constructed by adding 0, 4, 8, 12, 
16 and 20 nmol pNP standard solution in a 96-well plate. Tris-buffer and 0.5 M NaOH are 
added to bring a final volume of 200 µl in each well. Absorbance is measured at 405 nm. 
Each marker represents mean ± S.E.M of eight independent experiments. 
To investigate the effects of fluoride on MC3T3-E1 differentiation, cells 
were seeded at a density of 3000 cells/cm2 in 96-well plates and allowed 
to attach for 24 h in α-MEM containing 2% FBS. Then cells were treated 
for 4, 7 and 10 days with various concentrations of NaF (F- concentrations: 
0, 0.1, 1, 1.9, 9.5, 19ppm) (Sigma, UK) supplemented to the growth 
medium, which consisted of α-MEM with 5% FBS. 
At each time point, medium was removed and cells were washed twice 
with PBS. After that, wells were emptied and plates inverted on tissue 
paper before being stored in the freezer until all samples collected. Cells 
were lysed through a freezing and thawing process and reacted with a 
solution of 2.5 mg/ml 4-Nitropheyl phosphate disodium salt hexahydrate in 
Tris buffer solution with 1 mM MgCl2 (pH = 9.5, all from Sigma, UK) for 40 
min in 37 ºC. 0.5 M NaOH was used to stop the reaction and the intensity 
of yellow colour reaction product was quantified by measuring the 
y = 0.0457x - 0.0125 























pNP Standard Curve 
98 | P a g e  
 
absorbance at 405 nm and ALP activity of the test samples were 
calculated and expressed as nmol/ml/min. For each experimental group, 
ten wells were assessed under the same condition. 
 Cell proliferation by quantitative DNA content assay 2.3.1.2
Determining DNA quantity with the fluorochrome bisbenzimidazole 
(Hoechst 33258) is a well-established, simple, sensitive and inexpensive 
method to estimate mononuclear cell number. (Rago et al., 1990). It is 
based on the increased fluorescence intensity of the fluorochrome 
Hoechst 33258 upon binding cellular DNA. The reaction is highly specific 
and other cellular components such as RNA and proteins do not cause 
significant fluorescence intensity change.  
In this assay, it is vital to make the fluorochrome come into contact with 
the cellular DNA. Labarca et al. found that higher fluorescence yield was 
observed in the presence of high salt concentrations, which may be 
caused by improved DNA dissociation, resulting in more DNA binding site 
exposure for the binding of dye (Labarca and Paigen, 1980). Therefore, 
incubation with hypotonic distilled water and freezing are used to lyse cells 
and produce a relatively homogenous crude cell extracts. Afterwards, the 
fluorochrome bisbenzimidazole (Hoechst 33258) in a high salt TNE buffer 
(10 mM Tris, 1 mM EDTA, 2 M NaCl, pH 7.4) is added to the lysed cells in 
96-well plates, which are measured for the fluorescence intensity at 355 
nm emission and 460 nm excitation on a plate reader. This allows 
accurate determination of cell number by comparing fluorescence intensity 
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with an established standard curve, which is a linear correlation between 
fluorescence intensity and the cell number over a broad range (Fig. 2.3).  
 
Figure 2.3 Cell number standard curve for MC3T3-E1 cells. 1500-50,000 cells, using 
Hoechst 33258 after lysis by brief incubation in distilled water and freezing. Insert shows 
a second cell standard assay for 1000-10,000 cells. Fluorescence is expressed as 
arbitrary units. Each marker represents mean ± SE of eight independent experiments 
 
For the effects of fluoride on MC3T3-E1 proliferation, cells were treated as 
those in the differentiation (ALP) assay. At each time point, medium was 
removed and cells were washed twice with PBS, emptied by inversion and 
then stored at -20 ºC freezer. After 24 h, wells were incubated with 100 µl 
deionized water at room temperature for 2 h and returned to the freezer 
for another 24 h. This progress ruptured the cells and released DNA. 
Subsequently, the reactive mixture was made by adding fluorochrome 
bisbenzimidazole (Hoechst 33258) to TNE buffer buffer (10 mM Tris, 1 
mM EDTA, 2 M NaCl, pH 7.4) in a volume ratio of 1:50. 100 µl reactive 
mixture was added to each well and the product fluorescence intensity 
was measured in the plate reader. The accurate cell number was 
y = 0.2154x + 252.72 
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determined by comparing fluorescence intensity with the known cell 
number standard curve. For each experimental group, ten wells were 
assessed for each same condition. 
 Epithelial cells and oral fibroblasts 2.3.2
 Cytotoxicity by MTT assay 2.3.2.1
MTT assay is a technique for measuring the living cells activity to 
determine the cytotoxicity of drugs at different concentrations in vitro (van 
Meerloo et al., 2011, Plumb, 2004, Carmichael et al., 1988, Ciapetti et al., 
1993, Marks et al., 1992). 
Viable cells with active metabolism convert the yellow tetrazolium MTT (3-
[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide) into a purple 
coloured formazan product, while the dead cells do not have this ability. 
Then the purple formazan crystals can be solubilised in DMSO and the 
formazan concentration is detected by measuring absorbance spectra 
using a plate reader at 570 nm. Thus, colour formation is considered as a 
useful and accurate marker of the viable cells and the increase or 
decrease in cell viability could be detected by measuring the absorbance 
at 570 nm with validity in various cell lines (Mosmann, 1983). However, 
the exact cellular mechanism of MTT reduction into formazan is not well 
understood. Some researchers attributed it to the mitochondrial activity as 
mitochondrial dehydrogenases of viable cells cleave the tetrazolium ring, 
yielding purple formazan crystals (Riss et al., 2004, van Meerloo et al., 
2011).  
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Thus, to investigate the toxicity of F- concentrations on epithelial cells and 
fibroblasts, A431 and NHOF-1 were seeded at a density of 3000 cells/cm2 
in 96-well plates and allowed to attach for 24 h in DMEM containing 2% 
FBS. Then cells were treated for 1, 3 and 5 days with various 
concentrations of NaF (F- concentrations: 0, 0.1, 1, 1.9, 9.5, 19 ppm). 
At each time point, medium was removed and cells were washed twice 
with PBS. 30 μl MTT solution (5 mg/ml in PBS) was added to each well 
and the cells were incubated in 37 ºC for 4 h. After that, DMSO was added 
to dissolve the formed formazan crystals (100 μl/well). The intensity of 
purple colour reaction product was quantified by measuring the 
absorbance spectra at 570 nm in a plate reader. The final data was 
normalised with the control and presented in percentages.   
 Cell proliferation  2.3.2.2
A431 and NHOF-1 were treated with NaF concentrations (F-: 0, 0.1, 1, 1.9, 
9.5, 19 ppm) for 4 d, 7 d and 10 d. Then the cell number was investigated 
as previously done for MC3T3-E1 cells.  
 Assessing validity of human oral epithelial primary cells 2.3.2.3
As the purchased human oral epithelial primary cells were recently 
marketed from a commercial company (Celprogen, USA) and there was 
no publication, the specific epithelial cell markers were tested by 
immunostaining before using them in the later experiments.    
Cytokeratin 5 (CK5) is a cytoplasmic intermediate filament protein 
specifically expressed in epithelial cells from stratified squamous 
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epithelium including oral mucosa. Desmoglein-3 (Dsg3) is a 
transmembrane glycoprotein component of desmosomes, which are cell-
cell junctions between epithelial cells.  Therefore, CK5 and Dsg3 were 
chosen as two specific markers for the human oral epithelial primary cells. 
Cells were seeded on coverslips and 24 h later, they were washed twice 
with PBS and fixed with 4% formaldehyde for 10 min. Then the cells were 
permeabilized with 0.1% Triton X-100 in PBS for 2 min followed by the 
washing in PBS (5min x 2). For fluorescence staining, non-specific binding 
was prevented by blocking buffer for 30 min followed by incubation with 
target specific primary antibodies (kindly provided by Dr. Hong Wan, 
QMUL) diluted in blocking buffer for 1 h at room temperature. Cells were 
then washed three times with washing buffer and incubated in secondary 
antibodies (kindly provided by Dr. Hong Wan) for 1 h at room temperature. 
After two washes with washing buffer, cells were incubated with DAPI 
(kindly provided by Dr. Hong Wan) for 10 min for nuclear counter-stain. 
After a final wash with washing buffer, coverslips were mounted on slides 
using ProLong® Gold anti-fade liquid mount (Invitrogen, UK) and sealed 
with clear nail varnish. Coverslips were imaged using Leica DM5000 epi-
fluorescence microscope.  
Blocking buffer 
 10% goat serum in washing 
buffer 
Washing buffer 
 0.2% Tween 20 in PBS 
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2.4 Bioactive glass design and synthesis 
 Rationale 2.4.1
Bioactive glasses have been used to repair bone defects. However, recent 
studies by Monfoulet et al. revealed that a rapid pH rise, and subsequent 
deleterious effects on resident cells, during application is a major problem 
with the current bioactive glass bone grafts such as the traditional 45S5 
composition (Monfoulet et al., 2014).   
As discussed previously in the literature review (O’Donnell et al., 2008b, 
O’Donnell et al., 2008a, O'Donnell et al., 2009), the high phosphate 
content glasses, not only promote apatite formation, but also reduce the 
rate and extent of the pH rise, which may reduce the damage brought by a 
rapid pH rise, to the cells in the local environment and improve 
osseointegration. Furthermore, the higher phosphate content will enable 
the development of products with higher surface areas without running 
into the pH problems of the currently available bioactive glasses that use a 
coarse particle size. The finer particle size/ increased surface area will 
result in faster glass dissolution creating an environment in which HA and 
hopefully, bone can be more rapidly formed. 
Fluoride is of interest for the treatment of osteoporosis, with significant 
antibacterial ability and, is readily incorporated into bioactive glasses via 
complexing with calcium and sodium in glass network (Brauer et al., 2009, 
Brauer et al., 2012). However, it plays negative role at high sustained 
doses such as the inducing of skeletal and dental fluorosis. For the in vitro 
cell research, high doses of fluoride (10-4 to 10-3 M) suppressed osteoblast 
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proliferation, differentiation and can even induced apoptosis (Qu et al., 
2008). But Mneimne et al. reported, fluoride even at low content (4.53% in 
mole) significantly promoted apatite formation after immersion in Tris 
buffer solution (Mneimne et al., 2011) 
Therefore, the aim of this aspect for the project was to develop bioactive 
glasses with high phosphate and low fluoride content to reduce the rapid 
pH rise problem in current bioactive glass bone grafts, to form crystallite 
apatite in vitro within a short time period and to promote efficient 
osseointegration.  
 Bioactive glass design and compositions 2.4.2
The bioactive glasses produced in this research were based on the 
previous glass  (O’Donnell et al., 2008a) with the highest phosphate 
content and with a gradual fluoride addition in this study (Table 2-1).  
Table 2-1  Bioactive glass compositions. Compositions in Mol.%  
NC fixed at 2.08 
Glass       SiO2       Na2O       CaO       P2O5       CaF2 
P6.33F0       38.14       29.62       25.91       6.33        0 
P6.33F1       37.59       29.38       25.70       6.33       1.00 
P6.33F3       36.57       28.85       25.25       6.33       3.00 
P6.33F5       35.55       28.33       24.79       6.33       5.00 
P6.33F7       34.53       27.81       24.33       6.33       7.00 
P6.33F0 named ICSW9 in previous publications (O’Donnell et al., 2008b, O’Donnell et al., 
2008a, O'Donnell et al., 2009) 
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 Bioactive glass synthesis 2.4.3
Bioactive glasses in the system SiO2-P2O5-CaO-Na2O-CaF2 were 
prepared by the melt-quench route. Briefly, mixtures of analytical grade 
SiO2 (Prince Minerals Ltd, UK) P2O5, Na2CO3, CaCO3 and CaF2 (all from 
Sigma Aldrich, UK) were weighed in the appropriate amounts to give a 
batch size of 200 g. The batch was mixed thoroughly and placed in a 
platinum/rhodium crucible and melted at 1360 ºC for 1 hour in an 
electrically heated furnace (Lenton EHF 17/3). After melting, the glass was 
quenched rapidly into deionized water to prevent crystallization and phase 
separation. The resulting frit was washed with ethanol then dried in a 
drying cabinet overnight.   
100 g of the dried frits were then ground in a vibratory Gyro Mill  (Glen 
Creston, UK) for 2 x 7 minutes and sieved for 60 minutes in a sieve shaker  
(Retsch ,VS1000, Germany) to obtain below and above 38 μm particles. 
The size of the particles and the grinding time was kept constant in order 
to maintain control over the particle size distribution. Particles with a size 
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2.5 Bioactive glass characterization 
X-ray diffraction (XRD) is an useful tool for the investigation of material 
structure (Bear and Selby, 1956, Carlstrom and Engfeldt, 1954, Culity, 
1956, Trautz, 1955). When an x-ray beam hits an atom, the electrons 
around the atom start to oscillate with the same frequency as the incident 
beam does. Diffracted x-rays with interference to one another are 
generated when they leave the sample. This phenomenon is called x-ray 
diffraction. Hence, a diffracted x-ray may be described as a beam 
composed of a large number of scattered rays mutually reinforcing one 
another. However, if the atoms are in a crystal with regular arrangements, 
constructive interference will be developed in a very few directions. The 
waves will be in phase and there will be well defined x-ray beams leaving 
the sample, which could be collected and interpreted to produce a pattern 
with some featured regions of intensity in characteristic sharp peaks at 
specific analysis of 2θº, which can be used to identify the crystalline 
components of the sample. However, in amorphous materials, such as 
bioactive glasses which have randomly arranged atoms, destructive 
interference in almost all directions will occur, which are out of phase and 
there are no resultant strong coherent beams energy leaving the solid 
sample. Thus, there are no sharp peaks with amorphous materials, only 
broad diffuse humps are present. 
For the aims of this study, XRD was used to determine that whether 
synthetic bioactive glasses were amorphous or partially crystalline, 
whether the quenching process in deionized water initiated the reaction 
between bioactive glasses and water to form crystalline phase, and to 
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identify the different crystalline phases in bioactive glasses after 
immersion in different solutions. 
Here, 100 mg of each bioactive glass composition was studied using an X 
Pert Pro X-ray diffractometer (Panalytical, the Netherlands) with flat plate 
θ/θ geometry and Ni-filtered Cu-Kα radiation (Kα1= 1.540598 and Kα2= 
1.5444260Ǻ) at 45 kV/40 mA. The pattern was taken in the 2θ range of 5º 
to 70º with a step size of 0.0334º (2θ) and a step time of 2.0 seconds. The 
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2.6 Bioactive glass bioactivity study 
 Tris buffer solution preparation 2.6.1
Tris buffer solution, free of Ca2+ and PO4
3- ions with a pH 7.3, is an 
excellent medium to assess bioactive glass dissolution and apatite forming 
capacity (Shah et al., 2014b).   
For a 2 L batch of Tris buffer solution, 15.090 g tris-(hydroxymethyl) 
aminomethane (Sigma–Aldrich) was slowly dissolved in 800 ml deionised 
water, with the addition of 44.2 ml 1 M HCl and the solution was left in a 
shaking incubator at 37 °C overnight. Then the pH was adjusted to 7.3 by 
adding small amounts of 1 M HCl followed by the solution transferred to a 
2 litre flask where the total volume was adjusted to 2 L by adding 
deionised water.  
 Dissolution study 2.6.2
75 mg bioactive glass powder was weighed on a scale (±0.1 mg) and then 
transferred into a 50 ml Falcon tube with 50 ml Tris buffer solution. The 
bioactive glass powder in solution was kept in an orbital shaking incubator 
at 37 °C with an agitation rate of 60 rpm for 2, 8, 24, 72 and 168 hours. 
For each experimental group, three samples were assessed under the 
same conditions. 
At each time point, tubes were removed from the incubator with the pH 
immediately measured by a pH electrode (Oakton Instruments, Nijkerk, 
the Netherlands) to analyse the pH change resulting from reaction of the 
bioactive glasses. Then samples were filtered with filter paper (4-13 
micron pore size retention). The filtrate was collected in 50 ml Falcon 
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tubes and stored in a fridge at 4 °C. Remaining solid powders were stored 
in petri dishes in a 37 °C drying cabinet to dry overnight and were 
collected the following day. 
 Solution characterisation 2.6.3
Inductively coupled plasma-optical emission spectrometry (ICP-OES) is a 
powerful tool for the presence and quantity of elements. Within the 
technique, the sample solution is converted to an aerosol, enters the 
central tube of the plasma and exposed to radio frequency then it 
evaporates and breaks down into atoms. Due to the high temperature 
(10,000K) of the plasma, a large proportion of the atoms are ionized by 
losing its most loosely bound electron. Then the detector will receive an 
ion signal in proportion to the concentration of the ion. The concentrations 
of the samples can be determined through calibration with the reference 
standard. ICP-OES is highly sensitive with good precision, reproducibility 
and multi-element determinations for different elements including P and Si 
could be performed simultaneously. (Amadasi et al., 2013, Wang et al., 
2013b).  
However, for the fluoride, ICP-OES is not applicable. A fluoride selective 
electrode is a type of ion selective electrode sensitive to the concentration 
of the fluoride ion. It consists of a sensing element bonded into an epoxy 
body. When the sensing element is in contact with a fluoride containing 
solution, an electrode potential develops across the sensing element. 
Therefore, the first step is the calibration of the instrument, in which, the 
potentials of fluoride standard solutions are measured. By plotting the 
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measured potential values as a function of the fluoride ion concentration, 
the calibration line can be obtained, which is expected to be straight as 
showed in Fig. 2.4 below. In the next step, potentials in the tested 
solutions will be measured. Using the calibration straight line, the fluoride 
concentration in the samples can be calculated. 
 
Figure 2.4 Typical fluoride calibration curve. The standard curve is constructed by 
measuring the electrode potential of NaF concentrations (100-0.3125 ppm). Each marker 
represents mean ± S.E.M of three independent experiments. 
 
Therefore, in this study, the remaining solutions were analysed by both 
ICP-OES and fluoride ion selective electrode to examine the solutions 
from the bioactivity studies. ICP-OES (Varian Vista-PRO, Varian Ltd., 
Oxford, UK) was used to detect concentrations of silicon, calcium, sodium, 
and phosphorus in solution. All samples were diluted 1:10 with distilled 
water then stabilized and digested with the addition of 1% nitric acid. 
Fluoride selective electrode (Orion 9609BNWP with Orion pH/ISE meter 
y = 57.145x - 155.36 





























Fluoride calibration curve 
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710, both Thermo Scientific, Waltham, MA, USA) was used to measure 
fluoride levels with calibration standards. 
 Solid characterisation 2.6.4
Once the dried glass particles from the dissolution studies were collected, 
they were analysed by XRD (same conditions and instrument as 
described earlier) and FTIR (Fourier Transform Infrared Spectroscopy, 
Spectrum GX, Perkin-Elmer, Waltham, MA, USA; data collected from 
1600 cm-1 to 500 cm-1) to look primarily for apatite formation.  
FTIR, is sensitive to the mid-region electromagnetic spectrum (4000-200 
cm-1), and is an effective method to determine the molecule structures 
with their characteristic absorption of infrared radiation. Essentially, the 
energy associated with infrared beams are absorbed or transmitted by 
sample molecules. Then the rest energy can be detected and presented in 
a spectral plot against wavelength to create a fingerprint of the sample by 
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2.7 Cytotoxicity of bioactive glass conditioned medium 
 Preparation of bioactive glass conditioned medium 2.7.1
Cell culture medium more closely reflects the composition of the 
physiological environment and could be used to investigate cellular 
response to bioactive glass dissolution behaviour. Thus, 75 mg fine 
bioactive glass particles from each composition was immersed in 50 ml α-
MEM or DMEM with 1% antibiotic (penicillin and streptomycin) and kept in 
a shaker (60 rpm) at room temperature for 2, 8, 24 and 72 h. 
At each time point, the samples were centrifuged (800 rpm, 5 min) to 
separate the solution and solid. Solution was then filtered with filters (0.2 
micron pore size) for sterilization. Filtrate was further supplemented with 
1% L- glutamine and 5% FBS for α-MEM and 2% FBS for DMEM and 
stored in a fridge at 4 °C for cell treatment. The schematic representation 








Figure 2.5 Schematic representation of the bioactive glass conditioned medium 
preparation 
75mg glass particles + 
50ml cell culture media 
(α-MEM or DMEM + 1% 
P/S)  
2h, 8h, 24h and 72h, in 
a shaker (60 rpm) 




Adding 1% L-glutamine and 
5% FBS for α-MEM; 2% 
FBS for DMEM    
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 Cytotoxicity by MTT assay 2.7.2
MC3T3-E1, A431 and NHOF-1 cells were seeded at a density of 3000 
cells/cm2 in 96-well plates and allowed to attach for 24 h. To assess 
whether cells could survive in bioactive glass conditioned medium, cells 
were treated for 1, 3 and 5 days with the bioactive glass conditioned 
medium (all bioactive glasses immersed in medium for 2, 8, 24 and 72 h). 
For each experimental group, six samples were assessed under the same 
condition. At each time point, cytotoxicity was investigated by MTT assay 












114 | P a g e  
 
2.8 Cellular response to 72 h bioactive glass conditioned 
medium 
75 mg fine bioactive glass particles from each group was immersed in 50 
ml α-MEM or DMEM with 1% antibiotic and kept in a shaker (60 rpm) at 
room temperature for 72 h.  
Solution was collected and sterilized as previously reported. The 
remaining solid powders were washed with 70% ethanol then stored in 
fume cupboard to dry overnight and collected the following day. 
 Medium characterisation 2.8.1
The filtered solutions were analysed by both ICP-OES and a fluoride 
selective electrode to detect silicon, calcium, phosphorus and fluoride 
concentrations in bioactive glass conditioned medium.  
 Solid characterisation 2.8.2
Once the dried powders from the dissolution studies were collected, they 
were analysed by FTIR (Spectrum GX, Perkin-Elmer, Waltham, MA, USA; 
data collected from 1600 cm-1 to 500 cm-1) and XRD (same conditions and 
instrument as described earlier) to look primarily for apatite formation. 
 Osteoblasts 2.8.3
 Cell differentiation in bioactive glass conditioned medium 2.8.3.1
Filtered bioactive glass conditioned medium was further supplemented 
with 1% L- glutamine and 5% FBS and stored in a fridge at 4°C for cell 
treatment. MC3T3-E1 cells were treated for 7, 14 and 21 days with 72 h 
bioactive glass conditioned medium.  
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At each time point, medium was removed and cells were collected for ALP 
activity assay as described previously. For each experimental group, ten 
wells were assessed for each condition. 
 Cell proliferation in bioactive glass conditioned medium 2.8.3.2
Experimentally, cells were treated as in the cell differentiation assay. At 
each time point, medium was removed and cells were collected for DNA 
content assay as described previously. For each experimental group, ten 
wells were assessed for each condition. 
 Type I collagen formation in bioactive glass conditioned 2.8.3.3
medium 
Type I collagen is the most abundant structural protein in the human body 
and is a critical component of bone extracellular matrix to form the 
structural scaffolding for bone. Picro-Sirius red, an anionic dye, specifically 
binds strongly within the tertiary groove of collagen I fibrils and is well-
established to highlight collagen formation (Junqueira et al., 1979).   
In this study, bioactive glass conditioned medium was further 
supplemented with 5mM β-glycerophosphate and 50 µg/ml L-ascorbic 
acid (Sigma, UK) to make ‘osteogenic medium’. 
MC3T3-E1 cells were treated for 2, 3 and 4 weeks with bioactive glass 
conditioned osteogenic medium. After 10 min fixation in 2.5% 
glutaraldehyde at 4 ºC and three times deionized water wash, monolayers 
were incubated in 0.1% Sirius red F3B in 1.3% saturated aqueous solution 
of picric acid (all from Sigma, UK) for 1 h at room temperature. Cultures 
were then washed twice with 0.5% acidified water and three times in 
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deionized water to remove the unincorporated dye. After photographing 
the stained cultures, Type I collagen formation was quantified by 
measuring the concentration of Sirius red stain incorporated in cell-
mediated matrix (Kliment et al., 2011, Houghton et al., 1996). Briefly, the 
dye was extracted using a mixture of 0.1 M NaOH and absolute methanol 
(1:1, all from Sigma, UK) and incubated for 30 min at room temperature. 
200 µl aliquots of solution and dye were transferred to a 96-well plate and 
measured the absorbance at 570 nm. For each experimental group, three 
wells were assessed for each condition.     
 Mineralization in bioactive glass conditioned medium 2.8.3.4
Biomineralization, mediated by osteoblastic cells, is believed to 
accumulate calcium and inorganic phosphate which are regarded as 
nucleating agents for the formation of hydroxyapatite (Ca10(PO4)6(OH)2), 
the main inorganic component of bone.  
Alizarin red S (Sodium Alizarine sulfonate, C14H7NaO7S) is used to 
qualitatively identify calcium deposition by cells of an osteogenic lineage 
or in tissue sections (Bertoni et al., 2009, Verma et al., 2010). It can form 
an Alizarin red S-calcium complex in a chelation process. However, this 
reaction is not strictly specific for calcium, since magnesium, manganese, 
barium, and strontium may interfere, but these elements usually cannot 
reach the sufficient concentration to interfere with the staining (Lievremont 
et al., 1982). Furthermore, as Stanford et al. (Stanford et al., 1995) 
reported, Alizarin red S staining is particularly versatile based on that the 
dye could be extracted from the stained monolayer and readily assayed 
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for quantification. This sensitive method is based on cetylpyridinium 
chloride incubation followed by absorbance reading at 570 nm.  
In this study, for the detection of bone nodule formation, MC3T3-E1 cells 
were treated as those in the Type I collagen formation assay, at each time 
point, medium was removed and cells were washed twice with PBS and 
fixed in 2.5% glutaraldehyde at 4ºC for 10min. Then excess deionized 
water wash was carried out prior to addition of 200 μl of 40 mM Alizarin 
Red S (pH 4.1) per well. The plates were incubated at room temperature 
for 40 min and washed three times with deionized water after aspiration of 
the unincorporated dye.  
For quantification of staining, Alizarin Red S was extracted from the 
monolayer by incubation in 10% (w/v) cetylpyridinium chloride (CPC, 
Sigma, UK) in 10 mM sodium phosphate, pH 7.0, for 30 min at room 
temperature. The dye was then removed and 100 µl aliquots were 
transferred to a 96-well plate prior to absorbance reading at 570 nm. For 
each experimental group, three wells were assessed for each condition.     
 Osteogenic gene expression in bioactive glass conditioned 2.8.3.5
medium by relative quantitative polymerase chain reaction 
(qPCR) 
mRNA Extraction 
RNeasy mini kit (Qiagen, UK) was used to extract mRNA from cells 
according to the manufacture’s protocol. Briefly, MC3T3-E1 cells were 
treated with bioactive glass conditioned medium for 1 d, 4 d, 7 d, 14 d and 
21 d in 6-well plates. At each time point, cells were disrupted by Buffer 
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RLT (350 µl/well) followed by addition of 1 volume 70% ethanol to 
homogenize the lysate. Then the cell lysis sample was transferred to an 
RNeasy spin column placed in a collection tube and centrifuged for 15 s at 
16,000 x g to let the mRNA bind to the RNeasy membrane. To wash the 
spin column membrane, 350 µl Buffer RW1 was added, centrifuged and 
the flow-through was discarded. In order to further eliminate the DNA 
contamination in mRNA samples, RNase-Free DNase set (Qiagen, UK) 
was used here. The incubation mix (10 µl DNase I with 70 µl Buffer RDD) 
was added directly to the RNeasy spin column membrane where mRNA 
binding, and placed in room temperature for 15 min. Then, the DNase I 
was removed by a second wash with Buffer RW1. 500µl Buffer RPE was 
added to the RNeasy spin column with a 15 s centrifugation. Then 500 µl 
Buffer RPE was added again with a 2 min centrifugation to dry the column 
membrane, ensuring that no ethanol was carried over during RNA elution, 
which may interfere with downstream reactions. The RNeasy spin column 
was placed in a new collection tube and 30 µl RNase-free water was 
added directly to the spin column membrane with a 1 min centrifugation to 
elute mRNA. The purity of the isolated RNA was determined through 
measuring the optical density (OD) value (A260/A280) using the 
NanoDrop™ 1000 Spectrophotometer (Thermo Scientific, UK). 
cDNA synthesis 
After mRNA extraction, cDNA synthesis was carried out by reverse 
transcription reactions in 0.2 ml PCR tubes, each reaction contained the 
following using the transcriptor first strand cDNA synthesis kit (Roche, UK): 
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 5xbuffer                               4.0 µl 
 dNTP                                   2.0 µl 
 Random+OligoDT primers  0.8 µl 
 RNasin                                0.4 µl 
 Reverse Transcriptase        0.4 µl 
 mRNA                                  13 µl 
Reverse transcription reactions were performed using a thermos-cycler 
block at 42 ºC for 30 min, 85 ºC for 5 min and 4 ºC for 5 min. The resulting 
cDNA was diluted in 40 µl RNase-free water and stored in -20 ºC.   
Relative quantitative polymerase chain reaction (qPCR) 
Generation of PCR products can be detected by measurement of the 
SYBR Green I fluorescence signal. As SYBR Green I could intercalate into 
the double stranded DNA helix and its fluorescence is greatly enhanced 
upon binding to DNA due to conformational changes.  
Here, Glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) was 
used as a reference gene. All primers used in this study are listed as in 
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Table 2-2  Sequences of primer pairs used for qPCR analysis 
Name Primers 5’ – 3’ 
GAPDH Forward ATTGTCAGCAATGCATCCTG 
Reverse ATGGACTGTGGTCATGAGCC 
OPN Forward GAGATTTGCTTTTGCCTGTTTG 
Reverse TGAGCTGCCAGAATCAGTCACT 
Col1a1(Type I collagen) Forward CATGTTCAGCTTTGTGGACCT 
Reverse GCAGCTGACTTCAGGGATGT 
VEGF Forward CAGGCTGCTGTAACGATGAA 
Reverse GCTTTGGTGAGGTTTGATCC 
 
Reactions in 96-well plates were set up and each well contained the 
following: 
 2x SYBR Green I Master mix      5 µl 
 5 uM F/R Primer                          1 µl 
 dH2O                                           3 µl  
 template (cDNA)                          2 µl 
Once the loaded plate was sealed with a Roche sealing film and 
centrifuged for 30 s at 3000 rpm. The qPCR was carried out in LightCycler 
480 qPCR system (Roche) using the following protocol: 
 Denaturation (Hot Start)                            95°C     5 min 
 Amplification (45 cycles) 
                      Melting                                            95°C    10s   
                      Annealing                                        60°C    6s   
                      Extension                                         72°C    6s   
                      Acquisition                                       76°C    1s   
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 Melting Analysis  
                      Melting                                            95°C      30s   
                      Cooling/annealing                           65°C      30s   
                      Gradual heating + acquisition         65 to 99°C   
                      Cooling/termination                         40°C      5s   
The relative gene expression level was determined by comparing against 
the reference gene and normalised by the control group (normal cell 
culture medium treatment). Therefore, final data presented as mean fold 
change ± SE with respect to the control. For each experimental group, 
three samples were assessed under the same condition.       
 Angiogenesis gene expression and protein production in 2.8.3.6
bioactive glass conditioned medium by qPCR and Western 
blot 
The VEGF gene expression was performed as previously done and the 
primers used are represented in table 3-2. 
Western blot 
MC3T3-E1 cells were treated in bioactive glass conditioned medium or 
NaF concentrations (F- concentrations: 0, 0.1, 1.9 and 9.5ppm) in 10 cm 
tissue culture dish for 7 d, 14 d and 21 d. At each time point, cell culture 
dish was placed on ice and cells were washed with ice-cold PBS. Then 
cell lysates were extracted using RIPA lysis buffer with freshly added 
Protease Inhibitors (Roche, UK) and collected with the aid of cell scrapers. 
Lysates were transferred into pre-cooled micro-centrifuge tubes, sonicated 
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for 30 s on ice and centrifuged at 16,000 × g for 20 min in 4 ºC. Then the 
supernatant was transferred into new tubes and the protein concentration 
was determined by DC protein assay (Bio-Rad, UK). Briefly, 5 µl of each 
test sample was loaded into a 96-well plate alongside a set of bovine 
serum albumin standards (BSA, 0, 0.08, 0.16, 0.3125, 0.625, 1.25, 2.5, 5, 
10 µg/ml) to which 25 µl of Reagent A+ (solution A + solution Dc, 50:1) 
followed by 200 µl of Reagent B were added. The blue colour was allowed 
to develop for 15 min at room temperature followed by the measurement 
of sample absorbance using a plate reader. Absorbance of each sample 
and standard was obtained at a wavelength of 650 nm. The protein 
concentration of tested samples was calculated from the standard curve 
generated from the BSA standards. As in all Western blots, equal protein 
amounts of samples were loaded into gels in this study, the lysates were 
diluted with deionized water to keep the same protein concentration. 4x 
Laemmli sample buffer (Bio-Rad, UK) which contains blue dye to assist 
gel loading was added to the lysates followed with boiling at 100 ºC for 5 
min then -20 ºC storage. 
An equal amount of total protein was loaded into each lane of the 10% 
NuPAGE® Bis-Tris gel (Thermo scientific, UK) alongside molecular weight 
marker (full range rainbow marker, Invitrogen). The gel ran at 121 V for 90 
min at room temperature.  
Then the electrophoretic transfer of protein from gels to polyvinyl difluoride 
(PVDF) membrane (Thermo scientific, UK) was carried out at 35 V for 90 
min at 4 ºC. The PVDF membranes were then subjected to blocking of 
non-specific sites by incubation with blocking buffer for 1 h at room 
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temperature. Membranes were cut to divide the target protein area and 
the loading control then incubated with primary antibodies (anti-VEGF 
antibody (1:2000, Abcam), anti-Cyclophilin B antibody (1:6000, Abcam)) 
diluted in blocking buffer overnight at 4 ºC. After three washes (3 × 5 min) 
in TBST (see below), the membranes were incubated with secondary 
antibody (Goat anti-Rabbit IgG (H+L) Secondary Antibody (1:2000, 
Thermo scientific, UK)) for 1 h at room temperature. Finally, after three 
washes in TBST the membranes were subjected to the Enhanced 
Chemiluminescence (ECL) plus western blotting detection system 
(Amersham) to detect target proteins and recorded using hypersensitive 
ECL film (GE healthcare Bio-science).  
RIPA buffer 
 150mM NaCl 
 1.0% NP-40 
 0.5% sodium deoxycholate 
 0.1% sodium dodecyl sulfate 
(SDS) 
 50 mM Tris-HCl 
pH 8.0 
Running buffer (Invitrogen) 
 NuPAGE® MES SDS 
running buffer (20x) 
1x Transfer buffer 
 25mM Tris base 
 190mM glycine 
 20% methanol 
1xTBST 
 0.1% Tween 20 
 20mM Tris base 
 150mM NaCl 
pH 7.5 
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Blocking buffer 
 5% (w/v) non-fat dry milk 
 
  
Western blot analysis 
The exposed films from Western blots were scanned using a flatbed 
scanner with a minimum of 600 dpi and the bands density of blots was 
determined using Image J 1.49 (downloaded from: 
http://imagej.nih.gov/ij/index.html). As shown in Fig. 3.8A, a set of blot 
bands, shows bands densities of VEGF expression in MC3T3-E1 cells 
after treatment with bioactive glass conditioned medium, were selected 
and analysed together. This selection was then identified as the first lane 
(Analyse>Gels>Select first lane) followed by ‘Plot lanes’ 
(Analyse>Gels>Plot lanes) to generate a ‘Western demo plot’ (Fig. 3.8B). 
The lanes were then divided using the line tool to allow for the area of 
each peak to be determined separately (Fig. 3.8C). Using the ‘Wand tool’ 
each peak was selected to generate a band area with values (Fig. 3.8D, 
E). The peak values were then exported to an Excel spreadsheet where 
all values were normalised against the loading control (Cyclophilin B). The 
normalised band densities were expressed relative to the control and final 
data presented as mean fold change ± SE with respect to the control. For 
each experimental group, three samples were assessed for each condition.        
 
 












Figure 2.6  Western blot analysis using Image J (A) Bands selected for analysis. (B) 
Bands density plotted with Image J. (C) Bands separated by lines to allow for 
quantification of each peak. (D) Bands area selection. (E) Quantification of each peak.      
 
 Epithelial cells 2.8.4
A431 cells were treated in 72 h bioactive glass conditioned medium for 4, 
7 and 10 d. At each time point, medium was removed and cells were 
collected for DNA content assay as described previously. For each 
experimental group, ten wells were assessed under the same condition. 
 Oral fibroblasts 2.8.5
NHOF-1 cells were treated in 72 h bioactive glass conditioned medium for 
4, 7 and 10 d. DNA content assay was carried out as described 
previously. For each experimental group, ten wells were assessed under 
the same condition. 
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2.9 Antibacterial studies 
alamarBlue® is a cell viability assay reagent quantitatively measuring the 
cell proliferation particularly in bacteria and, it contains the cell permeable, 
non-toxic and weakly fluorescent blue indicator dye called resazurin (Bio-
Rad, 2015). Resazurin acts as an oxidation-reduction indicator to undergo 
colorimetric change in response to cellular metabolic reduction. The 
reduced form called resorufin is pink with high fluorescent and, the 
measured fluorescence intensity is proportional to the number of living 
cells respiring (Bio-Rad, 2015). Therefore, by detecting the level of 
oxidation during respiration, alamarBlue® is widely used as a direct 
indicator to quantitatively measure cell viability in numerous antibacterial 
studies (Collins and Franzblau, 1997, Carpenter et al., 2012, Scherr et al., 
2012, de Paula e Silva et al., 2013, Gemechu et al., 2013, Katawera et al., 
2014). 
In this study, typical supra-gingival bacteria, L. casei and S. mitis, sub-
gingival bacteria, A. actinomycetemcomitans and P. gingivalis (kindly 
gifted by Professor Rob Allaker, QMUL), were grown in brain heart 
infusion agar plates (Fisher Scientific, UK) for 48 h at 37 °C under aerobic 
or anaerobic conditions. Then the log phase cultures were harvested and 
the bacterial concentrations were measured with absorbance reading at 
595 nm.  
Bioactive glass particulates were sterilized by autoclaving (dry cycle) at 
121 °C for 15 min. Then the bioactive glass particulate suspensions in 
brain heart infusion broth at concentrations of 1.25, 2.5, 5, 10 and 20 
mg/ml were made and plated in 96-well plates (100 µL/well). The bacteria 
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(106 to 107 CFU/mL) were added subsequently (100 µL/well). Therefore, 
the final bioactive glass particle working concentrations were 0.625, 1.25, 
2.5, 5 and 10 mg/mL.  Sodium Fluoride (NaF) concentrations (2, 1, 0.5, 
0.25, 0.125 and 0 mM) in brain heart infusion broth were used to treat 
bacteria as well to investigate the antibacterial effects of F-.   
After incubation under aerobic or anaerobic conditions for 0, 2, 4 and 8 h, 
20 µl alamarBlue (Bio-Rad, UK) was added to each well and incubated for 
1 h according to the manufacture’s protocol. Then the plates were 
centrifuged for 10 min at 4000 rpm and 100 µl aliquots were transferred to 
new black 96-well plates, to measure the Fluorescent Intensity at 590 nm 
emission and 560 nm excitation. Percent inhibition of bacterial growth was 
then defined as 1 - (mean fluorescence of test wells / mean fluorescence 
of negative control well) × 100% (Carpenter et al., 2012, Collins and 
Franzblau, 1997). For each experimental group, four wells were assessed 
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2.10 Statistical analysis 
The elemental analysis was carried out with three samples per group. Cell 
assay data with bioactive glass conditioned medium are presented as 
means ± standard deviations. qPCR and western blot assay were 
performed with three samples per group and bacterial studies were four 
replicates. Comparisons of cell assay data were made using a one-way 
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Chapter 3 The bioactivity of high 




For bioactive glasses, the term ‘bioactivity’ refers to the ability and rate of 
apatite formation, which is necessary for surrounding tissues and cells to 
attach to the implanted bone grafts. As discussed previously in the 
literature review (O’Donnell et al., 2008b, O’Donnell et al., 2008a, 
O'Donnell et al., 2009), phosphate is present largely as an orthophosphate 
phase in bioactive glasses, which potentially promotes glass bioactivity 
leading to an increase of the apatite formation rate. Furthermore, higher 
phosphate content can reduce the rate and extent of local pH rise, which 
will reduce the deleterious effects brought by high alkalinity, on resident 
cells in the local environment (Monfoulet et al., 2014). Therefore, higher 
phosphate content may enable the development of products with higher 
surface areas without running into the pH problems. The finer particle size 
with increased surface area will result in faster glass dissolution creating 
an appropriate environment in which apatite and later bone can be more 
rapidly formed. 
The use of fluoride in bioactive glasses is of interest because of its effects 
in the treatment of osteoporosis and outstanding antibacterial ability. 
Fluoride is readily incorporated into bioactive glasses via complexing with 
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calcium and sodium, instead of forming of Si–F bonds in glass network 
(Brauer et al., 2009, Brauer et al., 2012). Furthermore, Mneimne et al. 
found that addition of fluoride into low phosphate containing bioactive 
glasses significantly promoted apatite formation after immersion in Tris 
buffer solution (Mneimne et al., 2011). However, at high sustained doses, 
fluoride plays negative role leading to skeletal and dental fluorosis. Using 
in vitro cell research, high doses of fluoride (10-4 to 10-3 M) supresses 
osteoblast proliferation, differentiation and can even induce apoptosis (Qu 
et al., 2008).  
Bioactive glasses apatite formation is investigated in vitro in solutions such 
as SBF and Tris buffer. Tris buffer solution, free of Ca2+ and PO4
3- ions 
with a pH 7.3, is an excellent medium to assess bioactive glass dissolution 
and apatite forming capacity (Shah et al., 2014b). A simulated body fluid 
(SBF), a solution with ion concentrations close to that of human blood 
plasma, was firstly proposed by Kokubo et al. in the 1990s and later 
widely applied by biomaterial scientists to evaluate the bioactive glasses 
and ceramics bioactivity in vitro and to predict the apatite formation ability 
in vivo (Kokubo et al., 1990, Kokubo and Takadama, 2006). However, 
tests in SBF are found to produce false positive and false negative results 
(Bohner and Lemaitre, 2009) and an apatite layer was formed in SBF but 
no direct bone bonding in vivo (Walsh et al., 2003, Theiss et al., 2005, 
Apelt et al., 2004). For most potential dental and orthopaedic biomaterials, 
cellular biocompatibility in vitro and animal studies are routinely 
investigated. Cell culture medium with proteins and amino acids more 
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closely reflects the appropriate composition of the physiological 
environment, therefore, it is considered as a more in vivo like model.  
Therefore, the aim of this Chapter is to assess the amorphous structure of 
the synthesised high phosphate and low fluoride containing bioactive 
glasses, monitor change in pH with dissolution, investigate apatite 
formation and ion release both in Tris buffer solution and cell culture 
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3.2 Results 
 Bioactive glass characterization 3.2.1
Obtaining an amorphous structure in the prepared bioactive glasses is 
important, since crystallization significantly reduces bioactivity. Through 
the XRD traces here (Fig. 3.1 below), all the prepared glasses in this study 
exhibited broad halos without sharp peaks, which is the typical feature of 
an amorphous structure. It indicates that all the bioactive glasses prepared 
during the course of this work do not contain a crystalline phase to any 
significant extent and the quenching process in deionized water did not 
initiate the reaction to form crystalline phase.  
 
Figure 3.1 XRD traces of all the initial glasses. (P6.33F0 indicates a bioactive glass 
contains 6.33 Mol.% phosphate and 0 Mol.% fluoride) 
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 Bioactive glass bioactivity study in Tris buffer solution 3.2.2
 pH change 3.2.2.1
Fig. 3.2 below shows the variation in pH as a function of incubation time 
for bioactive glasses from P6.33F0 to P6.33F7 after immersion in Tris 
buffer solution. All the bioactive glasses in this work clearly showed a pH 
rise within the first 2 h of immersion and a further but very slight increase 
in pH between 2 h and 72 h. For fluoride containing bioactive glasses 
P6.33F1 to P6.33F7, the pH stayed constant for the rest of the experiment 
(72 h to 168 h), while the pH in the fluoride free bioactive glass P6.33F0 
was still rising slightly at 168 h. It is also observed the addition of fluoride 
to bioactive glasses (P6.33F1 to P6.33F7) increased the final pH level 
slightly by around 0.07 to 0.14 pH.  
 
Figure 3.2 pH change of Tris buffer solution according to the incubation time. 75 
mg fine bioactive glass particles were immersed in 50 ml Tris buffer for different periods 
followed by an immediate pH measurement. Data is represented as mean ± SE. n=3. 
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Fig 3.3 illustrates the pH change as a function of fluoride content in the 
bioactive glasses. When fluoride was added from 0 to 7 Mol.% into the 
high phosphate bioactive glass, solution pH rose gradually but slightly and 
reached the highest value in the 7 Mol.% fluoride added glass after 8 h, 24 
h and 168 h immersion.  
 
Figure 3.3 pH change of Tris buffer solution according to the CaF2 content in the 
bioactive glasses. 75 mg fine bioactive glass particles were immersed in 50 ml Tris 
buffer for different periods followed by pH measurement. Data is represented as mean ± 
SE. n=3. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% 
fluoride) 
 
 Apatite formation 3.2.2.2
As depicted in Fig. 3.4 and Fig. 3.5 below, fluoride added to the bioactive 
glass compositions resulted in significant changes in the XRD traces and 
FTIR spectra after immersion in Tris buffer solution for 8 h, compared with 
the high phosphate but fluoride free bioactive glass.  
The XRD traces, patterns of hydroxyapatite (JCPDS 09-432), fluorapatite 
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fluorapatite (JCPDS 31-267) all overlap (Brauer et al., 2010). Therefore, 
the pattern of ‘apatite’ in the XRD traces is referred to here.  
After 8 h immersion in Tris buffer solution (Fig. 3.4), the typical apatite 
peaks at 26º, 32–34º, 47º, 50º and 52º 2θº appear in traces for the fluoride 
containing bioactive glasses. These peaks become intense and more 
clearly pronounced as the fluoride content increased from 1 to 7 Mol.%. 
For the bioactive glass P6.33F0, the XRD pattern shows a small peak at 
around 28.5º 2θ (starred), which may indicate the presence of a small 
amount of calcite (CaCO3).  
 
Figure 3.4 XRD traces for bioactive glasses immersed in Tris buffer solution for 8 h. 
75 mg fine bioactive glass particles were immersed in 50 ml Tris buffer for 8 h followed 
by a separation of solution and glass powder. Then the dried powders were tested using 
XRD. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% 
fluoride) 
 
After immersion in Tris buffer solution for 8 h, the FTIR spectra shows the 
sharpening of the Si-O-Si stretching band at about 1030 cm-1 in the 
fluoride added bioactive glasses P6.33F1 to P6.33F7 (Fig. 3.5). At the 
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same time, new bands appeared at around 800 cm-1, which were 
assigned to Si-O-Si bond vibration between two adjacent SiO4 tetrahedra 
as described previously for SBF-treated glasses (Brauer et al., 2010). 
These changes indicate the formation of a silica-gel surface layer after 
leaching of Na+ ions and formation of Si-OH groups in this ion-depleted 
glass. 
A split band at approximately 560-600 cm-1, is the most characteristic 
region for apatite and other orthophosphates. After immersion in Tris 
buffer for 8 h in this study, a single band in this region appeared in the 
high phosphate and fluoride free bioactive glass (P6.33F0), suggesting the 
presence of a disordered apatite or amorphous calcium phosphate. 
Characteristic split bands at 560 and 600 cm-1 appeared in the fluoride 
containing bioactive glasses P6.33F1 to P6.33F7, suggesting that adding 
fluoride significantly accelerates ordered and well crystallised apatite 
formation.  
Bands at about 870 cm-1 in the fluoride containing bioactive glasses after 
immersion in Tris buffer for 8 h indicate the presence of carbonate 
substitution in the formed apatite. It is pointed out that this carbonate band 
is usually considered as an indication for carbonate being incorporated 
into the apatite, resulting in the formation of HCA, rather than 
stoichiometric HA (Lu and Leng, 2005b). Furthermore, further broad CO3
2- 
bands are present in the region starting from 1410 cm-1 indicating a B-type 
substitution (i.e. carbonate replacing a phosphate group), rather than an 
A-type substitution (i.e. carbonate replacing a hydroxyl group),  which 
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would be shifted to higher wave numbers, starting from 1460 cm-1 (Brauer 
et al., 2010).  
 
Figure 3.5 FTIR spectra for bioactive glasses immersed in Tris buffer solution for 8 
h. 75 mg fine bioactive glass particles were immersed in 50 ml Tris buffer for 8 h followed 
by a separation of solution and glass powder. Then the dried powders were tested using 
FTIR. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% 
fluoride) 
 
In Fig. 3.6 and Fig. 3.7 below, the XRD traces and FTIR spectra of 
bioactive glass P6.33F1 (1 Mol.% CaF2) showed significant changes after 
immersion in Tris buffer in comparison to the pattern and spectrum of the 
unreacted bioactive glass (0h). As early as 2 h on exposure in Tris buffer 
solution, a small apatite peak at 26º 2θº appeared in the XRD trace. As 
immersion time increased, these typical apatite peaks at 26º and 32–34º 
2θº become larger in intensity and more clearly pronounced. It is 
consistent in the FTIR spectra: disappearance of the NBO (non-bridging 
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stretch band at about 1030 cm-1, new bands appeared at about 800 cm-1 
and a single band at 560-600 cm-1 indicates the presence of non-apatitic 
or amorphous calcium phosphate was observed after 2 h immersion. As 
immersion time increased to 8 h, characteristic split band at 560 and 600 
cm-1 appeared indicative of calcium phosphate crystallites.  
  
Figure 3.6 XRD traces for bioactive glass P6.33F1 with different immersion time in 
Tris buffer solution. 75 mg fine bioactive glass particles (P6.33F1) were immersed in 50 
ml Tris buffer for different experimental periods followed by a separation of solution and 
glass powder. Then the dried powders were tested using XRD.  
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Figure 3.7 FTIR spectra for bioactive glass P6.33F1 with different immersion time in 
Tris buffer solution. 75 mg fine bioactive glass particles (P6.33F1) were immersed in 50 
ml Tris buffer for different experimental periods followed by a separation of solution and 
glass powder. Then the dried powders were tested using FTIR. 
 
For the apatite formation in the high phosphate but fluoride free bioactive 
glass P6.33F0 as showed in Fig. 3.8 below, there was no significant 
changes after immersion in Tris Buffer for 2 to 24 h in comparison to the 
XRD pattern of the unreacted bioactive glass (0 h). Small peaks at around 
28.5º 2θº (arrowed) after 8 h and 24 h immersion may indicate the 
presence of a small amount of calcite (CaCO3) instead of apatite. Typical 
apatite peaks at 26º and 32–34º 2θº did not appear in the XRD traces until 
72 h immersion and a small peak at 26º 2θº (starred) appeared in the 24 h 
pattern, which indicates that apatite of bioactive glass P6.33F0 began to 
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typical apatite peaks at 47º, 50º and 52º 2θº did not pronounce clearly 
even after immersion for 168 h.  
 
Figure 3.8 XRD traces for bioactive glass P6.33F0 with different immersion time in 
Tris buffer solution. 75 mg fine bioactive glass particles (P6.33F0) were immersed in 50 
ml Tris buffer for different experimental periods followed by a separation of solution and 
glass powder. Then the dried powders were tested using XRD. 
 
Fig. 3.9 below represents the FTIR spectra of bioactive glass P6.33F0 
after immersion in Tris buffer. In comparison with the untreated bioactive 
glass (0 h), disappearance of the non-bridging oxygens (Si–O- alkali+) 
band at 920cm-1 and sharpening of the Si–O–Si stretch band at about 
1030 cm-1 were observed after 2-8 h immersion. As immersion time 
increased to 24 h, new bands appeared at about 800 cm-1 and a single 
band at 560-600 cm-1 indicates the presence of non-apatitic or amorphous 
calcium phosphate. Characteristic split band at 560 and 600 cm-1 
indicative of calcium phosphate crystallites appeared at immersion periods 
of 72 to 168 h. These data indicate that the rate of apatite formation in Tris 
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buffer solution was significantly accelerated by the fluoride addition (as 
low as 1 Mol.%).  
 
Figure 3.9 FTIR spectra for bioactive glass P6.33F0 with different immersion time in 
Tris buffer solution. 75 mg fine bioactive glass particles (P6.33F0) were immersed in 50 
ml Tris buffer for different experimental periods followed by a separation of solution and 
glass powder. Then the dried powders were tested using FTIR. 
 
 Ion release 3.2.2.3
The Ca and P concentrations in Tirs buffer reached a maximum after 2 h 
immersion and then dropped drastically from 2 h to 8 h (Fig. 3.10A, C 
below), which is consistent with the results of XRD and FTIR: that apatite 
formed in the fluoride added bioactive glasses after 2 h to 8 h immersion 
and consuming Ca and P in the process. 
In bioactive glass compositions, calcium content (derived from CaO and 
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7%. For the released Ca concentration change as a function of F content 
in the bioactive glasses (Fig. 3.10B), after 2 h immersion in Tris buffer, 
released Ca concentrations rose as F content increased. However, at the 
later time points from 8 h to 168 h, the released Ca concentration dropped 
slightly from bioactive glasses P6.33F0 to P6.33F3, then increased when 
bioactive glass fluoride content increased from 3% to 7%.  
Compared with the fluoride containing bioactive glasses, released P 
concentration of high phosphate but fluoride free bioactive glass P6.33F0 
was much higher after 8h (Fig. 3.10C), which indicates incorporation of 
fluoride promotes phosphate consumption and may result in the 
acceleration of apatite formation.   
P6.33F1, as the lowest fluoride containing bioactive glass in this study, 
shows some amorphous calcium phosphate formation in the XRD and 
FTIR patterns after 8 h exposure in Tris buffer. It may explain why the P 
concentration of P6.33F1 was a little higher than those in the other fluoride 
added bioactive glasses at the time point of 8h (Fig. 3.10C). 
Although the phosphate content was kept constant in all the bioactive 
glass compositions, the released P concentrations were variable as a 
function of bioactive glass F content (Fig. 3.10D). At 2 h, the released P 
concentrations dropped as bioactive glass F content increased from 0-3%. 
Then it increased from P6.33F3 to P6.33F7 bioactive glasses. However, 
from 8 h to 168 h immersion in Tris buffer, the released P concentration 
dropped sharply between the bioactive glasses with 0% fluoride and 1% 
fluoride, followed with a gradual decrease when the fluoride content 
increased from 1% to 3% and kept relatively constant at low 
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concentrations close to 0ppm when the bioactive glass F content 
increased from 3% to 7%. It indicates that with the high phosphate content 
in the bioactive glasses, small amount fluoride addition may significantly 
increase the apatite formation rate evidenced by phosphate consumption.  
The fluoride concentrations increased significantly after 2 h immersion in 
Tris buffer solution in all the investigated bioactive glasses. In the low 
fluoride containing bioactive glasses, P6.33F1 and P6.33F3, F 
concentrations decreased gradually from 2 h to 168 h. However, when 
bioactive glass fluoride content increased from 5% to 7%, the solution 
fluoride was relatively constant.  
Silicon concentrations peaked after 2 h immersion and then kept relative 
constant in the remaining experimental time. Na concentrations increased 
sharply in the first 2h immersion and then underwent a further gradual 
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Figure 3.10 Elemental concentrations in Tris buffer vs incubation time and CaF2 
content. 75 mg fine bioactive glass particles were immersed in 50 ml Tris buffer for 
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Then the filtrates were diluted 1:10 and the elemental concentrations were measured by 
ICP-OES and a fluoride ion selective electrode. Data was represented as mean ± SE. 
n=3. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% 
fluoride) 
 
 Bioactive glass bioactivity study in cell culture medium 3.2.3
 Apatite formation 3.2.3.1
After 72 h immersion in α-MEM, there was no difference between the 
untreated and treated bioactive glasses in the XRD traces (Fig. 3.11 
below). All the treated bioactive glasses showed similar patterns and no 
typical apatite peaks were observed. A small peak at around 28.5º 2θº 
appeared in glass P6.33F5, which may indicate the presence of a small 
amount of calcite (CaCO3) instead of apatite.  
  
Figure 3.11 XRD traces for bioactive glasses immersed in α-MEM for 72 h. Bioactive 
glass particulates were immersed in α-MEM then the solution and solids were separated 
after 72 h. The dried powders were investigated by XRD. (P6.33F0 indicates a bioactive 
glass contains 6.33 Mol.% phosphate and 0 Mol.% fluoride) 
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In the FTIR spectra, compared with the untreated bioactive glass with a 
non-bridging oxygen band at 920 cm-1, all the treated bioactive glasses 
showed disappearance of 920 cm-1 band and the sharpening of the Si-O-
Si stretch band at about 1030 cm-1 (Fig. 3.12 below). It indicates the 
formation of a silica-gel surface layer after leaching of Ca2+ and Na+ ions 
and formation of Si-OH groups. In all the treated bioactive glasses, a 
single P-O band was observed at around 570 cm-1 and suggests an 
amorphous or disordered crystalline apatite formation (Jones et al., 2001, 
Shah et al., 2014b). Furthermore, in the F containing bioactive glasses, 
new bands at about 870 cm-1 and further broad bands starting from 1410 
cm-1 indicating carbonate replaced phosphate in the formed apatite.  
 
 
Figure 3.12  FTIR spectra for bioactive glasses immersed in α-MEM for 72 h. 
Bioactive glass particulates were immersed in α-MEM then the solution and solids were 
separated after 72 h. The dried powders were investigated by FTIR. (P6.33F0 indicates a 











































147 | P a g e  
 
 Ion release 3.2.3.2
After 72 h immersion in α-MEM, solution calcium concentrations increased 
slightly as bioactive glass fluoride content increased from 0% to 7% (Fig. 
3.13 below). In the fluoride free and low fluoride containing bioactive 
glasses (P6.33F0, P6.33F1 and P6.33F3), solution calcium concentrations 
dropped slightly in comparison with that in the α-MEM. However, for the 
high fluoride containing bioactive glass, P6.33F7, calcium concentrations 
were significant higher than that in α-MEM.  
 
Figure 3.13  Elemental concentrations in α-MEM for 72 h. 75 mg fine bioactive glass 
particles were immersed in 50 ml α-MEM for 72h followed by a separation of solution and 
solids. Then the filtrates were diluted 1:10 and the elemental concentrations were 
measured by ICP-OES and a fluoride ion selective electrode. Data was represented as 
mean ± SE. n=3. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% phosphate 
and 0 Mol.% fluoride) 
 
Phosphate concentration in all the bioactive glass compositions was 
constant, however, the released concentrations in all the glass groups 
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bioactive glass fluoride content increased from 0% to 5% and slight 
increase was observed in P6.33F7 group.  
The α-MEM is silicon and fluoride free (Lonza, London, UK), F 
concentrations in the medium increased gradually as the bioactive glass 
fluoride content increased from 0% to 7% during 72 h immersion. Silicon 
concentrations in the α-MEM was the greatest in the P6.33F0 group and 
dropped slightly as the glass fluoride content increased. It is consistent 
with the bioactive glass composition that the glass silicon content 
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3.3 Discussion 
It is believed that increasing the P2O5 content in the bioactive glass 
enhances the reactivity of the bioactive glass, as the phosphate is often 
regarded to exist as a separate phase within the glass which is 
considerably more soluble than the silicate phase. When the bioactive 
glass is placed into solution the phosphate phase rapidly dissolves 
releasing ions (PO4
3-, Ca2+ and Na+) and apatite forms quickly (O'Donnell 
et al., 2009, O’Donnell et al., 2008b, O’Donnell et al., 2008a). However, it 
is found that, in Tris buffer solution, the formation of apatite occurred even 
more rapidly with the addition of fluoride (as low as only 1 Mol.%). 
Numerous experimental studies have reported that octacalcium phosphate 
(OCP), is a precursor phase, that is involved in apatite formation in vitro 
(Aoba, 1997, Iijima, 2001, Johnsson and Nancollas, 1992, LeGeros et al., 
1989, Siew et al., 1992, Tseng et al., 2006). Eanes et al. demonstrated 
that the presence of fluoride eliminated the formation of the intermediate 
OCP phase (Eanes and Meyer, 1978), and that only 0.1–2 mg/L fluoride in 
the mineralization solution can promote the hydrolysis of OCP to apatite 
(Iijima and Moradian-Oldak, 2005, Fan et al., 2009). This may explain why 
even the 1% fluoride significantly accelerates apatite formation in Tris 
buffer solution in this study. Furthermore, fluoride can accelerate epitaxial 
growth of apatite crystals on the OCP precursor, changing the crystal 
morphology. Fan et al. found that as little as 1 mg/L fluoride promoted 
formation of needle-like nano-crystals on enamel. Such crystals are similar 
to native crystals in width and thickness and therefore have the potential 
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to possess similar mechanical properties (Fan et al., 2009, Fan et al., 
2007).  
In the ion exchange processes (Hench et al., 1971, Hill, 1996): Na+ cations 
near the glass surface go into solution in exchange for H+ ions from the 
solution (from dissociation of water into H+ and OH-), which results in the 
solution pH increase significantly after 2 h immersion in Tris buffer. As the 
immersion time increased to 72 h, the ion exchange reaction slowed down 
resulting in a more gradual pH rise. From 72 h onwards, ion exchange and 
apatite formation finished in the fluoride containing bioactive glasses 
therefore the pH tended to stabilize from 72 h to 168 h. However, in the 
high phosphate, but fluoride free bioactive glass P6.33F0, the speed of 
reaction and apatite formation was slower, which resulted in continuous 
pH rise after 72 h immersion. Furthermore, fluoride complexes with 
calcium and sodium rather than forming Si-F bonds, resulting in 
decreasing the compactness of the glass network, which may promote 
greater solubility and make the glass structure easier to break down.   
As for the effect of fluoride content in the bioactive glass on the pH in 
aqueous solution, Brauer et al. and Mneimne et al. observed a decrease 
in solution pH as fluoride content increased (Brauer et al., 2010, Mneimne 
et al., 2011). It was explained that F- ions can be exchanged for OH- ions 
resulting in the removing of hydroxyl ions from solution. Therefore with 
increasing fluoride content in the bioactive glass, the pH rise was less 
pronounced. However, in this study, pH slightly increased (approximately 
0.07 to 0.14) as fluoride content increased from 0% to 7%. This difference 
between the studies may be attributed to the differences between 
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bioactive glass compositions. Brauer et al. used glasses with low 
phosphate content (1.02%-0.72 Mol.%) and high fluoride content (4.75%-
32.71 Mol.%) while Mneimne et al. designed high fluoride containing 
glasses with increased phosphate content, which was variable from 4.71% 
to 6.04 Mol.%. In this research, the bioactive glasses phosphate content 
was kept high and constant (6.33 Mol.%) while low fluoride concentration 
varies (1-7%), which may counterbalance the pH changes. In addition, as 
the total Ca content increased while the F content rose in this bioactive 
glass compositions, the large amount Ca would consume the acidic 
phosphate and result in minor pH increases between the F containing and 
F free bioactive glasses. It has been demonstrated that a high pH 
environment is favourable for apatite nucleation in SBF (Lu and Leng, 
2005a), and Brauer et al. suggest that apatite formation was very 
susceptible to slight pH changes in fluoride containing bioactive glass 
composition (Brauer et al., 2010). Therefore, in this project, addition of low 
fluoride content slightly increases Tris buffer pH and may also contribute 
to the faster apatite formation.  
Although the phosphate content was kept constant in all the bioactive 
glasses, interestingly, the released P concentrations were variable as a 
function of the fluoride content in the bioactive glasses. From 8 h to 168 h 
immersion, the solution P concentration dropped sharply between the 
bioactive glasses P6.33F0 and P6.33F1, followed by a gradual decrease 
when the fluoride content increased from 1% to 3% and kept relatively 
constant as it was increased to 7% (Fig. 3.10D). This indicates that the 
combination of high phosphate content in the bioactive glasses, and a 
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small amount fluoride may significantly promote the rate of apatite 
formation as evidenced from XRD and FTIR and, would explain the 
consumption of phosphate from solution. It is very interesting to notice that 
in 0-1% F bioactive glasses, especially phosphate free bioactive glass, 
released P concentrations increased slightly from 72 to 168 h immersion, 
which may be attributed to the B-type substitution in HA (carbonate 
replacing a phosphate group) evidenced in the previous FTIR spectra that 
further broad CO3
2- bands are present in the region starting from 1410 cm-1. 
However, in the fluoride containing bioactive glasses, formed fluoapatite 
was more stable than HA, and may resist the B-type substitution to some 
degree.  
In this study, as F content increased from 0 to 7 Mol.%, the Ca content 
(from CaO and CaF2) increased slightly and the Ca/P ratio was from 2.05 
to 2.47 which is higher than the Ca/P ratio (1.67) of hydroxyapatite 
(Ca10(PO4)6(OH)2). It means that there was sufficient calcium for apatite 
formation, which may explain the released calcium concentrations in Tris 
buffer solution was kept at similar levels as a function of F content in 
bioactive glasses (Fig. 3.10B), unlike the significant variations observed in 
released P levels (Fig. 3.10D). However, the released Ca concentrations 
of P6.33F0 (with lowest Ca content in bioactive glass composition) were 
slightly higher than those in bioactive glasses P6.33F1 and P6.33F3 after 
8 to 168 h immersion in Tris buffer, which may be attributed to accelerated 
apatite formation induced by fluoride that consumes calcium. When the F 
content increased from 3 to 7%, the released Ca concentrations were 
consistent with the Ca contents in bioactive glass compositions.  However, 
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Brauer et al. (Brauer et al., 2010) observed a decrease in calcium 
concentration in SBF with increasing CaF2 content in bioactive glass 
compositions after 1 w immersion. They attributed this to the formation of 
apatite and particularly, fluorite (CaF2), as they decreased the P2O5 
content from 1.02% to 0.72% when the CaF2 increased from 4.75% to 
32.71%. It may result in the use out of phosphate quickly to form apatite 
and large amounts of extra calcium and fluoride to form fluorite. Therefore, 
the higher F content in bioactive glasses, more Ca was consumed to form 
fluorite. However, in the bioactive glass compositions in this study, P2O5 
content was 6.33% with low fluoride addition (0-7 Mol.%). It suggests that 
the released calcium was used to form apatite instead of fluorite, which 
explains the results of released Ca concentrations in Tris buffer solution 
as a function of F content in bioactive glasses 
For the Si release into Tris Buffer solution, Brauer et al. previously 
suggested that apatite formed in SBF once Si had reached the solubility 
limit (around 60 ppm), as the formation of silica gel layer is regarded to aid 
the nucleation of apatite (Brauer et al., 2010). However, in this project, it is 
observed that the presence of silica-gel formation in FTIR for glass 
P6.33F3 after immersion in Tris buffer for 2 h, while the Si concentrations 
did not reach the solubility limit at this time point (around 30 ppm). It 
suggests that Si concentration in solution is less predictive of silica-gel 
and apatite formation as previously contested. These results are also 
confirmed by other researchers (Mneimne et al., 2011, Lusvardi et al., 
2009). For the Na concentrations, it is known that in the ion exchange 
process apatite formation starts from the exchange of bioactive glass Na+ 
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with solution H+, which results in the solution Na+ concentration increasing 
drastically in the first 2 h immersion. The gradual increase during the 
remainder of the experiment may be attributed to the further release of 
small amounts of Na from the bioactive glasses. 
Compared to Tris buffer solution testing, experiments with cell culture 
medium may provide a more in vivo-like model to examine how bodily 
fluids will interact with bioactive glasses. It is known that FTIR can give 
information on a range of structural changes during the dissolution and 
apatite crystallization process, such as changes to the silicate network. 
However, FTIR cannot unambiguously identify apatite as it can show the 
presence of crystalline orthophosphates. XRD allows for the identification 
of various phases such as apatite, calcite, or fluorite, but it is not suited to 
distinguish between different apatites, such as HA, HCA, or FAp when 
they are present as small crystallites (Shah et al., 2014b). After 72 h 
immersion in cell culture medium α-MEM, it is observed that a single band 
at approximately 570 cm-1 (Fig. 3.12), corresponding to the formation of an 
amorphous or disordered crystalline apatite such as OCP or amorphous 
calcium phosphate, which is considered as a precursor of apatite. 
O’Donnell et al. found that apatite formed in physiological solutions (SBF) 
in nanosized crystals (O'Donnell et al., 2009), which would not cause 
significant apatite peaks in XRD. Compared with the apatite formation in 
Tris buffer, the rate of formation is much slower in α-MEM. Sepulveda et 
al. attributed the delayed surface apatite formation in cell culture medium 
to the presence of proteins from serum (Sepulveda et al., 2002). In this 
study, however, serum was not added until the bioactive glass conditioned 
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α-MEM was used to treat cells, thus unable to interfere with the dissolution 
process. Magnesium (Mg), is involved in numerous metabolic pathways 
such as protein and nucleic acid synthesis, cell cycle, cytoskeletal integrity 
and bone remodelling (Diba et al., 2012, Staiger et al., 2006), is included 
in cell culture medium at a concentration of 0.8 mM. However, Mg2+ ion 
retards apatite formation, by adsorption onto crystal surfaces and blocking 
active growth sites, irrespective of whether Mg2+ ion originates from test 
medium or from the bioactive glass (Barrere et al., 2002, Dietrich et al., 
2009, Ma et al., 2011). Mg2+ can inhibit crystallization of the formed 
amorphous apatite layer through entering the forming hydroxyapatite 
nuclei and reduce apatite crystal growth (Diba et al., 2012, Vallet-Regi et 
al., 1999). Jallot et al. firstly demonstrated the presence of Mg in the Ca–P 
rich layer, but the Mg substituted apatite may be Ca deficient, which is 
more soluble than stoichiometric apatite (Jallot, 2003). Although Mg2+ 
slows down apatite layer formation, it is found to increase the layer 
thickness (Vallet-Regi et al., 1999, Dietrich et al., 2009). The Mg-
substituted hydroxyapatite materials were demonstrated to have excellent 
biocompatible and show greater osteoconductivity and higher material 
resorption (Ma et al., 2010). Furthermore, compared with the mechanism 
and kinetics of glass dissolution in vivo, this in vitro study differs. The 
continuous flow of physiological fluids promotes continuous glass 
dissolution, leading to thicker apatite layers in vivo (Sepulveda et al., 
2002). Therefore, such high phosphate, low fluoride containing bioactive 
glasses may be useful to accelerate bone defect regeneration when 
applied in vivo. 
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3.4 Future work 
It was found that apatite formation was significantly accelerated in 
bioactive glasses with addition of fluoride after immersion in Tris buffer 
solution. Whilst, FAp formation was reported in previous publications 
(Brauer et al., 2010, Mneimne et al., 2011), it is more acid resistant than 
hydroxyapatite, has better stability and slow of degradation kinetics (Al-
Noaman et al., 2013). In this study, FAp could not be identified by XRD 
and FTIR. Therefore, 19F MAS–NMR could be used to further explore 
whether FAp is generated by these bioactive glasses. 
For the investigation of bioactive glass bioactivity in cell culture, apatite 
formation was delayed or nano-sized apatite formed, as we did not find 
significant apatite peaks by XRD. Therefore, in the next step the 
experimental period can be prolonged and, 19F MAS–NMR can be used to 
further explore the bioactive glass bioactivity in cell culture medium.     
In order to replicate the in vivo situation more closely, a perfusion system 
with a constantly refreshing medium environment can be designed and 
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Chapter 4  Osteoblast responses 
 
4.1 Introduction 
Osteoblasts, developed from the osteoblasts progenitor populations 
(periosteal and endosteal), are the main cells in the new bone formation 
process as they are responsible for the synthesis and secretion of bone 
matrix in mineralization.  
Numerous in vitro and animal studies have demonstrated that fluoride can 
regulate bone-forming cell activities (Farley et al., 1983, Fernandes et al., 
2012, Huo et al., 2013, Kassem et al., 1994, Okuda et al., 1990, Pei et al., 
2012, Qu et al., 2008, Ren et al., 2011, Wang et al., 2011, Yan et al., 
2009). Furthermore, F- can be incorporated into bioactive glasses by 
complexing with calcium and sodium and F- significantly accelerates the 
apatite formation in Tris buffer as represented in the last Chapter. FAp, 
which is more acid resistant, is formed upon immersion of fluoride 
containing glasses into SBF (Brauer et al., 2010). For these reasons, the 
addition of fluoride into bioactive glass with later local delivery at 
appropriate concentrations would be beneficial for bone forming cells in 
dental and orthopaedic applications.  However, high levels of systemic 
fluoride are known to cause skeletal and dental fluorosis characterized by 
debilitating changes in the skeleton, and marked mottling and 
discoloration in the teeth (Chachra et al., 2008, Vestergaard et al., 2008) 
and caution must be applied.  
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For efficient osteogenesis, angiogenesis with vascular network 
development plays a crucial role, as bone-forming cells are highly 
metabolic requiring the supply of oxygen, nutrients and elimination of their 
byproducts. VEGF, released by osteoblastic and other cells (Spector et al., 
2001, Zelzer and Olsen, 2005), can promote differentiation of local 
mesenchymal stem cells into endothelial cells and, subsequently activate 
the transmembrane VEFGR2 receptors in endothelial cells, which in turn 
activates several pathways responsible for angiogenesis during the new 
bone formation and has therapeutic value for bone applications (Weibing 
and Wang, 2014, Schliephake et al., 2015, Izuagie et al., 2015, Bose et al., 
2013). 
Therefore, the aim of this Chapter is to investigate the osteogenic and 
angiogenic responses of osteoblast MC3T3-E1 to F- concentrations and 
conditioned medium derived from novel fluoride containing bioactive 
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4.2 Results 
 Cellular response to NaF concentrations  4.2.1
 Cell proliferation and differentiation  4.2.1.1
To confirm the effects of fluoride at various concentrations on the 
proliferation and differentiation of MC3T3-E1, a bisbenzimidazole-
chelation assay to assess DNA content by fluorescence intensity and an 
ALP-based assay generating a coloured reaction product measured 
spectrophotometrically were used.  
For the F- induced proliferation as showed in Fig. 4.1, compared with 
control group (0 ppm), the high fluoride concentrations, 9.5 and 19 ppm, 
suppressed MC3T3-E1 proliferation significantly in the whole experimental 
period. Other concentrations (0.1-1.9 ppm) showed increased levels in 
proliferation, but there was no statistical difference.  
 
Figure 4.1  Effects of F
-
 concentrations on cell proliferation in MC3T3-E1. Cells were 
treated with fluoride at a range concentration for 1 d, 4 d, 7 d, and 10 d. After treatment, 
cell proliferation was estimated using a bisbenzimidazole-chelation assay to assess DNA 
content by fluorescence intensity. Results are indicated the cell number. Each bar 
represents mean ± SE of ten independent experiments. * P <0.05 or ** P <0.01, 
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Fig. 4.2 represents the effects of F- concentrations on MC3T3-E1 
differentiation. It is found that 0.1 ppm F- significantly promoted 
differentiation over the whole experimental period (4 d to 10 d). However, 
the high doses fluoride in this study (9.5 ppm and 19 ppm, equal to 5x10-4 
and 10-3 M) suppressed MC3T3-E1 differentiation significantly. For the 
middle fluoride concentrations (1 ppm and 1.9 ppm), There were no 
significantly positive or negative effects on MC3T3-E1 differentiation.  
 
Figure 4.2  Effects of F
-
 concentrations on cell differentiation in MC3T3-E1. Cells 
were treated with fluoride at a range concentration for 1 d, 4 d, 7 d, and 10 d. After 
treatment, cell differentiation was estimated by using ALP assay. Results are indicated 
the ALP activity (nmol/ml/min). Each bar represents mean ± SE of ten independent 
experiments. * P <0.05 or ** P <0.01, compared with 0 ppm group. 
 
 Cytotoxicity of bioactive glass conditioned medium on 4.2.2
osteoblasts 
Compared with the control (normal medium without bioactive glass 
immersion), all the bioactive glass conditioned medium samples, except 
7% F- bioactive glass at 72 h, were not cytotoxic to the growth of MC3T3-
E1 cells (Fig. 4.3 A, B, C, D). In the 72 h conditioned medium, levels of 
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groups, 0-3% F content. However, this increase is small, and might be 
without meaning.  
    
    
Figure 4.3 Cytotoxicity of bioactive glass conditioned medium on MC3T3-E1. Cells                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
were treated with different conditioned medium (2 h, 8 h, 24 h and 72 h) for 1 d, 3 d and 5 
d. After treatment, cytotoxicity was estimated using MTT assay. Results are indicated the 
normalized data. Each marker represents mean ± SE of six independent experiments. ** 
P <0.01, compared with control group. (P6.33F0 indicates a bioactive glass contains 6.33 
Mol.% phosphate and 0 Mol.% fluoride) 
 
 Cellular response to 72 h bioactive glass conditioned medium 4.2.3
 Total quantification of cells cultured in bioactive glass 4.2.3.1
conditioned medium 
MC3T3-E1 proliferation in 72 h conditioned medium varied depending on 
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through an established calibration curve. The number of cells that survived 
was too few to be detected in the high F addition group (P6.33F7). 
However, significantly more cells were observed in P6.33F0 and P6.33F1 
groups than non-conditioned medium (control) from 7 d to 21 d in culture. 
The cell number was significantly lower in the P6.33F5 group compared 
with the control group.  
 
Figure 4.4 Effects of bioactive glass conditioned medium on cell proliferation in 
MC3T3-E1. Cells were treated in 72 h bioactive glass conditioned medium for 7 d, 14 d 
and 21 d. After treatment, cell proliferation was estimated using the bisbenzimidazole-
chelation assay to assess DNA content by fluorescence intensity. Results are indicated 
the cell number. Each bar represents mean ± SE of ten independent experiments. * P 
<0.05 or ** P <0.01, compared with control group. (P6.33F0 indicates a bioactive glass 
contains 6.33 Mol.% phosphate and 0 Mol.% fluoride) 
 
 Alkaline phosphatase (ALP) activity in cells cultured in 4.2.3.2
bioactive glass conditioned medium 
After treating for 7 d, 14 d and 21 d in the bioactive glass conditioned 
medium, MC3T3-E1 cells in the P6.33F0 and P6.33F1 groups produced 
significantly higher ALP activity than those in the control. At the time points 
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in P6.33F0. While in the 5% F addition glass (P6.33F5), ALP activity was 
significantly suppressed (Fig. 4.5).  
 
Figure 4.5 Effects of bioactive glass conditioned medium on cell differentiation in 
MC3T3-E1. Cells were treated with 72 h bioactive glass conditioned medium for 7 d, 14 d 
and 21 d. After treatment, cell differentiation was estimated using ALP assay. Results are 
indicated the ALP activity (nmol/ml/min). Each bar represents mean ± SE of ten 
independent experiments. * P <0.05 or ** P <0.01, compared with control group. + P 
<0.05, compared with P6.33F0. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% 
phosphate and 0 Mol.% fluoride) 
 
 Type I collagen formation in bioactive glass conditioned 4.2.3.3
medium 
Type I collagen formation was significantly promoted in P6.33F0 and 
P6.33F1 groups in comparison with that in control after 2 w, 3 w and 4 w 
culture (Fig. 4.6). At the time points of 2 w and 3 w, bioactive glass 
P6.33F1 induced more Type I collagen formation than P6.33F0. However, 
in the latest time point (4 w), it was significantly suppressed in 5% F 
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 control P6.33F0 P6.33F1 P6.33F3 P6.33F5 
2w 
     
3w 
     
4w 
     
 
 
Figure 4.6  Qualitative and quantitative results of Type I collagen formation in 
MC3T3-E1. After treatment in bioactive glass conditioned medium for 2 w, 3 w and 4 w, 
cells were incubated with Picro-Sirius red for collagen staining then the dye was 
extracted by incubation with NaOH and methanol mix for quantitative analysis. Each bar 
represents mean ± SE of three independent experiments. * P <0.05 or ** P <0.01, 
compared with the control. + P <0.05, compared with P6.33F0. (P6.33F0 indicates a 
bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% fluoride) 
 
 Cell mineralization in bioactive glass conditioned medium 4.2.3.4
Fig. 4.7 represents the qualitative and quantitative results of MC3T3-E1 
mineralization in bioactive glass conditioned medium. It was significantly 
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control after 2 w, 3 w and 4 w culture. At 2 w and 3 w, mineralization in 
P6.33F1 was significantly higher than that in P6.33F0. For the P6.33F3 
group, mineralization was significantly promoted in the later time points (3 
w and 4 w). However, in the 5% F addition group (P6.33F5), 
mineralization was significantly suppressed in all the treatment periods. 
 control P6.33F0 P6.33F1 P6.33F3 P6.33F5 
2w 
     
3w 
     
4w 
     
 
 
Figure 4.7  Qualitative and quantitative results of MC3T3-E1 mineralization in 
bioactive glass conditioned medium. After treatment in bioactive glass conditioned 
medium for 2 w, 3 w and 4 w, cells were incubated with Alizarin red S for bone nodule 
staining then the dye was extracted by incubation in 10% (w/v) cetylpyridinium chloride in 
10 mM sodium phosphate for quantitative analysis. Each bar represents mean ± SE of 
three independent experiments. * P <0.05 or ** P <0.01, compared with the control. + P 
<0.05, compared with P6.33F0. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% 
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 Osteogenic gene expression in bioactive glass conditioned 4.2.3.5
medium 
The expression of genes associated with osteogenesis, Col1a1 and OPN, 
were investigated as shown in Fig. 4.8.  Gene expression increased in the 
P6.33F0 and P6.33F1 groups in comparison with those in the control from 
1 d to 21 d. Furthermore, they were greater in P6.33F1 than those in the 
P6.33F0 through the whole experimental period. However, both Col1a1 
and OPN gene expression significantly decreased in the P6.33F5 group.  
 
 
Figure 4.8  Expression of pre-osteogenic markers. After treatment in bioactive glass 
conditioned medium, cells were collected for mRNA extraction, cDNA synthesis followed 
by qPCR to quantify the OPN and Col1a1 gene expression in MC3T3-E1. Normalized by 
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or ** P <0.01, compared with the control. (P6.33F0 indicates a bioactive glass contains 
6.33 Mol.% phosphate and 0 Mol.% fluoride) 
 
 Angiogenic gene expression and protein production in 4.2.3.6
bioactive glass conditioned medium and F- concentrations 
Compared with the control, VEGF gene expression was promoted by all 
the investigated bioactive glasses (P6.33F0 to P6.33F5) from 1 d to 21 d 
treatment (Fig. 4.9). When comparing the fluoride free glass (P6.33F0) 
and fluoride containing glasses (P6.33F1 to P6.33F5), the later exhibit 
greater levels of VEGF gene expression at the later time points of 14 d 
and 21 d.  
 
Figure 4.9  VEGF gene expression. After treatment in bioactive glass conditioned 
medium, cells were collected for mRNA extraction, cDNA synthesis followed by qPCR to 
quantify the VEGF gene expression in MC3T3-E1. Normalized by control and each bar 
represents mean ± SE of three independent experiments. * P <0.05 or ** P <0.01, 
compared with the control. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% 
phosphate and 0 Mol.% fluoride) 
 
As for the VEGF protein production after treatment in bioactive glass 
conditioned medium (Fig. 4.10), no significant difference was observed 
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21 d, greater VEGF protein production was observed in all the bioactive 
glass groups. Similar to the VEGF gene expression, the protein 
expression was also further promoted by the fluoride containing bioactive 
glasses than the fluoride free bioactive glass (P6.33F0).  
VEGF 
   
Cyclophilin B 
   
 7d 14d 21d 
 
                    
Figure 4.10  VEGF protein production by MC3T3-E1 in bioactive glass conditioned 
medium. After treatment in bioactive glass conditioned medium, cells were collected for 
protein extraction and the VEGF protein production was qualified using Western Blot and 
quantified by Image J. Normalized by the control and each bar represents mean ± SE of 
three independent experiments. * P <0.05 or ** P <0.01, compared with control group. + 
P <0.05, compared with P6.33F0 group. (P6.33F0 indicates a bioactive glass contains 
6.33 Mol.% phosphate and 0 Mol.% fluoride) 
 
The effects of F- concentrations on VEGF protein production as showed in 
Fig. 4.11 below. After treating with NaF concentrations (F- concentrations: 
0 - 9.5 ppm) for 7 d, it is found that VEGF protein production was slightly 
promoted by all the fluoride groups and significantly higher in the 9.5 ppm 
group, in comparison with the control (0 ppm).  However, at 14 d, there 
was no significant difference between control and fluoride groups. At 21 d, 
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more VEGF protein than those treated by fluoride concentrations. But 
there was no statistical difference between them.   
VEGF 
   
Cyclophilin B 
   
 7d 14d 21d 
 
                    
Figure 4.11  VEGF protein production by MC3T3-E1 in F
-
 concentrations. After 
treatment by NaF concentrations, cells were collected for protein extraction and the 
VEGF protein production was qualified using Western Blot and quantified by Image J. 
Normalized by the control and each bar represents mean ± SE of three independent 
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4.3 Discussion 
Compared to Tris buffer solution testing, experiments with cell culture 
medium may provide a more in vivo-like model to examine how bodily 
fluids will interact with bioactive glasses. All potential dental and 
orthopaedic biomaterials are routinely investigated by cell culture for 
biocompatibility. Therefore, keeping the same conditions as for the Tris 
buffer experiments, bioactive glass conditioned medium was produced 
(immersed for 2 h, 8 h, 24 h and 72 h) and then used to treat MC3T3-E1 
cells. It is found that the cell viability dropped as the treating time 
increased from 1 d to 5 d in the 2 h, 8 h and 24 h bioactive glass 
conditioned medium, which may attribute to the toxicity of high ion 
concentrations in the early immersed period (2 h, 8 h and 24 h). When the 
immersion time increased to 72 h, reactions between bioactive glass 
particles and surrounded solution tended stabilized, leading to the 
promoted cell viability in the 72 h bioactive glass conditioned medium.  
Therefore, 72 h bioactive glass conditioned medium was used to 
investigate the bioactive glass composition on the MC3T3-E1 cell 
osteogenic responses including proliferation, ALP activity, Type I collagen 
formation, bone nodule formation and osteogenic gene expression. It was 
found that those osteogenic activities were promoted by the high 
phosphate, F free or low F addition bioactive glasses (P6.33F0 to P6.33F1) 
but significantly suppressed when the F content increased to 5-7%.  
Inorganic phosphate plays a vital role and is essential for the biological 
mineralization, which is continual throughout life and is mainly achieved by 
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the function of osteoblasts, the activation of specific genes like ALP, 
osteopontin and osteocalcin and inorganic ions calcium and phosphate 
(Beck, 2003, Beck et al., 2003, Beck et al., 1998). Here, the high 
phosphate containing glasses resulted in the phosphate concentrations in 
bioactive glass conditioned medium kept similar to that in α-MEM (Fig. 
3.13), avoiding consumption of cell culture medium phosphate to form 
apatite. In bioactive glasses, silicon acts as network former, and numerous 
studies have demonstrated its stimulatory effects on cellular activities, 
such as regulating the expression of key osteoblastic marker genes, cell 
cycle regulators and extracellular matrix proteins, stimulate new bone 
formation in animal models, inhibit osteoclast phenotypic gene 
expressions, osteoclast formation and bone resorption in vitro, although 
the exact mechanism is yet to be understood (Calvo-Guirado et al., 2014, 
Chadwick et al., 2014, Friederichs et al., 2015, Henstock et al., 2015, 
Manchon et al., 2015, Mladenovic et al., 2014, Odatsu et al., 2015). In this 
study, the released silicon concentrations into cell culture medium ranged 
from 45 to 52 ppm depending on the bioactive glass compositions. 
Therefore, when compared with the control (no bioactive glass) in this 
study, the promoted osteogenic responses including proliferation, ALP 
activity, Type I collagen formation, bone nodule formation and osteogenic 
gene expression in MC3T3-E1 osteoblastic cells by the high phosphate 
but fluoride free bioactive glass (P6.33F0) may be attributed to the effects 
of phosphate and silicon.  
However, those activities were further increased in the P6.33F1 bioactive 
glass and significantly suppressed when the F content increased to 5-7%. 
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As discussed before in the literature review, fluoride interacts with 
mineralized tissues in a biphasic manner (Chachra et al., 2008, Aaseth et 
al., 2004). At low doses, it is passively incorporated into the minerals of 
both bone and teeth to form FAp, to improve the structure and amount of 
mineralized tissue, as well as the interface between the collagen and 
mineral during the treatment of osteoporosis. However, high doses of 
fluoride have undesirable effects including the occurrence of skeletal and 
dental fluorosis. Therefore, the MC3T3-E1 cells were treated with F- 
concentrations and the findings are consistent with the literature that, both 
differentiation and proliferation were promoted in cells treated with low F- 
concentrations (from 0.1 to 1.9 ppm) (Fig. 4.1-2). However, when F- 
concentrations increased to 9.5 and 19 ppm, both activities were 
significantly suppressed. In the bioactive glass conditioned medium study, 
it was found that osteoblastic cell activities were significantly promoted in 
the low fluoride containing bioactive glass (P6.33F1), but suppressed 
when the fluoride content increased to 5-7%. From the results of the 
fluoride ion release into cell culture medium (Fig. 3.13), the fluoride 
concentration was 2.8 ppm (0.15 mM) in P6.33F1 group while up to 12-16 
ppm (0.6-0.85 mM) in the 5-7% fluoride containing groups. It is consistent 
with the MC3T3-E1 cell responses in F- concentrations. Similar results 
were also reported when human osteoblast-like Saos-2 cells were treated 
with different NaF concentrations (0-1.6 mM) for 72 h, Huo et al. found 
that 0.2 mM fluoride resulted in a higher proliferation and expression of 
osteoblast marker genes associated with the activation of the BMP/Smad 
pathway (Huo et al., 2013). In goat osteoblasts, low NaF concentrations 
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(under 0.01 mM) promoted proliferation, differentiation and mineralization 
while high concentrations (0.1-1 mM) showed negative effects (Qu et al., 
2008). However, Wang et al. revealed that after treating with NaF 
concentrations (0.001 to 0.5 mM), primary mice osteoblast viability was 
inhibited in a dose- and time-dependent manner (Wang et al., 2011). 
Additionally, it was reported that only 0.01 mM NaF was required to 
reduce cell viability and promote apoptosis in the MC3T3-E1 cells, (Yang 
et al., 2011). This suggests the effects of fluoride on cells not surprisingly 
depend on the concentrations, time and cell type (primary cells or 
established cell line) (Everett, 2011). In this study, the bioactive glass 
P6.33F1 conditioned medium, with a released F- concentration around 
0.15 mM, significantly promoted the osteogenic responses of MC3T3-E1 
cells.  
For the angiogenic effects, we found that the VEGF gene expression and 
its protein production were both significantly promoted by the high 
phosphate but fluoride free bioactive glass P6.33F0 and further increased 
in the fluoride containing bioactive glass conditioned medium. Compared 
with the control, silicon and fluoride were released from bioactive glasses 
into medium. Silicon, aside from the potential osteogenic benefits as 
discussed before, several recent studies have noted that it may have 
angiogenic capabilities as well (Bose et al., 2013). Silicon containing 
bioactive glasses has been demonstrated to stimulate VEGF secretion 
and promote angiogenesis through in vitro and in vivo studies (Day, 2005, 
Gorustovich et al., 2010, Leu et al., 2009). In addition to bioactive glasses, 
utilizing a calcium silicate bioceramic resulted in VEGF expression in 
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human dermal fibroblasts, which was mainly induced by the presence of 
silicon (Li and Chang, 2013). Similarly, another study utilizing a calcium 
silicate in a rabbit femur defect was also able to demonstrate angiogenic 
effects (Wang et al., 2013a). Fielding et al. reported that 
neovascularization was increased up to three times with the incorporation 
of SiO2 and ZnO into β-tricalcium phosphate scaffolds in an  in vivo study 
(Fielding and Bose, 2013). Ca–Mg–Si-containing bioceramic enhanced 
angiogenesis of human aortic endothelial cells was reported by Zhai et al., 
and it was proposed that silicon ions might play an important role in the 
stimulation of angiogenesis (Zhai et al., 2012). However, very few 
publications discussed the effects of fluoride on angiogenesis. Through 
embedding different sponges into rabbit femur, Lalk et al (Lalk et al., 2013) 
found that MgF2 coated sponges exhibited the highest vascularization in 
comparison with the CaP coating. Similar results were reported by Liu et 
al. (Liu et al., 2012) that the deposition of VEGF in the thyroid gland was 
significantly promoted through NaF water feeding in a rat model. 
Therefore, MC3T3-E1 cells were also treated with a range of F- 
concentrations (0, 0.1, 1.9 and 9.5 ppm) for the VEGF protein production 
in this study. However, there was no significant difference between the 
control (0 ppm) and F- concentration groups after 7 d, 14 d and 21 d 
treatment. Therefore, the improved angiogenesis on MC3T3-E1 cells after 
treatment with bioactive glass conditioned medium may be attributed to 
the combined effects of silicon and fluoride. A sufficient supply of blood 
and oxygen is a key and dependent factor for osteogenesis in bone 
healing (Nuss and von Rechenberg, 2008, Karageorgiou and Kaplan, 
175 | P a g e  
 
2005, Kuzyk and Schemitsch, 2011). The fluoride containing bioactive 
glasses exhibited angiogenic potential in vitro and could be used as bone 
substitutes with the expected promotion of VEGF gene expression and 
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4.4 Future plan 
In this study, only Western Blot was used to measure the VEGF protein 
production inside of the MC3T3-E1 cells. In the future, the changed cell 
culture medium could also be collected to investigate whether the VEGF 
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From Chapters 3 and 4, it is concluded that the high phosphate low 
fluoride containing bioactive glasses significantly accelerate apatite 
formation in Tris buffer solution and promote the osteogenic and 
angiogenic responses of MC3T3-E1 pre-osteoblast cells.  
However, in periodontal bone defect treatment, the healing outcome will 
not only depend on the implanted biomaterials, apatite formation rate and 
osteoblast response, but also be determined by the surrounding soft 
tissues containing epithelial cells and fibroblasts (Vignoletti et al., 2014). 
Therefore, ideal strategies should be able to regenerate all damaged 
structures including the soft and hard tissues. 
The effects of fluoride on periodontal soft tissues are contradictory. Some 
studies have reported that fluoride does not have any significant positive 
effects on the severity of gingival inflammation and periodontal pocket 
formation (Reddy and Grobler, 1988, Haikel et al., 1989), whereas others 
suggested that the intake of fluoride in drinking water lowered the 
incidence and severity of periodontal disease and was beneficial to the 
periodontal tissues (Anuradha et al., 2002, Kumar and John, 2011). In 
addition, Lutfioglu et al. demonstrated in a rabbit model that, excessive 
fluoride intake may affect the homeostasis of periodontal soft tissues by 
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altering their degradation and formation (Lutfioglu et al., 2012). However, 
most of these investigations were based on clinical assessments and 
animal studies, and there is little data on the mechanisms of fluoride 
dependent biological reactions in periodontal soft tissues. 
Bioactive glasses have attracted more attention for their application in 
periodontal and implant therapy. Besides significant positive effects on 
bone cells and apatite formation, bioactive glasses also show benefits in 
soft tissue repair by increasing tissue strength (Gillette et al., 2001) and 
producing a transient reduction in the pro-inflammatory response to 
endotoxin (Rectenwald et al., 2002). Clinical research and animal studies 
show that bioactive glass prevent the apically directed growth of the 
junctional epithelium (Karatzas et al., 1999, Mengel et al., 2003, Mengel et 
al., 2006). However, there is insufficient data on the fluoride containing 
bioactive glasses and their effects on periodontal tissues and cells. 
Therefore, this Chapter presents data to demonstrate the effects of 
fluoride concentrations and bioactive glass conditioned medium on 
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5.2 Results 
 Immunofluorescence for human oral epithelial primary cells 5.2.1
Human oral epithelial primary cells derived from human oral cavity 
epithelial tissue have recently been marketed, but there is no previous 
publication to validate them. Thus, CK5 and Dsg3 were chosen as two 
epithelial cell specific markers for validation. After 24 h culture followed by 
immunofluorescence staining as showed in Fig. 5.1, the cytoplasmic 
intermediate filament protein CK5, and Dsg3, a transmembrane 
glycoprotein component of cell-cell junction desmosomes, were clearly 
expressed by these human oral epithelial primary cells.   
Dsg3 DAPI Merge 
   
CK5 DAPI Merge 
   
Figure 5.1  Expression of CK5 and Dsg3 in human oral epithelial primary cells 
assessed by fluorescence microscopy analysis. Cells were seeded at 70-80% 
confluence and were fixed by formaldehyde and immune-stained with the indicated 
antibodies. Nucleus and specific protein staining was merged using Image J.  
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DAPI is a specific stain for cell nuclei. However, significant cytoplasmic 
labelling was found between the cell nuclei as showed in Fig. 5.2 
(arrowed), which may be mycoplasma contamination (discussed later). As 
those human oral epithelial cells are primary cells and they have limited 
number of passages for effective use (passage 3 and 4 are the most 
appropriate for experiments), the mycoplasma elimination kits are not 
applicable. Therefore, epithelial cell line A431 cells were used in the later 
experiments.  
   
Figure 5.2  DAPI staining in human oral epithelial primary cells assessed by 
fluorescence microscopy analysis. Cells were seeded at 70-80% confluence and were 
fixed by formaldehyde and stained with DAPI.  
 
 Cellular response to NaF 5.2.2
 Epithelial cells 5.2.2.1
For the cytotoxicity of fluoride on A431 cells, compared with the control 
group (0 ppm), all the investigated F- concentrations (0.1 to 19 ppm) were 
not cytotoxic to the growth of A431 cells after 1 to 5 d treatment (Fig. 5.3), 
although the levels of MTT reaction products decreased slightly as the F- 
concentrations increased.  
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Figure 5.3 Cytotoxicity of F
-
 concentrations on A431 cells. Cells were treated with a 
range of NaF concentrations for 1 d, 3 d and 5 d. After treatment, cell viability was 
estimated using MTT assay. Results are indicated the normalized results. Each marker 
represents mean ± SE of ten independent experiments.  
 
For the proliferation as showed in Fig. 5.4, the numbers of A431 cells in 
both control and experimental groups increased significantly as the 
treatment time increased from 4 d to 10 d. However, when compared with 
the control group (0 ppm), A431 cell proliferation was suppressed 
significantly as the F- concentrations increased from 0.1 to 19 ppm during 
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Figure 5.4  Effects of fluoride on cell proliferation in A431 cells. Cells were treated 
with F
-
 concentrations for 4 d, 7 d and 10 d. After treatment, cell proliferation was 
estimated using the bisbenzimidazole-chelation assay to assess DNA content by 
fluorescence intensity. Results are indicated the cell number. Each bar represents mean 




Compared with the control group (0 ppm), F- concentrations from 1 to 19 
ppm were not cytotoxic to the growth of NHOF cells after 1 to 5 d 
treatment (Fig. 5.5). In the 9.5 and 19 ppm F- group, the levels of MTT 
reaction products were higher than that in the control. However, this 
increase is small, and not significantly greater.  
For the F- induced proliferation of NHOF cells as showed in Fig. 5.6, 
compared with control group (0 ppm), the high fluoride concentrations, 9.5 
and 19 ppm, significantly increased NHOF cell numbers during the whole 
experimental period. Other lower concentrations (0.1-1.9 ppm) did affect 
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Figure 5.5 Cytotoxicity of F
-
 concentrations on NHOF cells. Cells were treated with a 
range of NaF concentrations for 1, 3 and 5 d. After treatment, cytotoxicity was estimated 
using MTT assay. Results are indicated the normalized results. Each marker represents 




Figure 5.6  Effects of fluoride on cell proliferation of NHOF cells. Cells were treated 
with F
-
 concentrations for 4 d, 7 d and 10 d. After treatment, cell proliferation was 
estimated using the bisbenzimidazole-chelation assay to assess DNA content by 
fluorescence intensity. Results are indicated the cell number. Each bar represents mean 
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 Cellular response to bioactive glass conditioned medium 5.2.3
 Epithelial cells 5.2.3.1
For the cytotoxicity of bioactive glass conditioned medium on A431 cells, 
compared with the control group (normal medium without bioactive glass 
immersion), all the investigated bioactive glass groups, except P6.33F7 
bioactive glass, were not significantly cytotoxic to the growth of A431 cells 
from 1 to 3 d treatment (Fig. 5.7). However, when treatment time extended 
to 5 d, the growth of A431 cells was moderately inhibited by all bioactive 
glass conditioned medium.  
 
Figure 5.7 Cytotoxicity of bioactive glass conditioned medium on A431 cells. Cells 
were treated with bioactive glass conditioned medium for 1 d, 3 d and 5 d. After treatment, 
cytotoxicity was estimated using MTT assay. Results are indicated the normalized results. 
Each marker represents mean ± SE of ten independent experiments. (P6.33F0 indicates 
a bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% fluoride) 
 
For the proliferation, as shown in Fig. 5.8, A431 cell numbers in 
experimental groups did not increase much as the treatment time 
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proliferation was significantly suppressed in the bioactive glass 
conditioned medium groups during the whole experimental period. When 
comparing the P6.33F0 and F containing bioactive glass groups, the later 
significantly further decreased A431 cell numbers after 7 d and 10 d 
treatment.   
 
 
Figure 5.8 Effects of bioactive glass conditioned medium on cell proliferation in 
A431 cells. Cells were treated with bioactive glass conditioned medium for 4 d, 7 d and 
10 d. After treatment, cell proliferation was estimated using the bisbenzimidazole-
chelation assay to assess DNA content by fluorescence intensity. Results are indicated 
the cell number. Each bar represents mean ± SE of ten independent experiments. * P 
<0.05 or ** P <0.01, compared with control group. + P <0.05, compared with P6.33F0 




After treatment with the bioactive glass conditioned medium, the NHOF 
cell viability was not significantly affected, compared with the control 















































186 | P a g e  
 
 
Figure 5.9 Cytotoxicity of bioactive glass conditioned medium on NHOF cells. Cells 
were treated with bioactive glass conditioned medium for 1 d, 3 d and 5 d. After treatment, 
cytotoxicity was estimated using MTT assay. Results are indicated the normalized results. 
Each marker represents mean ± SE of ten independent experiments. (P6.33F0 indicates 
a bioactive glass contains 6.33 Mol.% phosphate and 0 Mol.% fluoride) 
 
For the effects of bioactive glass conditioned medium on NHOF cell 
proliferation (Fig. 5.10), compared with control group, the P6.33F5 and 
P6.33F7 groups significantly increased NHOF cell numbers during the 
whole experimental period, and at the early time point 4 d, both groups 
significantly induced more NHOF cell growth than that in the F free 
bioactive glass P6.33F0 group. For treatment time of 10 d, NHOF cell 
proliferation was significantly promoted by all the bioactive glass 
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Figure 5.10  Effects of bioactive glass conditioned medium on cell proliferation in 
NHOF cells. Cells were treated with bioactive glass conditioned medium for 4 d, 7 d and 
10 d. After treatment, cell proliferation was estimated using the bisbenzimidazole-
chelation assay to assess DNA content by fluorescence intensity. Results are indicated 
the cell number. Each bar represents mean ± SE of ten independent experiments. * P 
<0.05 or ** P <0.01, compared with control group. + P <0.05, compared with P6.33F0 
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5.3 Discussion 
DAPI (4', 6-diamidino-2-phenylindole) is a blue-fluorescent nucleic acid 
stain that preferentially associates with the minor groove of double-
stranded DNA, with a preference for the adenine-thymine clusters 
(Chazotte, 2011). When DAPI is bound to DNA, the fluorescence intensity 
will increase approximately 20-fold and its blue fluorescence stands out 
vividly against the green, yellow, or red fluorescent probes for other 
structures. Thus, it is a popular nuclear counterstain in multicolour 
fluorescent techniques. In this study, significant cytoplasmic DAPI labelling 
was found in the human oral epithelial primary cells. Most DNA is located 
in the cell nucleus, but a small amount can also be found in the 
mitochondria, which stays in cytoplasm. However, it is demonstrated that 
animal cells have a small mitochondria DNA (< 20 kb), which could not 
been detected without the usage of specific techniques (Dellinger and 
Geze, 2001). Therefore, in the human oral epithelial primary cells in this 
study, the detected cytoplasmic DAPI labelling can be attributed to 
mycoplasma contamination instead of mitochondria DNA in cytoplasm.  
Mycoplasma is the simplest bacteria and smallest free-living organism 
(~100 nm in diameter) with extremely basic genomes, and therefore, it 
exists as a parasite exploiting host cells to fulfil its energy requirements 
and component biosynthesis.  As the lack of a rigid cell wall around the 
cell membrane, mycoplasma is resistant to a number of common 
antibiotics used in cell culture, such as penicillin and streptomycin 
(InvivoGen, 2012). Mycoplasma can produce a variety of negative effects 
in the cultured eukaryotic cells they infect, such as altered levels of 
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protein, RNA and DNA synthesis, cellular metabolism alteration, induced 
chromosomal aberrations, cellular morphology and cytokine expression 
change, influence on signal transduction and etc. (Drexler and Uphoff, 
2002). A microarray analysis revealed that mycoplasma altered the 
expression of hundreds of genes including those encoding for receptors, 
ion channels, growth-factors, and oncogenes (Miller et al., 2003). 
Therefore, another epithelial cell line A431 (morphologically similar to 
normal differentiated squamous epithelial cells and derived from an 
epidermoid carcinoma in the vulva) was used in this study instead of the 
mycoplasma contaminated human oral epithelial primary cells.  
NaF concentrations (0.1 to 19 ppm, equal to 0.005 to 1 mM) did not 
demonstrate significant cytotoxicity to the A431 cells. However, cell 
proliferation was dose-dependently suppressed after 4 d to 10 d 
treatment. For lung epithelial cells A549, dose-dependent death was 
observed after exposure to 5-10 mM NaF, while low concentrations (0.25 - 
3.73 mM) were not toxic (Refsnes et al., 2002, Refsnes et al., 2003, 
Ameeramja et al., 2015). In another study, with oral epithelial ROE2 cells, 
exposure to NaF concentrations (1, 2 and 4 mM) significantly and 
concentration-dependently decreased cell viability, while low 
concentrations (0.25 and 0.5 mM) did not affect cell viability and 
proliferation (Tabuchi et al., 2014). For the human skin epithelial cell line, 
HaCaT, NaF at high dose (5 mM) strongly inhibited proliferation and 
blocked terminal differentiation, which was visible by keratin expression 
and failure to assemble stratified layers, while low does (0.5 mM) did not 
inhibit cellular proliferation or affect the cell differentiation significantly 
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(Prado et al., 2011, Dogan et al., 2002). For a human gingival epithelial 
cell line Smulow-Glickman (S-G), toxicity was first observed at 1 mM NaF 
after 24 h exposure (Zuckerbraun et al., 1998). He and Chen et al. 
demonstrated that fluoride induced DNA damage, cell cycle changes and 
led to apoptosis in oral mucosal cells (He and Chen, 2006). However, 
Arakawa et al. reported that, in human primary gingival epithelial cells, 
lower NaF concentrations promoted proliferation with the peak at 50 µM, 
while the high levels (higher than 500 µM) drastically reduced cell 
proliferation (Arakawa et al., 2009). It means that effects of NaF on 
epithelial cells not only depend on the concentrations but also be 
determined by cell types under study. In this study with A431 cells, the 
investigated NaF concentrations (0.1 - 19 ppm, equal to 5 µM - 1 mM) 
were not significant cytotoxic, cell numbers increased significantly from 4 d 
to 10 d treatment although they were dose-dependently suppressed when 
compared with the control (0 ppm).  
However, after incubation in bioactive glass conditioned medium, the 
A431 cell numbers did not increase greatly from 4 d to 10 d. In addition, 
when compared with the control, cell proliferation was significantly 
suppressed by bioactive glass conditioned medium and further decreased 
in the F containing groups. The effects of bioactive glasses on epithelium 
and epithelial cells are disputed. Ma et al. reported that the proliferation of 
GES-1 human gastric mucosa epithelial cells was significantly suppressed 
after 24 h treatment in 45S5 bioactive glass ionic dissolution, (Ma et al., 
2013a). A study with intestinal epithelial cell line Caco-2 suggested that 
surfaces coated with bioactive glass did not cause any cytotoxic effect on 
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the epithelial cells, whereas the cell migration was inhibited (Moosvi and 
Day, 2009). In a monkey model, the implanted bioactive glasses (Biogran) 
showed a promising inhibition of junctional epithelium apical migration, 
while the junctional epithelium was observed to migrate up to the defect 
base in the control sites (coagulum filling) (Villaca et al., 2005). However, 
a clinical study revealed that a long junctional epithelium healing with 
minimal new connective tissue attachment to the teeth was observed after 
applying bioactive glass ceramic (Perioglas) to treat the intra-bony defects 
(Nevins et al., 2000). No significant difference in total epithelium extension 
was observed between the bioactive glass (Perioglas) and control 
(naturally filled with coagulum) groups in a dog bone defect model 
(Carvalho et al., 2011). Cetinkaya et al. reported that the proliferation of 
gingival epithelial cells was more prominent after applying bioactive glass 
to treat intra-bony defects (Cetinkaya et al., 2007). In this in vitro study, 
the fluoride containing bioactive glass conditioned medium did not strongly 
inhibit A431 epithelial cell viability, but the cell proliferation was 
significantly suppressed, and further decreased in the F containing 
groups, which may be attributed to the combined effects of fluoride and 
bioactive glasses.  
In this study, NaF concentrations (0.1 to 19 ppm, equal to 0.005 to 1 mM) 
were not cytotoxic to fibroblasts NHOF and, 9.5 and 19 ppm fluoride 
significantly increased NHOF cell numbers during the whole experimental 
period. Fluoride was reported to be cytotoxic to fibroblasts at high 
concentrations: Dogan et al. observed that NaF strongly reduced the 
growth of mouse fibroblasts 3T3 at concentration of 10, 5 and 2.5 mM 
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(Dogan et al., 2002). For the human gingival fibroblast cell (CRL-2014), 
1.5 mM fluoride induced significant cellular damage such as increased 
oxidative stress, inflammation, and apoptosis (Inkielewicz-Stepniak et al., 
2014). In another study, NaF was observed to be cytotoxic to oral mucosal 
fibroblasts at concentrations of 4 mM or higher with inhibition of protein 
synthesis, mitochondrial function and depletion of cellular ATP, while no 
significant inhibition was found at concentrations lower than 2 mM (40 
ppm) (Jeng et al., 1998). 5% fluoride varnish (Duraflur) was observed to 
significantly lower human gingival fibroblast cell viability (Parirokh et al., 
2015). However, positive effects are initiated in fibroblasts by low fluoride 
doses: fluoride concentrations (0.0001 – 20 ppm) significantly increased 
the gene and protein levels of bone formation markers, core-binding factor 
α 1 (Cbfa1) and osteocalcin (OCN), in fibroblast cell line L929 (Duan et al., 
2014). NaF concentrations (lower than 2 mM) were non-cytotoxic for 
human periodontal ligament fibroblasts (Chien et al., 2006). 0.002% NaF 
did not affect human gingival fibroblast viability and induced cell 
proliferation. In addition, NaF was demonstrated to increase resistance to 
the interleukin-1β-induced gingival inflammation in human gingival 
fibroblasts (Lee and Choi, 2015). Lochaiwatana et al. revealed that the 
human gingival fibroblast cell viability was significantly promoted after 
incubation with F varnish for 48 h  (Lochaiwatana et al., 2015). A clear 
stimulation of cell proliferation and an enhancement of the mitochondrial 
respiratory activity were observed when fibroblasts (L929) were cultured 
with the fluoride surface-modified alloy and no significant change in 
apoptosis or viability rates was observed (Lozano et al., 2013). Using the 
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single cell gel (comet) assay with human skin fibroblasts, NaF (7 – 100 
ppm) did not contribute to DNA damage (i.e. induce strand breakage in 
DNA) and did not affect cell viability (Ribeiro et al., 2006). In this study, the 
NaF concentrations (9.5 and 19 ppm, equal to 0.005 to 1 mM) were 
observed to promote NHOF cell proliferation. However, the NHOF cell 
numbers were significantly promoted after incubation in bioactive glass 
conditioned medium even in the P6.33F0 glass. A study with sub-epithelial 
myofibroblasts, CCD-18Co, suggested that surfaces coated with bioactive 
glass significantly increased secretion of basic fibroblast growth factor 
from myofibroblasts (Moosvi and Day, 2009). The addition of bioactive 
glasses into chitosan membranes were not cytotoxic to the periodontal 
ligament cells and significantly promoted the proliferation and cell 
metabolic activity (Mota et al., 2012). The presence of exposed bioactive 
glass particles enhances human gingival fibroblast proliferation on 
composite surfaces in vitro (Abdulmajeed et al., 2014). Bioactive glass 
modified ceramics promoted human periodontal ligament fibroblasts 
attachment and proliferation (Kontonasaki et al., 2007). In another study, it 
is found that both the bioactive glass/hydroxyapatite composites 
themselves and their extracts do not induce negative effects in murine 
fibroblasts BALB/3T3 viability and do not cause inhibition in cell growth 
(Bellucci et al., 2015). Surfaces coated with 45S5 Bioglass® or bioactive 
glass conditioned medium produced a significant increase in the secretion 
of VEGF and basic fibroblast growth factor (bFGF) from human fibroblasts 
(CCD18Co) (Day, 2005, Gerhardt et al., 2013, Keshaw et al., 2005), 
however, at higher bioactive glass concentrations and longer periods of 
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incubation  on coated surfaces, cell proliferation was reduced (Day, 2005). 
Kubo et al. observed that although the bioactive glass decreased 
proliferation of periodontal-ligament fibroblasts, they increased the 
alkaline-phosphatase activity and the formation of nodules suggesting 
increased differentiation (Kubo et al., 1993, Kubo et al., 1995, Kubo et al., 
1997). In addition, Commercial BioglassTM (45S5) conditioned medium 
even significantly promoted the osteogenic potential of human periodontal 
ligament fibroblasts (Varanasi et al., 2011). Therefore, with the combined 
effects of low fluoride and bioactive glass, proliferation of fibroblasts 
NHOF was significantly promoted in this study.  
With the highest capacity of proliferation among periodontal tissues 
involved in wound healing, epithelial cells are the first cells to migrate to 
the site of injury, becoming a problem as they cause the formation of a 
long, non-keratinized junctional epithelium which prevents the migration of 
the cells from the periodontal ligament and alveolar bone. Therefore, in 
periodontal surgeries, the guided tissue regeneration (GTR) technique is 
widely applied by using a resorbable or non-resorbable membrane acting 
as a physical barrier against the migration of epithelial cells from the 
superficial soft tissue flap into the underlying grafted site. This procedure 
allows the necessary time for the cell repopulation of the periodontal 
ligament and adjacent alveolar bone, and will favour the regeneration of 
lost and damaged tissue (Kay et al., 1997). Periodontal ligament is a 
specialized connective tissue embedded between the cementum and the 
inner wall of the alveolar bone socket. It not only has an important role in 
supporting teeth and the homeostasis of periodontal tissues, but also 
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contributes to alveolar bone remodelling and tissue regeneration, since it 
contains a heterogeneous cell population including fibroblasts, 
cementoblasts, osteoblasts, and progenitor/stem cells, in which fibroblasts 
are the predominant cell type. Therefore, specific proliferation and 
migration of periodontal ligament cells, mainly fibroblasts, are crucial in 
successful periodontal tissue regeneration. In this study, bioactive glass 
conditioned medium was not cytotoxic to either epithelial cells or 
fibroblasts. In addition, epithelial cell numbers were significantly 
decreased while fibroblast proliferation was promoted, and the 
incorporation of fluoride into bioactive glasses brought greater effects. The 
mechanism of fluoride action is unknown as the wide variations of 
effective fluoride concentrations which suggest that different cell types 
react in a different way (Prado et al., 2011).  
To conclude, the novel low fluoride high phosphate bioactive glasses in 
vitro promoted fibroblast growth and suppressed epithelial cells. In vivo, 
they may also block the epithelium migration and subsequent long 
junctional epithelium, stimulate the rapid re-establishment of periodontal 
ligament and allows for new bone formation without applying or minimal 
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5.4 Future plan 
A migration test can be carried out using epithelial cells, to investigate 
whether those high phosphate low fluoride containing bioactive glasses 
can block the epithelial cell migration ability.  
Angiogenic and osteogenic potentials can be explored for fibroblasts 
NHOF after treated with those high phosphate low fluoride containing 
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Chapter 6 Antibacterial study 
 
6.1 Introduction 
Oral alveolar bone resorption and tooth loss can be induced by 
periodontal disease, which is a bacterially induced inflammatory disease 
resulting in the destruction of soft and hard tooth-supporting (periodontal) 
tissues (Bostanci and Belibasakis, 2012). Peri-implantitis is also an 
inflammatory reaction associated with loss of supporting bone tissue 
around the dental implants and mainly caused by periodontal pathogens. 
Bacterial infections will hinder the repair of periodontal bone defects 
process and sometimes, lead to surgical failures, carry a financial 
consequence and reduce patient well being (Yuan et al., 2014). Some oral 
pathogens associated with periodontal disease have also been associated 
with dental implant and defect repair failure (van Winkelhoff et al., 2000). 
Porphyromonas gingivalis is highly associated with chronic periodontitis, 
and can be detected in up to 85% of the disease affected sites (Tribble et 
al., 2013). Aggregatibacter actinomycetemcomitans is mainly detected in 
aggressive periodontitis, a severe and rapidly progressing form that most 
often starts at an early age (Brigido et al., 2014). Dental caries is a chronic 
bacterial disease that induces demineralization and destruction of the hard 
tissue of teeth. However, caries can progress to affect the tooth pulp and 
spreads to the periodontal tissues and even the jaws (Featherstone, 2004). 
Oral bacteria Lactobacillus and Streptococcus are important in caries 
development, especially Lactobacillus which is found in root caries and 
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deep dentinal caries associated with pulpitis (Mitchell, 2011, Badet and 
Thebaud, 2008). More importantly, Streptococcus mitis has been 
demonstrated as a dental plaque pioneer colonizer, which initials the 
plaque formation and development. Therefore, ideal periodontal intra-bony 
defect regeneration needs to eliminate the active disease and the potential 
infection during or after surgery. 
Fluoride is widely incorporated into dental restorative materials, besides 
the ability to form FAp and to reduce demineralisation as well as enhance 
re-mineralization, it is also known for anti-microbial properties (Burke et 
al., 2006). It can inhibit the tooth demineralizing dental plaque acid 
production of various oral pathogens such as Streptococcus and 
Actinomyces (Van Loveren, 2001, Kawashima et al., 2013). It also acts 
directly as an enzyme inhibitor, of the glycolytic enzyme enolase, to 
interfere with bacterial metabolism (Marquis, 1995). Another action 
involves the formation of metal-fluoride complexes, most commonly AlF4-, 
which interact with bacterial F-ATPase and nitrogenase enzymes resulting 
in bacterial activity inhibition (Lellouche et al., 2009).    
Therefore, the aim of this Chapter is to investigate the antibacterial effects 
of those novel fluoride containing bioactive glasses on supra- and sub-
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6.2 Results 
 Effect on supra-gingival bacteria 6.2.1
In all the investigated bioactive glasses, the antimicrobial activity on L. 
casei was significantly dependent on the bioactive glass particulate 
concentrations after 4 h incubation (Fig. 6.1). However, for the S. mitis, the 
bactericidal effect stayed at appropriately 80% and did not change 
significantly as the bioactive glass concentrations increased from 0.625 
mg/mL to 10 mg/mL, except the fluoride free bioactive glass P6.33F0, in 
which the percentage of growth inhibition promoted slightly.  
 
Figure 6.1  Growth inhibition percentage of L. casei and S. mitis after exposure to a 
range of bioactive glass particle concentrations for 4 h. L. casei and S. mitis were 
incubated under aerobic condition with a range of bioactive glass particulate 
concentrations (0-10 mg/mL) for 4 h. The growth inhibition percentage was detected 
using alamarBlue kit and normalized with negative control (no bioactive glass). Data is 
represented as mean ± SE of four independent experiments. (P6.33F0 indicates a 
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With different concentrations of bioactive glass particles and incubation 
time, the antimicrobial activity varied (Fig. 6.2). For L. casei, antimicrobial 
activity is changing as a function of treatment time, and bioactive glass 
concentrations. With 1.25 mg/mL particulates incubated for 2 h, no 
difference was observed between bioactive glasses. When the treatment 
time increased to 4 h and 8 h, the antibacterial activity increased as the 
bioactive glass F content increased (Fig. 6.2 A). If bioactive glass particle 
concentrations increased to 10 mg/mL as showed in Fig. 6.2 B, the 
bactericidal effect on L. casei significantly increased and was dependent 
on the treatment period. However, there was no difference between the F 
free and F containing bioactive glasses.  
 
Figure 6.2  Growth inhibition percentage of L. casei and S. mitis after exposure to 
1.25 mg/mL and 10 mg/mL bioactive glass particles. L. casei and S. mitis were 
incubated under aerobic condition with 1.25 mg/mL and 10 mg/mL bioactive glass 
particles for 2 h, 4 h and 8 h. The growth inhibition percentage was detected using 
alamarBlue kit and normalized with negative control (no bioactive glass). Data is 
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For the S. mitis with 1.25 mg/mL particulates (Fig. 6.2 A), antimicrobial 
activity increased drastically as the treatment time increased from 2 h to 4 
h but only slight increase was observed between the F free and F 
containing bioactive glasses and no difference between the F contents. 
However, the antibacterial activity dropped when incubation time 
increased to 8 h and it was significantly dependent on the bioactive glass 
F content, the higher bioactive glass F content, the greater S. mitis growth 
inhibition. When the particulate concentration increased to 10 mg/mL as 
represented in Fig. 6.2 B above, the bactericidal effect on S. mitis did not 
increase as much as that in the L. casei. It was the same at 4 h and 8 h, 
and no difference was observed between bioactive glasses. 
 
Figure 6.3  Growth inhibition percentage of L. casei and S. mitis after exposure to 
NaF concentrations. L. casei and S. mitis were incubated under aerobic condition with 
NaF concentrations (0 to 2 mM) for 2 h, 4 h and 8 h. The growth inhibition percentage 
was detected using alamarBlue kit and normalized with negative control (no NaF). Data 
is represented as mean ± SE of four independent experiments.  
 
As the bioactive glass experiments questioned to role of fluoride, the 
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investigated (Fig. 6.3 above). It was found that fluoride did not show 
significant bactericidal effects on L. casei. However, the antimicrobial 
activity on S. mitis was clearly dependent on the F concentrations. The 
higher the F content the greater the bactericidal effect.  
 
 Effect on sub-gingival bacteria 6.2.2
For the sub-gingival bacteria, A. actinomycetemcomitans and P. gingivalis, 
the antibacterial activity on P. gingivalis was significantly dependent on the 
bioactive glass particulate concentrations after 4 h incubation in all the 
bioactive glasses (Fig. 6.4 below). For the A. actinomycetemcomitans, 
however, F free bioactive glass P6.33F0 showed very low bactericidal 
effects and no change was observed as the particle concentration varied. 
When the bioactive glass F content increased to 1-3%, antibacterial 
activity on A. actinomycetemcomitans significantly rose and was 
dependent on the particle concentrations. However, the particle 
concentration dependent effect decreased as the bioactive glass F content 
increased to 5% and 7%.  
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Figure 6.4 Growth inhibition percentage of P. gingivalis and A. 
actinomycetemcomitans after exposure to a range of bioactive glass particle 
concentrations for 4 h. P. gingivalis and A. actinomycetemcomitans were incubated 
under anaerobic condition with bioactive glass particle concentrations (0 to 10 mg/mL) for 
4 h. The growth inhibition percentage was detected using alamarBlue kit and normalized 
with negative control (no bioactive glass). Data is represented as mean ± SE of four 
independent experiments. (P6.33F0 indicates a bioactive glass contains 6.33 Mol.% 
phosphate and 0 Mol.% fluoride) 
 
With 1.25 mg/mL bioactive glass particulate treatment (Fig. 6.5 A), the 
antimicrobial activity on A. actinomycetemcomitans, from 2 h to 8 h 
incubation, increased slightly when bioactive glass F content increased 
from 0% to 1% followed by a drastic rise as bioactive glass F content 
increased to 5% and kept constant in the 5-7% F containing bioactive 
glasses. If bioactive glass particle concentration increased to 10 mg/mL as 
showed in Fig. 6.5 B, the total antibacterial effect on A. 
actinomycetemcomitans increased and rose significantly as the bioactive 
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Figure 6.5  Growth inhibition percentage of P. gingivalis and A. 
actinomycetemcomitans after exposure to 1.25 mg/mL and 10 mg/mL bioactive 
glass particles, P. gingivalis and A. actinomycetemcomitans were incubated under 
anaerobic condition with 1.25 mg/mL and 10 mg/mL bioactive glass particles for 2 h, 4 h 
and 8 h. The growth inhibition percentage was detected using alamarBlue kit and 
normalized with negative control (no bioactive glass). Data is represented as mean ± SE 
of four independent experiments. 
 
For the P. gingivalis, with 1.25 mg/mL bioactive glass particle treatment 
(Fig. 6.5 A), the antibacterial activity increased significantly as the 
bioactive glass F content increased from 1% to 5% after 4 h incubation. 
However, when increased to 8 h, the bactericidal effects in 0-3% F 
containing bioactive glass groups dropped close to 0 but still kept around 
20% in the 5-7% F containing bioactive glasses. In Fig. 6.5 B, the 
antibacterial activity on P. gingivalis increased significantly when the 
particle concentration increased to 10 mg/mL and there was no difference 
between bioactive glasses after 2 h and 4 h incubation. However, when 
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glasses and kept significantly higher in the 3-7% F containing bioactive 
glasses.  
Both bacteria, P. gingivalis and A. actinomycetemcomitans, are viability 
sensitive to and dose dependent on the F concentrations (Fig. 6.6). 
However, the antimicrobial activity on A. actinomycetemcomitans was 
significantly higher than that on the P. gingivalis. 
 
Figure 6.6 Growth inhibition percentage of P. gingivalis and A. 
actinomycetemcomitans after exposure to NaF concentrations. P. gingivalis and A. 
actinomycetemcomitans were incubated under anaerobic condition with NaF 
concentrations (0 to 2 mM) for 2 h, 4 h and 8 h. The growth inhibition percentage was 
detected using alamarBlue kit and normalized with negative control (no NaF). Data is 
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6.3 Discussion 
The pioneer colonizer S. mitis plays an important role in the establishment 
of dental plaque and L. casei is considered as a cariogenic bacterial 
species in numerous antibacterial studies. In addition, they also stay in 
saliva, which is a link between the different tissues and structures of the 
oral cavity (Mitchell, 2011, Badet and Thebaud, 2008). P. gingivalis is 
highly associated with the chronic periodontitis (Tribble et al., 2013) while 
A. actinomycetemcomitans is mainly detected in aggressive periodontitis, 
a severe and rapidly progressing form that most often starts at an early 
age (Brigido et al., 2014). Various degrees of bone loss are frequently 
encountered in periodontal diseases. In the treatment of bone defect 
repair following inserting of bone graft substitutes, there is a risk of 
bacterial colonization with the production of protein-specific adhesions on 
the surfaces of implanted materials, which may result in the failure of the 
implants (Coraca-Huber et al., 2014).  
In this study, after incubation with bioactive glass particulates at a 
concentration of 1.25 mg/mL, the bactericidal effect on bacteria, including 
plaque pioneer colonizer S. mitis and periodontal pathogens A. 
actinomycetemcomitans and P. gingivalis, was increased significantly as 
the bioactive glass F content increased. It suggests the antibacterial effect 
was mainly from fluoride, which was confirmed by experiments in which 
bacteria were treated with NaF. It was found that the bacteria viability was 
sensitive to and dose-dependent on the F concentrations. Numerous 
studies have demonstrated the antimicrobial activity of fluoride 
(Naorungroj et al., 2010, Ogaard et al., 2001). A 30 min exposure test, 
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both A. actinomycetemcomitans and P. gingivalis exhibited a significant 
decrease of colony-forming units in a NaF concentration-dependent 
manner (Shimogishi et al., 2014). A 6-month clinical study found that the 
fluoride containing dentifrice resulted in a significant reduction in the 
number of anaerobic bacteria on both the dental implants and control 
teeth at 3 months (Sreenivasan et al., 2011). F surface-modified titanium 
specimens significantly inhibit the growth of both P. gingivalis and A. 
actinomycetemcomitans compared with the polished titanium (Yoshinari et 
al., 2001). Rostami et al. investigated the antibacterial ability of bioactive 
glasses and they found the fluoride containing ones had significant 
antibacterial activity against E. coli, P. aeruginosa and S. aureus, which 
are responsible for most infections, while the fluoride-free bioactive glass 
samples did not show any antibacterial  activity (Rostami et al., 2015). 
Fluoride is also widely incorporated in dental vanish, mouth rinse and 
bonding products for its outstanding antibacterial ability (Pinar Erdem et al., 
2012, Randall et al., 2014, Sajjan et al., 2013, Shinonaga et al., 2015, 
Slutzky et al., 2014, Wang et al., 2012, Wiegand et al., 2007, Yoshihara et 
al., 2001). It acts in multiple ways to affect the metabolism of cariogenic 
and other bacteria. Firstly, fluoride can bind directly to many enzymes 
such as heme-containing enzymes and metallo-enzymes to modulate and 
even interfere bacterial metabolism (Marquis, 1995). Fluoride also can 
form complexes with metals, such as aluminum or beryllium, and the 
metal-fluoride complexes are able to interact with a variety of enzymes, 
regulating phosphatases resulting in enzyme activity inhibition (Lellouche 
et al., 2009).  
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The role of L. casei is disputed. It can serve as a probiotic to promote and 
support a beneficial balance of microorganisms living in the human 
gastrointestinal tract (Probiotic, 2010). Teanpaisan et al. even found that L. 
casei was able to inhibit the growth of both periodontitis- and caries-
related pathogens (Teanpaisan et al., 2011). However, in some 
antibacterial studies, L. casei is considered as a dental cariogenic 
bacterial species (Da Silva et al., 2012, Korkmaz et al., 2013, Pupo et al., 
2014, Zhang et al., 2014). In this study, L. casei was found resistant to the 
NaF concentrations and the antibacterial activity did not change 
significantly as the bioactive glass F content increased.  
Similar findings are also reported in other publications. For example, 
Bradshaw et al. reported that the growth of S. mutans was significantly 
reduced by 1mM NaF, which did not alter the viability of lactobacilli 
(Bradshaw et al., 1990). Clinically, the long-term use of fluoridated mouth 
rinses decreased the levels of S. mutans in saliva without affecting the 
levels of lactobacilli (Yoshihara et al., 2001). Arthur et al. also found that 
Actinomyces, S. sanguinis and S. mutans were more sensitive to fluoride 
than L. casei (Arthur et al., 2014). This suggests the antibacterial ability 
and sensitivity against fluoride depend on the bacteria types. In this study, 
S. mitis, A. actinomycetemcomitans and P. gingivalis were sensitive to 
NaF concentrations and the bactericidal effect was increased significantly 
as the bioactive glass F content increased. 
However, even the base glass P6.33F0 in this study showed antibacterial 
activity against all the investigated bacteria. In particular, after incubation 
with bioactive glass particulates at a concentration of 10 mg/mL, the 
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growth of both supra-gingival bacteria L. casei and S. mitis was 
significantly inhibited, and there was no difference between different 
bioactive glasses. This suggests that the antibacterial effect was mainly 
from bioactive bioactive glass particles instead of fluoride. Several studies 
have demonstrated that bioactive glass (SiO2–Na2O–CaO–P2O5), without 
specific ions, has a clear growth-inhibitory effect against numerous 
aerobic and anaerobic clinically important pathogens (Coraca-Huber et al., 
2014, Gergely et al., 2014, Lepparanta et al., 2008, Stoor et al., 1998, 
Fooladi et al., 2013). Bioactive glass S53P4 showed a clear antibacterial 
ability in the treatment of chronic osteomyelitis in clinical studies 
(McAndrew et al., 2013, Romano et al., 2014). Mortazavi et al. found the 
sol-gel-derived bioactive glass nanoparticles had antibacterial effects on 
aerobic bacteria like E. coli, P. aeruginosa, and S. aureus (Mortazavi et al., 
2010). Munukka et al. reported that bioactive glasses had a broad 
spectrum of antibacterial effect on 29 clinically important bacterial species 
(Munukka et al., 2008). The antibacterial mechanism of bioactive glass in 
most studies is attributed to the alkaline nature of surface reactions with 
pH elevation. This is unfavorable for bacteria and is caused by the 
bioactive glass sodium release and increased osmotic pressure from ions 
(silicon, calcium, sodium and phosphate) dissolution, creating an hostile 
environment where the bacteria cannot adhere and subsequent proliferate 
that causes infections (Echezarreta-Lopez and Landin, 2013, Drago et al., 
2013, Rahaman et al., 2014). TEM observation revealed that needle-like 
bioactive glass debris on bacterial surface interferes with bacterial 
structure, and indicates that debris from the bioactive glass particles may 
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be one of the reasons for destruction of cellular structure and bacterial 
death (Hu et al., 2009). Zehnder et al. found that the bactericidal effect of 
bioactive glasses correlated not only with the pH but also with high silicon 
ion levels in the supernatant (Zehnder et al., 2006).   
Zhang et al. revealed that bioactive glasses without any special 
bactericidal ions showed strong antibacterial effects for a wide selection of 
aerobic bacteria but the antibacterial effects depended on glass 
composition and bacterial species (Zhang et al., 2010). In the treatment of 
dental caries, the release of therapeutic ions such as fluoride is of great 
importantance for the antibacterial activity of dental material (Marczuk-
Kolada et al., 2006). Besides that, particle size also plays an important 
role in the antibacterial effect. Coraca-Huber et al reported that S53P4 
bioactive glass <45 µm was more efficient against bacterial biofilm growth 
in vitro compared with glass particles of 0.5–0.8 mm (Coraca-Huber et al., 
2014). This may be attributed to the increased glass surface area, 
facilitating faster and quantitatively superior release of alkali ions 
compared to the granular form (Gergely et al., 2014).  
Furthermore, Allan et al. reported the 45S5 Bioglass® particulates exerted 
an antibacterial effect on certain supra- and sub-gingival oral bacteria and 
they even found the glass conditioned supernatants showed antibacterial 
properties as well (Allan et al., 2001). It demonstrated that direct contact 
between glass particulates and bacterial cells was not required to produce 
an antibacterial effect, which suggested that bacteria could be killed 
before they encounter the glass scaffold surface.  
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In this study, the bioactive glass particulates (<38 µm) with the 
incorporation of F showed a clear antibacterial effect against the plaque 
pioneer colonizer S. mitis and periodontal pathogens A. 
actinomycetemcomitans and P. gingivalis. This ability may be an important 
advantage for the successful osso-integration when these glasses are 
incorporated in bone graft substitutes and implanted in dental bone 
defects, as bacterial colonization has been suggested to be an important 
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6.4 Future plan 
Besides dental bone defect repair, those high phosphate fluoride 
containing bioactive glasses can be incorporated into bone graft 
substitutes for the bone fracture and osteoporosis treatment. And, they 
can even be added to dental products such as bonding materials, fillings, 
toothpaste and mouth rinse for more applications. Therefore, the 
antibacterial activity of our novel bioactive glasses against some specific 
cariogenic pathogens and more common inflammation induced bacteria 
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Chapter 7 Concluding discussion 
7.1 Concluding discussion 
Autologous bone grafts are currently considered as the ‘gold standard’ to 
repair or regenerate defective bone tissue. However, significant 
drawbacks including extra painful harvest surgery, donor site morbidity, 
inadequate supply and even the risk of surgical complications limit their 
clinical utilization (Lareau et al., 2015, Shibuya and Jupiter, 2015, Jakob et 
al., 2012, Bhatt and Rozental, 2012, Zimmermann and Moghaddam, 
2011).  
Synthetic biomaterials are an alternative clinical strategy to repair the 
defective bone tissues. In order to obtain a favourable biological outcome, 
ideally these synthetic grafts should emulate the chemical and physical 
structure of the native bone tissue, as well as being osteoinductive for the 
bone-forming cells, angiogenic for the vessel growth, display antibacterial 
ability and be non-toxic for the surrounding soft tissues especially during 
the periodontal defective bone repair. Bioactive glasses have been widely 
studied for their specific clinical applications due to their significant 
advantages such as promoting HA layer on their surface and bonding with 
the surrounding living tissues, being osteoinductive and degradable. 
Therefore, the strategy adopted in this work in order to achieve the above 
requirements was to consider the effect of bioactive glass compositions on 
material properties and biological performances.  
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Relevant literature reviewed in Chapter 1, including periodontium, 
periodontitis and periodontal regeneration, as well as bioactive glasses 
(especially the effects of phosphate and fluoride). The objectives and 
outline for this project are listed at the end of Chapter 1. Chapter 2 
presents the experimental work performed with the aim of designing novel 
and optimal bioactive glass compositions and investigating the biological 
performances including osteogenesis by bone nodule and Type I collagen 
formation, angiogenesis by VEGF gene and protein production, effects on 
periodontal soft tissues and antibacterial ability.  
Results presented in Chapters 3-6 highlighted the significant effects of 
high phosphate and low fluoride addition to bioactive glasses. In particular, 
the bioactive glass fluoride content should be carefully considered since 
high fluoride influenced the viability of MC3T3-E1 cells. Promising 
improvements in the differentiation and proliferative rate of osteoblast 
precursor cells were seen in the low fluoride containing glass groups. 
These results were followed by studies further concerning the effects of 
those novel bioactive glasses on osteogenesis such as mineralization, 
Type I collagen formation and gene expression, angiogenesis including 
VEGF gene expression and protein production, influences on oral soft 
tissues including epithelial cells and fibroblasts, and finally the ability to 
prevent bacterial growth. Overall, the composition with 1% fluoride 
addition significantly accelerated apatite formation in Tris buffer solution, 
promoted osteogenic and angiogenic markers in MC3T3-E1 cells, 
prevented the epithelial cells growth and displayed antibacterial ability. 
However, it is difficult to recommend an ‘optimised’ bioactive glass 
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composition from this in vitro study without conducting further 
experimental work as it differs from the in vivo environment. This chapter 
summarises the conclusions that can be drawn from the presented 
experimental findings. 
 Apatite formation 7.1.1
Increasing the P2O5 content in the glass enhances the reactivity of the 
glass, as the phosphate is often regarded to exist as a separate 
orthophosphate phase within the glass, which potentially promotes glass 
bioactivity leading to an increase of the apatite formation rate (O'Donnell 
et al., 2009, O’Donnell et al., 2008b, O’Donnell et al., 2008a). Furthermore, 
higher phosphate content can reduce the rate and extent of local pH rise 
induced by the bioactive glass dissolution, which may reduce the 
deleterious effects brought by high alkalinity, on resident cells in the local 
environment (Monfoulet et al., 2014). Therefore, higher phosphate content 
will enable the development of products with higher surface areas without 
running into the pH problems. The finer particle size with increased 
surface area will result in faster glass dissolution creating an appropriate 
environment in which apatite and later bone can be more rapidly formed. 
However, with increasing phosphate content, there is an increased 
tendency to obtain crystallised bioactive glasses instead of amorphous 
nature, since O’Donnell et al. found that when the P2O5 content reached to 
9.25 Mol.%, the bioactive glass was crystallised. Therefore, based on the 
previous studies, 6.33 Mol.% phosphate was added as a high, but ‘safe’ 
concentration in this project.  
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It is found that in this project, in Tris buffer solution, the formation of 
apatite occurred even more rapidly with the addition of fluoride (as low as 
only 1 Mol.%), which may be attributed to:  
(1) The presence of fluoride eliminated the formation of the intermediate 
octacalcium phosphate phase, which is a precursor phase involved in 
apatite formation in vitro (Aoba, 1997, Iijima, 2001, Johnsson and 
Nancollas, 1992, LeGeros et al., 1989, Siew et al., 1992, Tseng et al., 
2006);  
(2) Fluoride complexes with calcium and sodium rather than forming Si-F 
bonds, resulting in decreasing the compactness of the glass network, 
which may make the glass structure easier to break down and promote 
glass solubility and reactivity;  
(3) Increasing fluoride content slightly increases Tris buffer pH, since a 
high pH environment is favourable for apatite nucleation in SBF (Lu and 
Leng, 2005a), and apatite formation was also very susceptible to slight pH 
changes in fluoride containing glass composition (Brauer et al., 2010).  
As Tris buffer solution is free of Ca2+ and PO4
3- ions with a pH 7.3, it is an 
excellent medium to assess bioactive glass dissolution and apatite forming 
capacity and therefore widely used by biomaterial researchers. However, 
experiments with cell culture medium can provide a more in vivo-like 
model to examine how bodily fluids will interact with bioactive glasses. 
Therefore, in this project, the apatite formation in cell culture medium (α-
MEM) was also examined.  
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It is interesting to find that the reaction was significantly different in the two 
solutions. No significant apatite peaks were found in the XRD patterns 
after immersion in α-MEM, which may be attributed to the limitation of the 
technique since XRD allows for the identification of various phases such 
as apatite, calcite, or fluorite, but it is not sensitive enough to detect when 
they are present as small crystallites. It means small or nano-sized apatite 
may be formed after immersion in α-MEM but did not cause significant 
apatite peaks in XRD pattern, evidenced from the single band at 
approximately 570cm-1 in FTIR spectra (Fig 4.12), corresponding to the 
formation of an amorphous or disordered crystalline apatite such as OCP 
or amorphous calcium phosphate, which is considered as a precursor of 
apatite. If this is the real outcome, biomimetic nano-structured apatite 
would display better ability for the protein binding and encourage 
osteoblast attachment and proliferation.  
 Osteogenesis 7.1.2
For an ideal bone-graft substitute, besides the primary requirement to fill 
the defective site, form an apatite surface for bonding to the surrounding 
live tissues and provide scaffolding for the bone cells to adhere, proliferate 
and form extracellular matrix, it is also required to stimulate and activate 
bone-forming cells and promote growth factors production to accelerate 
new bone growth in the bony defect area.  
Numerous in vitro and animal studies have demonstrated that fluoride can 
modulate bone-forming cell activities (Farley et al., 1983, Fernandes et al., 
2012, Huo et al., 2013, Kassem et al., 1994, Okuda et al., 1990, Pei et al., 
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2012, Qu et al., 2008, Ren et al., 2011, Wang et al., 2011, Yan et al., 
2009). Addition of fluoride into bioactive glasses has been demonstrated 
to significantly accelerate the apatite formation in Tris buffer as 
represented in the Chapter 4. However, high levels of systemic fluoride 
are known to cause skeletal and dental fluorosis characterized by 
debilitating changes in the skeleton, and marked mottling and 
discoloration in the teeth (Chachra et al., 2008, Vestergaard et al., 2008) 
and caution must be applied.  
As expected, the osteogenic responses of MC3T3-E1 cells including 
proliferation, ALP activity, Type I collagen formation, bone nodule 
formation and osteogenic gene expression were promoted by the high 
phosphate, low F addition glass (P6.33F1) but significantly suppressed 
when the F content increased to 5-7%, which can be attributed to the 
biphasic manner of fluoride interacts with mineralized tissues as discussed 
before in the literature review (Chachra et al., 2008, Aaseth et al., 2004).  
However, it is interesting to find that in this study, compared with the 
control (no glass), the above osteogenic activities were also significantly 
promoted by the high phosphate but fluoride free glass (P6.33F0), which 
may be attributed to the effects of high phosphate and silicon. As 
phosphate plays a vital role and is essential in the biological mineralization 
and included as a basic element in the cell culture medium, in this study, 
the high phosphate containing glasses resulted in the phosphate 
concentrations in glass conditioned medium being kept similar to that in α-
MEM (Fig. 4.13), avoiding of consumption of medium phosphate to form 
apatite. While numerous studies have demonstrated stimulatory effects of 
219 | P a g e  
 
silicon on cellular activities, such as regulating the expression of key 
osteoblastic marker genes, cell cycle regulators and extracellular matrix 
proteins, stimulating new bone formation in animal models, inhibiting 
osteoclast phenotypic gene expression, osteoclast formation and bone 
resorption in vitro although the exact mechanism is yet to be understood 
(Calvo-Guirado et al., 2014, Chadwick et al., 2014, Friederichs et al., 
2015, Henstock et al., 2015, Manchon et al., 2015, Mladenovic et al., 
2014, Odatsu et al., 2015).  
 Angiogenesis 7.1.3
For efficient osteogenesis, angiogenesis and vascular network 
development to provide a sufficient supply of blood and oxygen play a 
crucial role as bone-forming cells are highly metabolic requiring the supply 
of oxygen, nutrients and elimination of their by-products (Nuss and von 
Rechenberg, 2008, Karageorgiou and Kaplan, 2005, Kuzyk and 
Schemitsch, 2011). Therefore, the angiogenic potential of those novel high 
phosphate and low fluoride containing bioactive glasses was also 
investigated.   
There is no doubt that the VEGF gene expression and its protein 
production were both significantly promoted by the high phosphate but 
fluoride free glass P6.33F0, since silicon released from bioactive glasses 
has been demonstrated to stimulate VEGF secretion and promote 
angiogenesis through in vitro and in vivo studies (Day, 2005, Gorustovich 
et al., 2010, Leu et al., 2009, Li and Chang, 2013, Wang et al., 2013a, 
Fielding and Bose, 2013, Zhai et al., 2012).  
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However, the VEGF gene expression and protein production were further 
promoted by the fluoride containing glasses, compared with the P6.33F0 
glass. As there is no publication which directly discusses the effects of 
fluoride on VEGF production and only few animal studies indirectly 
suggest fluoride containing biomaterials may promote angiogenesis, then 
MC3T3-E1 cells were treated with a range of F- concentrations (0, 0.1, 1.9 
and 9.5ppm) for the VEGF protein production in this study. There was no 
significant difference between the control (0ppm) and F- concentration 
groups after 7d, 14d and 21d treatment. Therefore, the improved 
angiogenesis on MC3T3-E1 cells after treatment with fluoride containing 
bioactive glasses may attribute to the combined effects of silicon and 
fluoride.  
 Effects on oral soft tissues 7.1.4
Periodontal intra-bony defects represent a major challenge as the ultimate 
goal is the regeneration of lost periodontal tissues including both the soft 
and hard. Therefore, a variety of clinical treatment modalities including the 
use of autogenous bone grafts and bone substitutes materials, barrier 
membranes and growth factors have been proposed to promote the 
periodontal tissue regeneration. In this way, the healing outcome will not 
only depend on the regeneration of the alveolar bone, but also be 
determined by the surrounding soft tissues to promote an adequate 
sealing by the gingival tissue which contains epithelial cells and fibroblasts 
(Vignoletti et al., 2014).  
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During the wound healing process, epithelial cells have the highest 
proliferation capacity and can be the first cells to migrate to the injury site. 
This becomes a problem as they form a long, non-keratinized junctional 
epithelium and will prevent the migration of the cells from the periodontal 
ligament and alveolar bone. Therefore, in periodontal surgeries, the 
guided tissue regeneration technique is widely applied by using a 
resorbable or non-resorbable membrane acting as a physical barrier 
against the epithelial cell migration, from the superficial soft tissue flap into 
the underlying graft site. This procedure allows the necessary time for the 
cell repopulation of the periodontal ligament and adjacent alveolar bone, 
and will favour the regeneration of lost and damaged tissue (Kay et al., 
1997).  
In this project, the bioactive glasses were not cytotoxic to the epithelial cell 
growth, compared with the control. However, they significantly suppressed 
the cell proliferation, which was further decreased by the fluoride 
containing bioactive glasses. It may be attributed to the combined effects 
of fluoride and bioactive glasses, since it also found that the epithelial cell 
proliferation was does-dependently suppressed after treating with NaF 
concentrations in this project.  
Periodontal ligament is a specialized connective tissue embedded 
between the cementum and the inner wall of the alveolar bone socket. It 
not only has an important role in supporting teeth and the homeostasis of 
periodontal tissues, but also contributes to alveolar bone remodelling and 
tissue regeneration, since it contains a heterogeneous cell population 
including fibroblasts, cementoblasts, osteoblasts, and progenitor/stem 
222 | P a g e  
 
cells, in which fibroblasts are the predominant cell type. Therefore, specific 
proliferation and migration of periodontal ligament cells, mainly fibroblasts, 
are crucial in successful periodontal tissue regeneration.  
In this project, fibroblast proliferation was significantly promoted by all the 
bioactive glasses after 10 d treatment, which also may be attributed to the 
combined effects of bioactive glass and fluoride, but mainly from bioactive 
glasses, since only the high NaF concentrations (9.5 and 19 ppm) were 
found to increase the fibroblast proliferation.  
Therefore, if applied in vivo to repair the periodontal intra-bony defects, 
those high phosphate and low fluoride containing bioactive glasses 
potentially act to prevent the long, non-keratinized junctional epithelium 
growth, promote the periodontal ligament reestablishment and then to 
simplify the periodontal surgery process without using or minimal the 
guided tissue regeneration technique and increase the success of 
defective bone repair.  
 Antibacterial ability 7.1.5
For a successful periodontal bony defect treatment, besides the tissue 
regeneration, the first and important requirement is eliminating the active 
disease and avoiding infection during or after the surgery. To reach this 
goal, antimicrobial approaches are needed. As the use of systemic 
antibiotics can induce the development of bacterial resistance and may 
not be suitable for patients with some other diseases, local antibacterial 
application is an alternative option and, it is the best if the implanted graft 
substitutes themselves can be antimicrobial.   
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Fluoride is well known for the antibacterial ability, so as expected in this 
project, bioactive glasses showed strong prevention effects on the dental 
plaque pioneer colonizer S. mitis and cariogenic bacterial L. casei, and 
most importantly, they also significantly suppressed the growth of P. 
gingivalis and A. actinomycetemcomitans, which are highly associated 
with the chronic periodontitis and aggressive periodontitis respectively in 
numerous in vitro and in vivo studies.  
However, it is noticeable that even the base glass P6.33F0 in this study 
showed antibacterial activity against all the investigated bacteria, in which 
condition the antibacterial effect was from bioactive glass particles instead 
of fluoride, the mechanism in which can be attributed to the alkaline nature 
of surface reactions with pH elevation in most studies. Therefore, with the 
combined antibacterial ability of bioactive glasses and fluoride, those high 
phosphate and low fluoride addition bioactive glasses will be 
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7.2 Conclusion 
In summary, this project has shown that as a potential bone substitute, the 
high phosphate and low fluoride addition bioactive glasses resulted in 
significantly faster apatite formation in Tris buffer solution, and promoted 
osteoblast-like cell pre-osteogenic, pro-angiogenic responses, and 
prevented epithelial cell growth while promoted fibroblast proliferation, and 
significantly inhibited the growth of periodontal pathogens in vitro. Such 
novel bioactive glasses would be expected to stimulate bone formation 
and overcome problems associated with infection and the poor 
vascularisation in large bone graft sites and hopefully reduce the need for 
further clinical intervention, and in particular, will be advantageous for the 
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7.3 Future prospective 
The experimental work performed has achieved the initial project 
objectives outlined in Chapter 1. However, it is difficult to conclude that 1% 
fluoride containing bioactive glass (P6.33F1) is the ‘optimal’ composition 
to be applied as bone substitutes without conducting animal studies and 
further experimental work, although glass P6.33F1 has shown significant 
positive effects on apatite formation, pre-osteogenic and pro-angiogenic 
responses, oral soft tissues and pathogens growth in vitro. Due to the 
complexity of in vivo environment, an ‘optimised’ form also should be 
obtained to satisfy clinical requirements such as good handling 
characteristics, biomimetic compressive strength and proper degradable 
rate, since the bioactive glasses investigated in this project are in 
particles, which are difficult for in vivo applications. Therefore, the future 
work would focus on how to transfer those particles into clinical applied 
substitutes followed by proper animal studies.  
Currently, granular bone graft materials, such as the Straumann® Bone 
Ceramic and Geistlich Bio-Oss®, are the common clinical available options 
when filling the alveolar socket or undertaking guided bone regeneration 
for fixation of an implant. Straumann® Bone Ceramic is a fully alloplastic 
biphasic calcium phosphate composed of hydroxylapatite and β-tricalcium 
phosphate, while Geistlich Bio-Oss® is derived from bovine bone. They 
are granules (i.e. 0.25 - 2 mm size) and have been used successfully 
offering a scaffolding and somewhat resorbable and osteoconductive bone 
substitute material. However, low resorption rate is a problem cannot be 
ignored. As hydroxyapatite is a stable crystalline phase may take many 
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years to be degraded, and in some instances may never occur, while it is 
desirable that after use of a bone substitute material rapid resorption and 
replacement with host bone will occur.  
PerioGlas® from NovaBone is another granular bone graft material 
composed of bioactive glass 45S5. It has been demonstrated to form 
hydroxycarbonate apatite layer creating an ideal environment for cellular 
attachment and for protein and growth factor absorption, enhance cell 
signalling and upregulate the bone forming process. Most importantly, it is 
completely resorbable. Therefore, combining the advantages of bioactive 
glasses and high phosphate low fluoride effects, it is an option to prepare 
the bioactive glasses investigated in this project into granules prior to in 
vivo study.  
As granules are the most common bone graft materials currently, there 
are still some noticeable disadvantages, such as, granular bone 
substitutes are typically wetted and mixed with patients’ blood or saline 
solution prior to implantation, which lengthens the surgical time. By the 
nature of granules, they have no inherent bulk strength until they have 
been fully osseointegrated so that they can easily be deformed by the 
application of pressure and force which can cause potential granule 
migration from the implantation site and the formation of voids in the 
material, may result in incomplete guided bone regeneration.  
Therefore, introduction of an injectable material that hardens in situ can be 
an alternative option to address the problems caused by granular bone 
substitutes and to avoid unnecessary discomfort for the patient, difficulty 
for the clinician, lengthening of surgical time and compromised in vivo 
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performance. Currently, vertebroplasty and kyphoplasty procedures use 
injectable polymethylmethacrylate (PMMA) cement that provides support 
within the vertebral body. The negative characteristics of PMMA-based 
bone cements are the strongly exothermic reaction, toxic effects of the 
monomer which leads to poor osteointegration and pain. In addition, the 
PMMA bulk does not ‘mechanically integrate’ with bone and will carry all 
the weight, effectively isolating the pre-existing bone to osteogenic stimuli. 
This will lead to further bone resorption and complications 
Recently a novel injectable bone substitute material has been developed 
and patented at the Bart’s and The London School of Medicine and 
Dentistry, Queen Mary University of London (Patent Number: 
PCT/EP2012/076844). The novel material is a mixture of bioactive glass 
and Ca(H2PO4)2 powder which reacts when mixed with water to form 
hydroxyapatite through the following reaction:  
Bioactive Glass + Ca(H2PO4)2 → Ca10(PO4)6(OH)2 
After implantation the cement hardens in vivo in 15 minutes after initial 
mixing. As the cement sets to form hydroxyapatite, the mineral phase of 
bones and teeth, it is able to be osseointegrated, resorbed, and then 
replaced by host bone. 
However, only four basic bioactive glass components (Ca, Na, P and Si) 
were included in the previous patent. The glass composition can be 
altered at will to change the properties of the cement including setting 
time, strength, resorption rate and influence on osteogenic rate. Thus the 
cement can be tailored to have the exact properties desired to give the 
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material an ideal setting time and strength for optimal bone remodelling to 
facilitate healing. 
As the numerous positive effects from high phosphate and low fluoride 
addition investigated in this project, it is another option to develop a novel 
injectable bone graft material with those high phosphate and low fluoride 
addition bioactive glasses as a precursor. This new cement material will 
combine the benefits of high phosphate, fluoride, bioactive glass and 
cement, such as fast implantation by injection, mouldable to implant site, 
no implant migration, porous, yet resistant to force, osteoconductive, 
resorbable, antibacterial and positive effects on oral soft tissue 
regeneration. 
For bone grafting substitutes, porous interconnecting structures with 
micro-pores or macro-pores can provide a higher surface area for cell 
attachment, and subsequently invading the scaffold to proliferate and form 
extra cellular matrix at early time points (Bonfield, 2006). Bonfield also 
suggested there was a particular requirement for the pore size of those 
porous scaffolds, greater than 100 µm in diameter was a key requirement 
both for ingression of cells and to develop associated vascularization to 
maintain viable bone (Bonfield, 2006). Therefore, to develop an injectable 
bone substitute with porous structure and proper strength, both fine (0-38 
µm size) and coarse (i.e. 100-200 µm size) bioactive glass powder can be 
produced and used to react with Ca(H2PO4)2 salt according to the above 
reaction, in which, the fine bioactive glass particles and Ca(H2PO4)2 salt 
react on contact with aqueous solution to form the cement phase. Upon 
mixing the glass dissolves rapidly, releasing Ca2+ and PO4
3- ions that react 
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with the Ca(H2PO4)2 salt to form the hydroxyapatite cement phase. 
Incorporation of the coarse bioactive particles is not to react during the 
initial setting but will degrade rapidly leaving a network of pores, such as 
100-200 µm, that will facilitate the ingrowth of cells and 
neovascularization. In this way, the bulk cement strength is maintained but 
the rate of remodelling is increased. 
Therefore, the future plan for this project could be transferring the 
investigated novel high phosphate low fluoride bioactive glasses into 
injectable cements, then the cement properties including setting time, 
dissolution and compressive strength will be explored in vitro, followed by 
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Chapter 9 Appendix 
 
9.1 Bone biology 
Bone tissue is highly organized, dynamic and vascularized, extremely 
specialized and able to regenerate and remodel.  
 Bone structure 9.1.1
The macrostructure of bone can be thought as central marrow space and 
endosteum surrounded by bone matrix and periosteum (Fig. 9.1 below). 
There are two types of mature bone, cortical, also known as compact 
bone, and cancellous, referred as trabecular or spongy bone.  
 
Figure 9.1 Anatomy of bone (Regard et al., 2012) 
Cortical bone is dense, forms the outer layer of most bones with a porosity 
of 5-10% (Buck and Dumanian, 2012). As the low ratio of surface to 
volume, it provides protection and support for the inner                                                                                   
regions and, gives resistance to torsion and bending and provides 
compressive strength. 
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Cancellous bone is located inside of cortical bone in long bones (in 
epiphysis and prox/distal diaphysis) and with a porosity up to 50-90% 
(Buck and Dumanian, 2012). It exhibits macro-sized pores with large 
surface area, which is thought to facilitate the metabolic activity of bones 
mediated by osteoblasts and osteoclasts (Regard et al., 2012). Cancellous 
bone and diaphysis shaft provides storage space for bone marrow, which 
contains stem cells are essential for the growth of tissues and blood cell 
production (Brydone et al., 2010).  
Periosteum, a fibrous connective membrane, covers the external surface 
of bone and is tightly attached via thick collagenous fibres. It provides 
attachment site for ligaments, contributes to an additional vascular supply 
and is the main storage for osteoprogenitor cells and osteoblasts, thus 
being particularly vital in fracture repair.   
For the bone microstructure as shown in Fig. 9.2 A, cortical bone is 
consisted of precisely organized osteons, known as Haversian systems. 
Osteons are typically microscopic cylinders running roughly parallel to the 
long axis of bone (Buck and Dumanian, 2012). At their centre are osteonic 
(Haversian) canals containing vessels and nerves. Surrounding these 
canals are concentric rings (lamellae) of matrix. Spaces between the 
lamellae are called lacunae, where mature bone cells and osteocytes are 
resident. Neighbouring lacunae are connected by small channels named 
canaliculi, which allows  osteocyte connectivity (Florencio-Silva et al., 
2015). Communication between osteons is maintained by canals, also 
known as Volkmann canals, which contain blood vessels and nerves.  
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As shown in Fig. 9.2 B, cancellous bone forms a honeycomb-like network 
of trabeculae with irregular cavities between, which contain bone marrow. 
Blood vessels are embedded in the bone marrow to provide nutrients to 
osteoblasts, osteocytes and osteoclasts resident in the trabeculae (Buck 
and Dumanian, 2012).  
 
 
Figure 9.2 A, B Microstructure of cortical and cancellous bone 
(Taken from: http://faculty.southwest.tn.edu/rburkett/A&P1_bone_tissue_lab.htm and 
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As shown in Fig. 9.3 below, collagen fibrils are the predominant 
components of nanoscale osteons. Inorganic bone apatite crystals are 
trapped within collagen fibrils in the form of plates or needles (Sato and 
Webster, 2004).  
 
Figure 9.3 Macro- to nanostructures of bone (Sato and Webster, 2004) 
 
 Bone blood supply 9.1.2
Bone is highly vascularized with complex blood vessel networks as shown 
in Fig. 9.4. In tubular bones, for example, they have a dual blood supply 
(Buck and Dumanian, 2012). The predominant supply is the nutrient artery 
penetrating the diaphysis supplying the medullary cavity and providing 
nutrients to cells resided in the cortical bone through countless micro-
canals.  There are also numerous smaller metaphyseal and epiphyseal 
arteries that generally arise from the arteries that provide oxygen and 
nutrients to the cancellous bone and the adjacent joint and anastomose 
with the diaphyseal capillaries.  




Figure 9.4  Schematic view of blood supply to a long bone  
(Taken from: https://quizlet.com/20960701/bone-001-flash-cards/ )  
 
Bone with high metabolic activity relies on a branched blood vessel 
system with an optimal distance less than 200 μm (Rouwkema et al., 
2008, Novosel et al., 2011). Therefore, the construction of new bones by 
graft substitutes for reparative purposes relies on angiogenesis for the 
vascularisation within these new grafts to supply oxygen and nutrients. 
Skeletal development and repair can be considered as an angiogenic–
osteogenic coupling mechanism mediated by osteoblast lineage cells and 
endothelial cells (Maes and Clemens, 2014).  
Angiogenic phenomena are governed by many interacting signalling 
pathways, among which the vascular endothelial growth factor (VEGF) 
pathway is considered as the most crucial (Nomi et al., 2002). VEGF, a 
heparin-binding homodimeric glycoprotein of 45 kDa, is a potent mitogen 
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for macro- and microvascular endothelial cells and considered as a major 
regulator of neovascularization under physiological and pathological 
conditions (Ferrara and Davis-Smyth, 1997, Ferrara, 2004). It is widely 
expressed in different tissues by a variety of cell types including 
osteoblasts, in which the VEGF expression levels are influenced in 
response to a variety of extracellular stimuli (Spector et al., 2001). Fig. 9.5 
below represents the regulation of osteogenesis-angiogenesis coupling by 
VEGF. Mature osteoblasts located on the bone surface express VEGF, 
which is induced in response to extracellular stimuli such as hypoxia. 
VEGF acts through its receptors (VEGFR) on endothelial cells to induce 
angiogenesis and thus indirectly promote the supply of oxygen and 
nutrients required for osteogenesis. Increased vascularization also leads 
to a higher input of pre-osteoblasts and increased levels of osteogenic 
growth factors. In addition, it is also found that VEGF can affect 
osteogenesis directly as an autocrine regulator of osteoblastic 




259 | P a g e  
 
 
Figure 9.5 Schematic view of osteogenesis-angiogenesis coupling regulation by 
VEGF (Adapted from (Schipani et al., 2009, Ferrara and Davis-Smyth, 1997)) 
 
 Bone cells  9.1.3
There are three distinct types of bone cells: the matrix producing 
osteoblasts, tissue resorbing osteoclasts and osteocytes.  
Osteoblasts, responsible for the synthesis and secretion of bone matrix, 
are developed from pre-osteoblasts, which are generated from 
osteoprogenitor cells and, further from mesenchymal stem cells. Generally, 
osteoblasts are 10 - 20 μm in size with characteristic morphology of 
protein synthesizing cells, including abundant rough endoplasmic 
reticulum and prominent Golgi apparatus, as well as various secretory 
vesicles (Florencio-Silva et al., 2015). Thus, they can regulate the 
mineralization process, for instance, by synthesizing tightly packed 
collagen to provide lattices for the growth of hydroxyapatite crystals 
(Kirsch, 2012). Osteoblasts are rich in alkaline phosphatase (ALP), an 
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enzyme involved in calcification. They also secrete a number of proteins 
such as osteocalcin, osteopotin and bone sialoprotein linked to the 
mineralization and maturation of bone matrix (Florencio-Silva et al., 2015).  
Osteocytes are non-proliferative, terminally differentiated cells of the 
osteoblast lineage and reside within the bone matrix and in newly formed 
osteoid (Noble, 2008). They are smaller and less active than osteoblasts. 
Due to their distribution throughout the bone matrix and extensive 
interconnectivity, osteocytes probably sense bone deformation, regulate 
osteoclast and osteoblast functions through mechanosensor action and 
thereby signalling the need for adaptive remodelling of bone size, shape, 
and distribution to accommodate prevailing loads (Seeman and Delmas, 
2006, Bonewald and Johnson, 2008).  
Osteoclasts are derived from a monocyte lineage cells, which are formed 
in the bone marrow and attracted to bone surfaces to fuse and form 
multinucleated cells (20-100 μm) to complete bone resorption (Boyce, 
2013). The formation and functions of osteoclasts are centred on receptor 
activator of NF-κB ligand (RANKL) and macrophage-colony-stimulating 
factor (M-CSF), which are now considered to be the main cytokines that 
drive osteoclastogenesis and regulate osteoclastic bone resorption 
(Weitzmann, 2013, Boyce et al., 2012). RANKL, regulated by 
osteoprotegerin (OPG) from osteoblasts, belongs to the TNF super-family 
and, M-CSF is crucial for the proliferation, survival, and differentiation of 
osteoclast precursors, which are both produced mainly by marrow stromal 
cells and osteoblasts (Clarke, 2008). Besides the main function of bone 
resorption, osteoclasts also play other roles, such as, they can regulate 
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osteoblast precursors differentiation and, drive the hematopoietic stem 
cells move from the bone marrow to the bloodstream; they are also 
involved in immune responses including cytokine secretion to affect their 
own functions and other cells in inflammatory and neoplastic processes 
affecting bone (Boyce et al., 2009). 
 Bone matrix 9.1.4
Organic component: 
The organic matrix of bone, gives tensile strength, is secreted by 
osteoblasts and constitutes about 10% bone volume (Posner and Beebe, 
1975). It mainly consists of collagenous proteins (up to 85-90%), which 
are predominantly type I collagen and some type III and V collagens that 
may play roles in determining collagen fibril diameter at certain stages of 
bone formation (Clarke, 2008). The organic matrix also contains some 
non-collagenous proteins including proteoglycans, glycosylated proteins 
and other growth factors such as bone morphogenic proteins, osteocalcin, 
osteonectin, and bone sialoprotein, which contribute in bone 
mineralization, and remodelling (Buck and Dumanian, 2012). ALP, the 
main glycosylated protein in bone, is bound to osteoblast surfaces and 
also found free in mineralized matrix. It is considered to be involved in pre-
osteoblast differentiation and bone mineralization (Whyte, 1994).  
Inorganic component: 
The inorganic bone matrix, constitutes 90% of overall bone volume and is 
mainly composed by inorganic material (up to 90%). It gives stiffness to 
resist compression and, is considered to be the main mineral store in 
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humans and animals. Inorganic bone matrix contains 99% of the body’s 
calcium, 85% of the phosphorous and 40-60% of the magnesium and 
sodium (Buck and Dumanian, 2012). Hydroxyapatite [Ca10(PO4)6(OH)2] is 
the main component in  inorganic matrix, with small amounts of carbonate, 
magnesium and acid phosphate (Clarke, 2008). Bone hydroxyapatite is 
very small (200Å in dimension at most), poorly crystallized (more soluble 
than geologic hydroxyapatite crystals), which makes it reactive and allows 
to participate in metabolism (Clarke, 2008).  
 Bio-mineralization 9.1.5
Bio-mineralization is a cell-mediated process, through which living 
organisms use biomolecular pathways to control deposition of inorganic 
chemical compounds within and outside the cells (Kirsch, 2012).  
Bone matrix synthesis starts from the secretion of collagen proteins by 
osteoblasts, followed by matrix mineralization, which takes place in two 
phases: the vesicular and the fibrillary phases (Yoshiko et al., 2007). 
Matrix vesicles (MVs), small (20–200 nm) spherical bodies located in the 
pre-mineralized matrix of dentin, cartilage and bone, are considered as the 
initial site in bio-mineralization (Anderson, 2003). During the vesicular 
phase, calcium is absorbed into MVs via an annexin channel and 
phosphate enters through a type III Na+ dependent phosphate transporter 
to form apatite inside of MVs (Golub, 2009). Acidic phospholipids and 
other MV constituents are thought to regulate the nucleation of these 
nanocrystals. The fibrillary phase occurs when these apatite crystals grow, 
become bigger, protrude through the MV membrane and are finally 
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exposed to the extracellular environment, resulting in the further growth of 
these hydroxyapatite crystals (Florencio-Silva et al., 2015).   
 Bone remodelling 9.1.6
Bone remodelling is a dynamic process involving continuous removal of 
discrete packets of old bone, replacement of these packets with newly 
synthesized matrix, and subsequent mineralization of the matrix to form 
new bone (Kini and Nandeesh, 2012). It is dominated by osteoclasts and 
osteoblasts to maintain normal physiological structure and mineral content 
(Das and Crockett, 2013). The bone remodelling process is composed of 
four sequential phases, named osteoclast activation, bone resorption, 
reversal phase and new bone formation, in which the remodelling sites 
may develop randomly but also are targeted to areas that require repair 
(Clarke, 2008).  
Osteoclast activation involves recruitment and activation of mononuclear 
monocyte-macrophage osteoclast precursors from the circulation which 
fuse to form multi-nucleated osteoclasts. After binding to the bone matrix, 
these giant resorbing cells secrete hydrogen ions into the resorbing sites 
to lower the pH (as low as 4.5), which helps mobilize bone minerals (Silver 
et al., 1988). Some enzymes like tartrate-resistant acid phosphatase 
(TRAP) and matrix metalloproteinase 9 (MMP9) are secreted by activated 
osteoclasts to digest the organic matrix (Delaisse et al., 2003). Reversal 
phase follows the completion of bone resorption. Osteoblast precursors 
are recruited, proliferate and differentiate into mature osteoblasts. They 
synthesize new collagenous organic matrix and regulate mineralization of 
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matrix by releasing small, membrane-bound matrix vesicles that 
concentrate calcium and phosphate and enzymatically destroy 
mineralization inhibitors such as pyrophosphate or proteoglycans (Clarke, 
2008). Then, osteoblasts change into osteocytes as they are surrounded 
by (and buried within) matrix, which completes the bone remodelling cycle 
(Dobelin et al., 2010). Fig. 9.6 represents the bone remodelling process.  
 
Figure 9.6 Schematic representation of bone remodelling  
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9.2  Oral microorganism 
The oral cavity is a complex and dynamic ecosystem covered with 
epithelium, with grooves as well as hollows in the teeth and around the 
gingival margin, these sites promote the development of microorganisms 
(Struzycka, 2014). Commonly known as ‘dental plaque’, oral microbial 
communities colonizing the oral hard and soft tissues profoundly affect 
oral health. In the periodontal pocket, over 400 bacteria species have 
been identified, demonstrating diversity and complexity (Paster et al., 
2006). Extensive clinical research and animal studies have demonstrated 
that the oral microbial flora is responsible for two major human oral 
diseases: dental caries and gum disease (He and Shi, 2009). The cause 
of dental caries is usually the supra-gingival microbiome dominated by 
Gram-positive aerobic bacteria, such as Streptococcus sanguinis, 
Streptococcus mutans, Streptococcus mitis, Streptococcus salivarius, and 
lactobacilli, while the sub-gingival microbiome associated with gingivitis 
and periodontal disease is made up primarily by Gram-negative anaerobic 
bacteria, such as Aggregatibacter (Actinobacillus) 
actinomycetemcomitans, Fusobacterium nucleatum and Porphyromonas 
gingivalis (He and Shi, 2009) .  
An oral microbial biofilm, also known as dental plaque, is a group of 
microorganisms on the surfaces between the teeth and along the gingival 
margins. It initiates and develops in three main steps as represented in 
Fig. 9.10 below: attachment and colonization of the pioneer bacterial 
species, co-adhesion and co-aggregation of other microorganism species, 
followed by the biofilm development including the metabolic 
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communication and competitive interactions among microorganisms, and 
most noticeable, the production and accumulation of deleterious bacterial 
metabolites such as extracellular polysaccharides to influence the host. In 
addition, the matured biofilm may function as a barrier against antibiotics 
(Struzycka, 2014, Hojo et al., 2009).  
 
Figure 9.7 A diagrammatic representation of biofilm formation on the tooth surface 
(Hojo et al., 2009) 
Streptococcus mitis (S. mitis) is a Gram-positive bacteria species that 
predominantly colonizes human oral teeth, tongue, cheeks and 
subgingival sites. More importantly, it is considered to be a representative 
‘pioneer colonizer’ of oral cavity (Nagayama et al., 2001). During the 
formation and development of the bacterial biofilm, the initial attachment is 
critical since all other bacteria species (especially pathogenic species) rely 
on the initial colonizers as the base structure of the biofilm to adhere. 
Therefore, S. mitis plays an important role in the establishment of dental 
plaque (Wang et al., 2015, Nagayama et al., 2001). Song et al. observed 
that S. mitis enhanced the adhesion and biofilm formation of pathogenic 
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species pseudomonas aeruginosa (Song et al., 2015). A wide range of 
strategies have been used by S. mitis to effectively colonize the human 
cavity, including the expression of adhesins, immunoglobulin A proteases 
and toxins, and modulation of the host immune system (Mitchell, 2011). 
Furthermore, in vulnerable immune-compromised patients, S. mitis may 
use the same colonization and immune modulation factors as virulence 
factors promoting its opportunistic pathogenesis. Shelburne et al. reported 
that S. mitis caused a disproportionate percentage of serious infections in 
cancer patients (Shelburne et al., 2014). Thus, S. mitis is also considered 
as an infrequent opportunistic pathogen in healthy infants and adults 
implicated in a variety of diseases from dental caries, to bacterial infective 
endocarditis, bacteraemia, meningitis, eye infections and pneumonia. 
However, very little is understood about how exactly it causes these 
various diseases (Mitchell, 2011). Therefore, the role of traditionally 
viewed non-pathogenic bacteria S. mitis in biofilms should not be ignored.   
Dental caries, a multifactorial disease that induces demineralization and 
destruction of the teeth, is determined by the coexistence of three main 
factors: microorganisms, carbohydrates derived from the dietary, and host 
immune system (Struzycka, 2014). When cariogenic microorganisms 
accumulate in dental plaque and ferment dietary carbohydrates over 
sufficient time, their metabolism products such as lactic, formic, acetic and 
propionic acids will locally decrease pH level below 5.5, resulting in 
demineralization and proteolytic breakdown of teeth. (Simon-Soro et al., 
2013, Struzycka, 2014). Dental caries progress can also affect the tooth 
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pulp and spreads to the periodontal tissues and even the jaws 
(Featherstone, 2004).  
Historically, Lactobacilli are the first microorganisms implicated in dental 
caries development although they comprise only a small percentage (<1%) 
of the human normal oral microbial flora. A strong correlation has been 
established between saliva Lactobacillus count and the presence of 
carious decay. In addition, Lactobacilli are found in root caries especially 
in deep dentinal caries associated with pulpitis (Badet and Thebaud, 2008, 
Byun et al., 2004, Michalek et al., 1981, Piwat et al., 2015). Lactobacillus 
casei (L. casei), one of the bacteria species belonging in the genus 
Lactobacilli, is a Gram-positive, rod shaped, facultative anaerobic non-
spore-forming and catalase-negative bacteria (Teanpaisan et al., 2011). L. 
casei resides in the human oral cavity, intestinal tracts and reproductive 
systems, and also naturally found in various environments such as raw 
and fermented dairy products. The effects of L. casei, however, are 
disputed. Commercially, it can serve as probiotics to promote and support 
a beneficial balance of microorganisms living in the human gastrointestinal 
tract (Probiotic, 2010). In addition, Teanpaisan et al. reported that L. casei 
was able to inhibit the growth of both periodontitis- and caries-related 
pathogens (Teanpaisan et al., 2011). However, in numerous antibacterial 
studies, L. casei is considered as dental cariogenic bacteria species (Da 
Silva et al., 2012, Korkmaz et al., 2013, Pupo et al., 2014, Zhang et al., 
2014). By using real-time PCR, Byun et al. demonstrated that L. casei was 
the most prevalent species of lactobacilli in carious dentine samples (Byun 
et al., 2004) 
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Periodontal disease has been recognized as one of the most common 
bacterially induced inflammatory diseases resulting in the destruction of 
the periodontal tissues, leading to oral alveolar bone and tooth loss 
(Bostanci and Belibasakis, 2012). Among the factors that contribute to 
periodontal disease, bacteria are essential and the major pathogens have 
been identified, however, host factors such as oral hygiene together with 
environmental factors such as smoking also play important roles to 
regulate the disease occurrence and severity (Page et al., 1997).  
For the treatment of periodontitis induced tooth loss, dental implants have 
become a highly successful and routine procedure. However, early 
failures caused by bacterial infection and late plaque-induced peri-
implantitis are still observed clinically (Norowski and Bumgardner, 2009). 
Peri-implantitis is a periodontitis-like process, since untreated periodontitis 
can result in the loss of natural teeth, while peri-implantitis may ultimately 
lead to the dental implants loss (Meffert, 1996, Pye et al., 2009, Quirynen 
et al., 2002). Substantial evidence indicates that bacterial plaque is the 
primary etiologic factor to stimulate the host immune responses and 
induce the production of pro-inflammatory cytokines, resulting in the loss 
of both teeth and implants. In addition, pathogens associated with 
periodontal disease have also been associated with dental implant and 
defect repair failure (van Winkelhoff et al., 2000). Furthermore, active 
periodontitis also has been linked to increased morbidity of certain 
systemic conditions including cardiovascular disease, preeclampsia, low 
birth weight and rheumatoid arthritis (Moreno and Contreras, 2013, Tribble 
et al., 2013, Atanasova and Yilmaz, 2014).  
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A strong correlation has been established between Porphyromonas 
gingivalis (P. gingivalis) and periodontal disease activity in adults (Duncan, 
2003). As a keystone pathogen for periodontitis, this Gram-negative 
anaerobe species is a late colonizer in bacterial plaque, however, it can 
rapidly and actively invade gingival sulcus epithelial cells, and potentially 
the underlying soft and hard tissues. Firstly, P. gingivalis can survive, 
replicate and disseminate from cell to cell through actin cytoskeleton 
bridges, and affect cell-cycle pathways after intracellular invasion 
(Bostanci and Belibasakis, 2012). There are four main virulence factors in 
P. gingivalis including lipopolysaccharide (LPS), capsular polysaccharide 
(CPS), fimbriae and gingipains, which contribute to P. gingivalis 
colonization, invasion, establishment, and persistence within the host, 
induce pro-inflammatory cytokines evasion by destructing host immune 
system mechanisms and damage to protective periodontal tissues 
(Bostanci and Belibasakis, 2012, Moreno and Contreras, 2013, Mysak et 
al., 2014). Secondly, after invading the protective barrier gingival epithelial 
cells, P. gingivalis blocks the epithelial cell interleukin-8 (IL-8) response to 
other oral bacteria, suggesting that the host may not detect the presence 
of local bacterial colonization and cannot direct leukocytes to remove them 
(Darveau, 2009), resulting in the rapid establishment and growth of other 
species found in subgingival biofilms. These properties may be among the 
reasons that P. gingivalis is so frequently associated with active tissue 
destruction (Page et al., 1997). In addition, it is also found that the 
destructed tissue can release peptides and heme-containing compounds, 
which in turn stimulate the growth of P. gingivalis (Hajishengallis and 
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Lamont, 2014). The clinical attachment loss and ongoing periodontal 
inflammation generates a periodontal pocket, which is deep, protected 
from disturbance and, more likely to be anaerobic, and has a stable, 
slightly alkaline pH, providing ideal conditions for P. gingivalis propagation 
(Tribble et al., 2013). An in vitro study demonstrated that P. gingivalis 
inhibited the migration of oral epithelial cells and this may be involved in 
delayed wound healing (Laheij et al., 2013).  
Localized, aggressive periodontitis occurs in a severe and rapidly 
progressing form and most often affects young adults aged 25-30 years 
old. It particularly affects first molars and incisors (Brigido et al., 2014).  
Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), 
previously known as Actinobacillus actinomycetemcomitans, has been 
frequently associated with the initiation and progression of aggressive 
periodontitis from longitudinal studies of both humans and animals (Fine et 
al., 2010). It is found in 90% of localised aggressive periodontitis and 30-
50% of severe adult periodontitis (Raja et al., 2014). A. 
actinomycetemcomitans is a Gram-negative, non-motile, facultative 
anaerobic coccobacillus bacterium and considered as an early colonizer of 
the human oral cavity. It may use buccal cells as a reservoir for initial 
attachment and eventual movement to non-shedding tooth surfaces (Fine 
et al., 2010).  
A. actinomycetemcomitans produces a variety of virulence factors to 
modulate the host immune system, induce tissue destruction and inhibit 
tissue repair. Firstly, surface proteins such as adhesins and invasins, 
promote colonization by binding with specific receptors in the saliva, tooth, 
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extra cellular matrix and epithelial cells. The surface ultrastructure entities 
of A. actinomycetemcomitans including extracellular amorphous material 
and vesicles mediate the aggregation. In addition, the bacterium fimbriae 
enhances adhesion by three to four fold (Raja et al., 2014). Secondly, A. 
actinomyctemcomitans produces two important exotoxins named 
cytolethal distending toxin (CDT) and leukotoxin. CDT is demonstrated to 
cause death of the host tissues by blocking cell proliferation (Johansson, 
2011). While leukotoxin activates the immune cells in the periodontal 
pocket and the surrounding tissues (Haubek and Johansson, 2014), it 
selectively causes the death of cells of hematopoietic origin, by binding to 
the specific target cell receptor named lymphocyte function associated 
receptor 1 (LFA-1), which is only expressed on leukocytes. In the 
monocytes and macrophages, leukotoxin activates caspase-1, a cysteine 
proteinase that causes a pro-inflammatory response by activating and 
secreting IL-1β and IL-18. This results in an imbalance of the host 
response and promotes the degenerative processes in the tooth-
supporting tissues (Johansson, 2011). In addition, leukotoxin is 
demonstrated to induce a substantial pro-inflammatory effect in human 
endothelial cells (Haubek and Johansson, 2014). Taken together, the 
mechanisms by which leukotoxin kills leukocytes and promotes 
inflammatory responses are closely related to the pathogenic mechanisms 
of periodontitis. A. actinomyctemcomitans also can produce 
lipopolysaccharide (LPS) to induce the expression of membrane IL-1 in 
macrophages, enabling them to promote bone resorption in vitro 
(Henderson et al., 2003). In addition, A. actinomyctemcomitans has been 
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reported to produce a number of, as yet unidentified,  proteins with cell 
cycle-inhibitory activity to cause T cell apoptosis and to inhibit osteoblast 
proliferation and bone collagen synthesis (Raja et al., 2014, Fives-Taylor 
et al., 1999).  
Therefore, during the periodontal defect regeneration, therapeutic 
strategies targeting the elimination of plaque pioneer colonizer S. mitis, 
cariogenic microorganism L. casei and periodontal disease pathogens 
including P. gingivalis and A. actinomyctemcomitans should be considered, 
to maintain tissue of oral cavity and to reduce incidence of systemic 
conditions. 
 
